Processing 00000000.tx.1: Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy David T. 

Phrase: "Alterations in mitochondrial function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   737   C1515926:Alteration [Idea or Concept]

Phrase: "in a mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "of hypertrophic cardiomyopathy David T."
Processing 00000000.tx.2: Lucas1, Prafulla Aryal1, Luke I. 

Phrase: "Lucas1,"

Phrase: "Prafulla Aryal1,"

Phrase: "Luke I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.3: Szweda2, Walter J. 

Phrase: "Szweda2,"

Phrase: "Walter J."
Processing 00000000.tx.4: Koch3, and Leslie A. 

Phrase: "Koch3,"

Phrase: "and"

Phrase: "Leslie A."
Processing 00000000.tx.5: Leinwand1 1Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado 80309; 

Phrase: "Leinwand1 1Department of Molecular, Cellular,"

Phrase: "and"

Phrase: "Developmental Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0011756:Developmental Biology [Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "University of Colorado,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0009399:Colorado [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Boulder,"

Phrase: "Colorado 80309"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009399:Colorado [Geographic Area]

Phrase: ";"
Processing 00000000.tx.6: 2Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio 44106; 

Phrase: "2Department of Physiology"

Phrase: "and"

Phrase: "Biophysics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005553:Biophysics [Biomedical Occupation or Discipline]

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio 44106"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028905:Ohio [Geographic Area]

Phrase: ";"
Processing 00000000.tx.7: 3Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Familial hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease characterized by varying degrees of ventricular hypertrophy and myofibrillar disarray. 

Phrase: "3Department of Surgery,"

Phrase: "Duke University Medical Center,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0041740:University [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]
   812   C1446468:Duke [Laboratory Procedure]

Phrase: "Durham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454851:Durham [Geographic Area]

Phrase: "North Carolina 27710  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Familial hypertrophic cardiomyopathy (HCM)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0949658:Cardiomyopathy, Hypertrophic, Familial [Disease or Syndrome]
   913   C0264789:Familial cardiomyopathy [Disease or Syndrome]
   901   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0020564:Hypertrophic [Pathologic Function]
   827   C0241888:Familial [Functional Concept]
   827   C0333959:Hypertrophic [Functional Concept]
   827   C0878544:Cardiomyopathy [Disease or Syndrome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "is"

Phrase: "an autosomal dominant disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   734   C0443147:Autosomal dominant [Intellectual Product]

Phrase: "characterized by varying degrees of ventricular hypertrophy"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0340279:Ventricular hypertrophy [Disease or Syndrome]
   778   C2911650:VENTRICULAR HYPERTROPHY [Finding]
   748   C0018827:Ventricular [Body Part, Organ, or Organ Component]
   748   C0020564:Hypertrophy [Pathologic Function]
   748   C0449286:degrees [Quantitative Concept]
   748   C0542560:degrees [Intellectual Product]
   748   C1522565:Ventricular [Spatial Concept]
   748   C1880022:Characterized [Activity]
   714 E C0441889:Degree [Qualitative Concept]
   714 E C1561545:degree [Quantitative Concept]
   714 E C2348088:Degree [Quantitative Concept]

Phrase: "and"

Phrase: "myofibrillar disarray."
Processing 00000000.tx.8: Mutations in cardiac contractile proteins cause HCM. 

Phrase: "Mutations in cardiac contractile proteins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "HCM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   861   C0020564:Hypertrophic [Pathologic Function]
   861   C0333959:Hypertrophic [Functional Concept]
   861   C0878544:Cardiomyopathy [Disease or Syndrome]
Processing 00000000.tx.9: However, there is an unexplained wide variability in the clinical phenotype, and it is likely that there are multiple contributing factors. 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "an unexplained wide variability in the clinical phenotype,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   789   C1862371:Wide clinical variability [Finding]
   769   C1834667:Variable clinical phenotype [Finding]
   767   C1842176:Clinical variability [Finding]
   744   C2827666:Variability [Conceptual Entity]
   731   C1837514:Variable phenotype [Finding]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that there"

Phrase: "are"

Phrase: "multiple contributing factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.10: Because mitochondrial dysfunction has been described in heart disease, we tested the hypothesis that mitochondrial dysfunction contributes to the varying HCM phenotypes. 

Phrase: "Because"

Phrase: "mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "has"

Phrase: "been"

Phrase: "described in heart disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0018799:Heart disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0018787:Heart [Body Part, Organ, or Organ Component]
   770   C1281570:Heart [Body Part, Organ, or Organ Component]
   770   C1552738:described [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "contributes to the varying HCM phenotypes."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   748   C0020564:Hypertrophic [Pathologic Function]
   748   C0031437:Phenotypes [Organism Attribute]
   748   C0333959:Hypertrophic [Functional Concept]
   748   C0878544:Cardiomyopathy [Disease or Syndrome]
   748   C1880177:Contribute [Activity]
   714 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.11: Mitochondrial function was assessed in two transgenic models of HCM: mice with a mutant myosin heavy chain gene (MyHC) or with a mutant cardiac troponin T (R92Q) gene. 

Phrase: "Mitochondrial function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "was"

Phrase: "assessed in two transgenic models of HCM"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   754   C1519606:Transgenic Model [Experimental Model of Disease]
   744   C0003069:Transgenic [Animal]
   744   C0020564:Hypertrophic [Pathologic Function]
   744   C0205448:Two [Quantitative Concept]
   744   C0333959:Hypertrophic [Functional Concept]
   744   C0878544:Cardiomyopathy [Disease or Syndrome]
   744   C1516048:Assessed [Activity]
   744   C3161035:Models [Intellectual Product]

Phrase: ":"

Phrase: "mice with a mutant myosin heavy chain gene (MyHC)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1417166:MICE gene [Gene or Genome]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "or with a mutant cardiac troponin T"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1096316:cardiac troponin [Laboratory Procedure]
   778   C1420827:TROPONIN T [Gene or Genome]
   748   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   748   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1522601:Cardiac [Spatial Concept]

Phrase: "(R92Q"

Phrase: ")"

Phrase: "gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.12: Despite mitochondrial ultrastructural abnormalities in both models, the rate of state 3respiration was significantly decreased only in the mutant MyHC mice by ~23%. 

Phrase: "Despite mitochondrial ultrastructural abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "in both models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "the rate of state 3respiration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "only in the mutant MyHC mice"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1420192:heavy chain [Gene or Genome]
   762   C0678941:Gene Mutant [Gene or Genome]
   762   C1417166:MICE gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205171:Only [Quantitative Concept]
   742   C0337112:Chain [Manufactured Object]
   742   C0439539:Heavy [Qualitative Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1524075:Chain [Idea or Concept]
   742   C1720467:Only [Intellectual Product]

Phrase: "by ~23%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.13: Notably, this decrease in state 3respiration preceded hemodynamic dysfunction. 

Phrase: "Notably,"

Phrase: "this decrease in state 3respiration"

Phrase: "preceded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:preceded [Temporal Concept]

Phrase: "hemodynamic dysfunction."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.14: The maximum activity of -ketogutarate dehydrogenase as assayed in isolated disrupted mitochondria was decreased by 28% compared with isolated control mitochondria. 

Phrase: "The maximum activity of -ketogutarate dehydrogenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "assayed in isolated disrupted mitochondria"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0026237:Mitochondria [Cell Component]
   760   C0205409:Isolated [Functional Concept]
   760   C0332454:Disrupted [Qualitative Concept]
   760   C1548221:Isolated [Idea or Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "decreased by 28%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared with isolated control mitochondria."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0026237:Mitochondria [Cell Component]
   760   C0205409:Isolated [Functional Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.15: In addition, complexes I and IV were decreased in mutant MyHC transgenic mice. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "complexes I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IV"

Phrase: "were"

Phrase: "decreased in mutant MyHC transgenic mice."
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   790   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0025936:Mice, Transgenic [Mammal]
   764   C1420192:heavy chain [Gene or Genome]
   762   C0678941:Gene Mutant [Gene or Genome]
   762   C1417166:MICE gene [Gene or Genome]
   742   C0003069:Transgenic [Animal]
   742   C0017337:Gene [Gene or Genome]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0337112:Chain [Manufactured Object]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0439539:Heavy [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1524075:Chain [Idea or Concept]
   708 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.16: Inhibition of -adrenergic receptor kinase, which is elevated in mutant MyHC mouse hearts, can prevent mitochondrial respiratory impairment in mutant MyHC mice. 

Phrase: "Inhibition of -adrenergic receptor kinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "is"

Phrase: "elevated in mutant MyHC mouse hearts,"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   790   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1420192:heavy chain [Gene or Genome]
   762   C0678941:Gene Mutant [Gene or Genome]
   748   C1512359:Mouse Heart [Tissue]
   742   C0017337:Gene [Gene or Genome]
   742   C0018787:Hearts [Body Part, Organ, or Organ Component]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205250:Elevated [Qualitative Concept]
   742   C0337112:Chain [Manufactured Object]
   742   C0439539:Heavy [Qualitative Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1524075:Chain [Idea or Concept]
   742   C3163633:Elevated [Qualitative Concept]
   708 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "can"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "mitochondrial respiratory impairment in mutant MyHC mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.17: Thus our results suggest that mitochondria may contribute to the hemodynamic dysfunction seen in some forms of HCM and offer a plausible mechanism responsible for some of the heterogeneity of the disease phenotypes. mitochondria; 

Phrase: "Thus"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "may"

Phrase: "contribute to the hemodynamic dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0019010:Hemodynamic [Organ or Tissue Function]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   760   C1880177:Contribute [Activity]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "seen in some"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "forms of HCM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   770   C0020564:Hypertrophic [Pathologic Function]
   770   C0333959:Hypertrophic [Functional Concept]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C0878544:Cardiomyopathy [Disease or Syndrome]
   770   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "offer"

Phrase: "a plausible mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for some of the heterogeneity of the disease phenotypes. mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1273518:Responsible [Finding]

Phrase: ";"
Processing 00000000.tx.18: transgenic  INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES FAMILIAL HYPERTROPHIC CARDIOMYOPATHY (HCM) is an autosomal dominant disease characterized by varying degrees of ventricular hypertrophy and myofibrillar disarray. 

Phrase: "transgenic  INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "FAMILIAL HYPERTROPHIC CARDIOMYOPATHY"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0949658:Cardiomyopathy, Hypertrophic, Familial [Disease or Syndrome]
   913   C0264789:Familial cardiomyopathy [Disease or Syndrome]
   901   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0020564:Hypertrophic [Pathologic Function]
   827   C0241888:Familial [Functional Concept]
   827   C0333959:Hypertrophic [Functional Concept]
   827   C0878544:Cardiomyopathy [Disease or Syndrome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "(HCM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   861   C0020564:Hypertrophic [Pathologic Function]
   861   C0333959:Hypertrophic [Functional Concept]
   861   C0878544:Cardiomyopathy [Disease or Syndrome]

Phrase: ")"

Phrase: "is"

Phrase: "an autosomal dominant disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   734   C0443147:Autosomal dominant [Intellectual Product]

Phrase: "characterized by varying degrees of ventricular hypertrophy"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0340279:Ventricular hypertrophy [Disease or Syndrome]
   778   C2911650:VENTRICULAR HYPERTROPHY [Finding]
   748   C0018827:Ventricular [Body Part, Organ, or Organ Component]
   748   C0020564:Hypertrophy [Pathologic Function]
   748   C0449286:degrees [Quantitative Concept]
   748   C0542560:degrees [Intellectual Product]
   748   C1522565:Ventricular [Spatial Concept]
   748   C1880022:Characterized [Activity]
   714 E C0441889:Degree [Qualitative Concept]
   714 E C1561545:degree [Quantitative Concept]
   714 E C2348088:Degree [Quantitative Concept]

Phrase: "and"

Phrase: "myofibrillar disarray."
Processing 00000000.tx.19: The vast majority of mutations in HCM thus far identified occur in genes encoding sarcomeric proteins, including -myosin heavy chain (MyHC), myosin light chains, -cardiac actin, -tropomyosin, cardiac troponin T (cTnT), cTnI, and cardiac myosin-binding protein C (41, 42, 45). 

Phrase: "The vast majority of mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "in HCM thus far"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   812   C0020564:Hypertrophic [Pathologic Function]
   812   C0205108:far [Spatial Concept]
   812   C0333959:Hypertrophic [Functional Concept]
   812   C0878544:Cardiomyopathy [Disease or Syndrome]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "occur in genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017337:Genes [Gene or Genome]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "sarcomeric proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "myosin heavy chain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420192:heavy chain [Gene or Genome]
   827   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0337112:Chain [Manufactured Object]
   827   C0439539:Heavy [Qualitative Concept]
   827   C1524075:Chain [Idea or Concept]

Phrase: "(MyHC"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420192:heavy chain [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C0439539:Heavy [Qualitative Concept]
   812   C1524075:Chain [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "myosin light chains, -"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027108:Myosin Light Chains [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0337112:chains [Manufactured Object]
   827   C1306462:Light [Functional Concept]
   827   C1524075:Chains [Idea or Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "cardiac actin, -"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "tropomyosin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041197:Tropomyosin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cardiac troponin T (cTnT),"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1096316:cardiac troponin [Laboratory Procedure]
   901   C1420827:TROPONIN T [Gene or Genome]
   827   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   827   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1522601:Cardiac [Spatial Concept]

Phrase: "cTnI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1305957:cTnI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3538828:cTnI [Gene or Genome]

Phrase: "and"

Phrase: "cardiac myosin-binding protein C"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
  1000   C1417523:MYOSIN-BINDING PROTEIN C, CARDIAC [Gene or Genome]
   937   C0213150:myosin-binding protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0949656:Cardiac Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1149266:myosin binding [Molecular Function]
   840   C1168438:Protein C [Laboratory Procedure]
   840   C1418943:PROTEIN C [Gene or Genome]
   840   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   804   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1522601:Cardiac [Spatial Concept]

Phrase: "(41,"

Phrase: "42,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.20: In addition to being genetically diverse, the disease is also clinically heterogeneous. 

Phrase: "In addition to"

Phrase: "being"

Phrase: "genetically diverse,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0042333:Genetic Diversity [Natural Phenomenon or Process]
   861   C1880371:Diverse [Qualitative Concept]

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "also clinically heterogeneous."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019409:Heterogeneous [Qualitative Concept]
Processing 00000000.tx.21: For example, mutations in the MyHC gene result in generally uniform hypertrophy, hemodynamic dysfunction, and variable sudden death. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "mutations in the MyHC gene result"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0596611:gene mutations [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in generally uniform hypertrophy,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0020564:Hypertrophy [Pathologic Function]
   755 E C0333959:Hypertrophic [Functional Concept]

Phrase: "hemodynamic dysfunction,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "variable sudden death."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0011071:Sudden death [Pathologic Function]
   901   C0085298:Sudden death NOS [Pathologic Function]
   901   C1964022:Sudden death [Finding]
   827   C0011065:Death [Organism Function]
   827   C1276802:Sudden [Qualitative Concept]
   827   C1306577:Death, NOS [Finding]
Processing 00000000.tx.22: On the contrary, mutations in cTnT display moderate or no hypertrophy and a high incidence of sudden death (45). 

Phrase: "On the contrary,"

Phrase: "mutations in cTnT"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "moderate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]

Phrase: "or"

Phrase: "no hypertrophy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020564:Hypertrophy [Pathologic Function]
   928 E C0333959:Hypertrophic [Functional Concept]

Phrase: "and"

Phrase: "a high incidence of sudden death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021149:Incidence [Quantitative Concept]
   753   C0220856:incidence [Functional Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.23: Thus, although it is clear that mutations in cardiac contractile proteins result in HCM, the underlying mechanisms responsible for the wide variability in phenotype have not been determined. 

Phrase: "Thus,"

Phrase: "although"

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that mutations in cardiac contractile proteins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "result in HCM,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   770   C0020564:Hypertrophic [Pathologic Function]
   770   C0333959:Hypertrophic [Functional Concept]
   770   C0878544:Cardiomyopathy [Disease or Syndrome]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "the underlying mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for the wide variability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "determined."
Processing 00000000.tx.24: Undoubtedly, in addition to the primary mutation, many secondary and tertiary responses contribute to the disease phenotypes of HCM. 

Phrase: "Undoubtedly,"

Phrase: "in addition to the primary mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "many secondary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027627:secondary [Neoplastic Process]
  1000   C0175668:Secondary [Temporal Concept]
  1000   C0205436:Secondary [Quantitative Concept]

Phrase: "and"

Phrase: "tertiary responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "contribute to the disease phenotypes of HCM."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0020564:Hypertrophic [Pathologic Function]
   744   C0031437:Phenotypes [Organism Attribute]
   744   C0333959:Hypertrophic [Functional Concept]
   744   C0878544:Cardiomyopathy [Disease or Syndrome]
   744   C1880177:Contribute [Activity]
   711 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.25: One candidate might be cardiac mitochondria. 

Phrase: "One candidate"

Phrase: "might"

Phrase: "be"

Phrase: "cardiac mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.26: Mitochondria, which occupy a large portion of the myocyte volume, play a critical role in the constant supply of energy to the heart. 

Phrase: "Mitochondria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "which"

Phrase: "occupy"

Phrase: "a large portion of the myocyte volume,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449719:Portion [Spatial Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in the constant supply of energy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "to the heart."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]
Processing 00000000.tx.27: In fact, increasing evidence suggests that mitochondria could play an important role in the pathogenesis of heart disease (18, 33, 37, 44). 

Phrase: "In fact,"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "could"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the pathogenesis of heart disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "(18,"

Phrase: "33,"

Phrase: "37,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.28: Ide et al. 

Phrase: "Ide et al."
Processing 00000000.tx.29: (18) reported that mitochondria exhibit respiratory dysfunction in a rapid pacing model of heart failure. 

Phrase: "(18"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "respiratory dysfunction in a rapid pacing model of heart failure."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1260922:RESPIRATORY DYSFUNCTION NOS [Sign or Symptom]
   757   C0340515:dysfunction heart [Pathologic Function]
   739   C0031847:dysfunction [Functional Concept]
   739   C0277785:Dysfunction, NOS [Qualitative Concept]
Processing 00000000.tx.30: Abnormalities in mitochondrial respiration in patients with heart failure have been reported and attributed to decreases in the rates of NADH-ubiquinol oxidoreductase (complex I) and cytochrome c oxidase (complex IV) activities of the electron transport chain (1, 2, 46). 

Phrase: "Abnormalities in mitochondrial respiration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   777   C1260922:abnormal respiration [Sign or Symptom]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with heart failure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0018801:Heart failure [Disease or Syndrome]
  1000   C0018802:Heart Failure [Disease or Syndrome]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "attributed to decreases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0547047:decreases [Quantitative Concept]
   756 E C0392756:Decrease [Qualitative Concept]
   756   C0449234:Attribute [Idea or Concept]
   756   C1704772:Attribute [Conceptual Entity]
   756   C1882133:Attribute [Qualitative Concept]

Phrase: "in the rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]

Phrase: "of NADH-ubiquinol oxidoreductase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0682753:NADH oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030016:Oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1537381:oxidoreductase [Gene or Genome]

Phrase: "(complex I)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "cytochrome c oxidase"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0010760:CYTOCHROME C OXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
           Cytochrome Oxidase
   901   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   901   C1153524:cytochrome c [Molecular Function]
   901   C1426584:CYTOCHROME C [Gene or Genome]
   827   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325304:cytochrome [Molecular Function]

Phrase: "(complex IV) activities of the electron transport chain"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0441655:Activities [Activity]
   725   C0005529:Active Transport [Physiologic Function]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.31: The majority of research investigating the mechanisms responsible for mitochondrial dysfunction in heart failure has focussed on electron transport chain components. 

Phrase: "The majority of research"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "investigating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigating [Functional Concept]

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for mitochondrial dysfunction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in heart failure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0018801:Heart failure [Disease or Syndrome]
  1000   C0018802:Heart Failure [Disease or Syndrome]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "focussed on electron transport chain components."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C2244392:electron transport chain [Molecular Function]
   790   C0013846:Electron Transport [Molecular Function]
   753   C0005528:Transport, NOS [Cell Function]
   753   C0013852:Electron [Quantitative Concept]
   753   C0337112:Chain [Manufactured Object]
   753   C0449432:Components [Manufactured Object]
   753   C1317949:Transport [Manufactured Object]
   753   C1524075:Chain [Idea or Concept]
   753   C3463986:Electron [Bird]
   753   C3495449:transport [Medical Device]
   719   C0205234:Focus [Spatial Concept]
   719   C1285542:focus [Functional Concept]
   719 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.32: However, it is widely believed that the supply of NADH to the electron transport chain is the rate-limiting step of NADH-linked mitochondrial respiration (3, 5, 16, 10, 29). 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "widely"

Phrase: "believed"

Phrase: "that"

Phrase: "the supply of NADH"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243163:supply [Idea or Concept]
   770   C0699914:supply [Quantitative Concept]
   770   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   770   C1561604:supply [Functional Concept]
   770   C1875802:SUPPLY [Medical Device]
   770   C1999230:Supply [Activity]

Phrase: "to the electron transport chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]

Phrase: "is"

Phrase: "the rate-limiting step of NADH-linked mitochondrial respiration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1261552:Step [Conceptual Entity]
   742   C1704379:Step [Functional Concept]
   742   C1705117:Step [Quantitative Concept]
   742   C2825408:Step [Manufactured Object]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "16,"

Phrase: "10,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.33: Alterations in the rate of NADH synthesis and delivery to the electron transport chain would therefore likely have profound effects on respiratory activity. 

Phrase: "Alterations in the rate of NADH synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "delivery to the electron transport chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011209:Delivery [Therapeutic or Preventive Procedure]
   753   C0559563:delivery [Finding]
   753   C1705822:Delivery [Activity]

Phrase: "would"

Phrase: "therefore likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "profound effects on respiratory activity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.34: Inhibition of -ketoglutarate dehydrogenase (-KGDH), a tricarboxylic acid cycle intermediate, has been reported to have detrimental effects on mitochondrial respiration in various diseases such as cardiac ischemia-reperfusion injury, Alzheimer's disease, and Parkinson's disease (19, 21, 28, 25). 

Phrase: "Inhibition of -ketoglutarate dehydrogenase (-KGDH),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a tricarboxylic acid cycle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]

Phrase: "intermediate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "detrimental effects on mitochondrial respiration"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in various diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "such as cardiac ischemia-reperfusion injury,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C0035126:Ischemia-Reperfusion Injury [Injury or Poisoning]
           Reperfusion Injury
   887 E C0349419:Ischaemic reperfusion injury [Injury or Poisoning]
   812   C3263722:Injury [Injury or Poisoning]
   812   C3263723:Injury [Injury or Poisoning]

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(19,"

Phrase: "21,"

Phrase: "28,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.35: In addition, unlike mitochondrial electron transport chain components, inactivation of -KGDH has been shown to directly correlate with a decrease in state 3(ADP dependent) respiration (17). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "unlike mitochondrial electron transport chain components,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0449432:Components [Manufactured Object]
   771   C1325653:Mitochondrial electron transport chain [Cell Component]
   771 E C1705248:Component [Conceptual Entity]
   717   C1752477:mitochondrial electron transport [Molecular Function]
   717   C2244392:electron transport chain [Molecular Function]

Phrase: "inactivation of -KGDH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "correlate with a decrease in state 3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]

Phrase: "(ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: ")"

Phrase: "respiration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035203:Respiration [Physiologic Function]
  1000   C0282636:respiration [Cell Function]
  1000   C1160636:respiration [Biologic Function]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.36: Therefore, inhibition of -KGDH as a likely mediator of mitochondrial dysfunction and contributor to the pathogenesis of HCM should be investigated. 

Phrase: "Therefore,"

Phrase: "inhibition of -KGDH as a likely mediator of mitochondrial dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "contributor to the pathogenesis of HCM"

Phrase: "should"

Phrase: "be"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.37: Transgenic mouse models of HCM caused by cardiac-specific mutations in MyHC and cTnT have been made (13, 38, 40, 43). 

Phrase: "Transgenic mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mouse, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "models of HCM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   770   C0020564:Hypertrophic [Pathologic Function]
   770   C0333959:Hypertrophic [Functional Concept]
   770   C0878544:Cardiomyopathy [Disease or Syndrome]
   770   C3161035:Model [Intellectual Product]

Phrase: "caused by cardiac-specific mutations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   760   C0026882:Mutations [Genetic Function]
   760   C0205369:Specific [Qualitative Concept]
   760   C1522601:Cardiac [Spatial Concept]
   760   C1552740:specific [Intellectual Product]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in MyHC"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420192:heavy chain [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C0439539:Heavy [Qualitative Concept]
   812   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "cTnT"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1096316:cardiac troponin [Laboratory Procedure]
   901   C1420827:TROPONIN T [Gene or Genome]
   827   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   827   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1522601:Cardiac [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "(13,"

Phrase: "38,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.38: Each model exhibits several features of HCM in humans, but they differ substantially relative to each other. 

Phrase: "Each model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "several features of HCM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "in humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "but"

Phrase: "they"

Phrase: "differ"

Phrase: "substantially relative to each other."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.39: At 4mo of age, mutant MyHC mice of both genders exhibit ventricular hypertrophy but normal hemodynamic function. 

Phrase: "At 4mo"

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "mutant MyHC mice of both genders"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1417166:MICE gene [Gene or Genome]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "ventricular hypertrophy"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0340279:Ventricular hypertrophy [Disease or Syndrome]
  1000   C2911650:VENTRICULAR HYPERTROPHY [Finding]
   861   C0018827:Ventricular [Body Part, Organ, or Organ Component]
   861   C0020564:Hypertrophy [Pathologic Function]
   861   C1522565:Ventricular [Spatial Concept]
   789 E C0007799:Ventricles [Body Space or Junction]
   789 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]
   789 E C0333959:Hypertrophic [Functional Concept]
   789 E C2355627:Ventricle [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "normal hemodynamic function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.40: At 8mo of age, females continue to exhibit significant hypertrophy, but mutant MyHC male mice exhibit left ventricular hypertrophy, chamber dilation, systolic and diastolic dysfunction, exercise intolerance, and altered adrenergic responsiveness (13). 

Phrase: "At 8mo"

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0015780:Females [Finding]
  1000   C0086287:Females [Population Group]
   966 E C0043210:female [Population Group]
   966 E C1705497:Female [Qualitative Concept]
   966 E C1705498:Female [Qualitative Concept]

Phrase: "continue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "significant hypertrophy,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020564:Hypertrophy [Pathologic Function]
   789 E C0333959:Hypertrophic [Functional Concept]

Phrase: "but"

Phrase: "mutant MyHC male mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "left ventricular hypertrophy,"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0149721:Left Ventricular Hypertrophy [Disease or Syndrome]
  1000   C3484363:Left ventricular hypertrophy [Clinical Attribute]
   901   C0340279:Ventricular hypertrophy [Disease or Syndrome]
   901   C2911650:VENTRICULAR HYPERTROPHY [Finding]
   865   C0225897:Left Ventricle [Body Part, Organ, or Organ Component]
   865   C1269892:Left ventricle [Body Part, Organ, or Organ Component]
   827   C0018827:Ventricular [Body Part, Organ, or Organ Component]
   827   C0020564:Hypertrophy [Pathologic Function]
   827   C0205091:Left [Spatial Concept]
   827   C1522565:Ventricular [Spatial Concept]
   827   C1552822:left [Functional Concept]
   755 E C0007799:Ventricles [Body Space or Junction]
   755 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]
   755 E C0333959:Hypertrophic [Functional Concept]
   755 E C2355627:Ventricle [Body Part, Organ, or Organ Component]

Phrase: "chamber dilation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0012359:Dilation [Pathologic Function]
   861   C0393293:Dilation [Therapeutic or Preventive Procedure]
   861   C0700124:Dilation [Functional Concept]

Phrase: "systolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039155:Systolic [Temporal Concept]

Phrase: "and"

Phrase: "diastolic dysfunction,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0520863:Diastolic dysfunction [Pathologic Function]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "exercise intolerance,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0241885:Exercise intolerance [Sign or Symptom]
   861   C0231199:Intolerance [Organism Function]
   861   C1744706:intolerance [Intellectual Product]
   861   C2355652:Intolerance [Organism Attribute]
   789 E C0231200:Intolerant [Functional Concept]

Phrase: "and"

Phrase: "altered adrenergic responsiveness"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   755   C0205342:Responsive [Functional Concept]
   727 E C2371924:Responsivity [Mental Process]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.41: These mice express ~10% of their MyHC as the mutant, with the total amount of MyHC remaining unchanged (43). 

Phrase: "These mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "express"

Phrase: "~10% of their MyHC"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1420192:heavy chain [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0337112:Chain [Manufactured Object]
   748   C0439539:Heavy [Qualitative Concept]
   748   C1524075:Chain [Idea or Concept]

Phrase: "as the mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "with the total amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "of MyHC remaining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1527428:Remaining [Qualitative Concept]
   717   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.42: Hearts with mutations in cTnT (either a COOH-terminal truncation or R92Q missense mutation) result in significantly decreased heart mass (38, 40). 

Phrase: "Hearts with mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0018787:Hearts [Body Part, Organ, or Organ Component]
   756 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "in cTnT"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1096316:cardiac troponin [Laboratory Procedure]
   901   C1420827:TROPONIN T [Gene or Genome]
   827   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   827   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1522601:Cardiac [Spatial Concept]

Phrase: "(either"

Phrase: "a COOH-terminal truncation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706395:Truncation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "R92Q missense mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599155:Missense Mutation [Genetic Function]
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "result in significantly decreased heart mass"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   753   C0018787:Heart [Body Part, Organ, or Organ Component]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C0577559:Mass [Finding]
   753   C1274040:Result [Functional Concept]
   753   C1281570:Heart [Body Part, Organ, or Organ Component]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
   753   C3152252:Mass [Quantitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "(38,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.43: In addition, R92Q cTnT transgenic mouse hearts are hypercontractile and exhibit diastolic dysfunction. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "R92Q cTnT transgenic mouse hearts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   801   C1512359:Mouse Heart [Tissue]
   795   C0018787:Hearts [Body Part, Organ, or Organ Component]
   762 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "hypercontractile"

Phrase: "and"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "diastolic dysfunction."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0520863:Diastolic dysfunction [Pathologic Function]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.44: The three R92Q lines of mice express 33%, 67%, and 94% of their TnT as mutant, with the mutant protein replacing the endogenous TnT, leaving total TnT levels unchanged (40). 

Phrase: "The three R92Q lines of mice"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0205132:lines [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "express"

Phrase: "33%,"

Phrase: "67%,"

Phrase: "and"

Phrase: "94% of their TnT"

Phrase: "as mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "with the mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "replacing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1299987:replacing [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "the endogenous TnT,"

Phrase: "leaving"

Phrase: "total TnT levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.45: In both of these models, transgenic expression of wild-type -MyHC or wild-type cTnT did not result in any detectable abnormalities (38, 39). 

Phrase: "In both"

Phrase: "of these models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "transgenic expression of wild-type -MyHC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0017262:Gene Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "wild-type cTnT"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1096316:cardiac troponin [Laboratory Procedure]
   840   C1420827:TROPONIN T [Gene or Genome]
   804   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   804   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1522601:Cardiac [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in any detectable abnormalities"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   756   C0459424:Abnormal result [Finding]
   726 E C1704258:Abnormality [Finding]

Phrase: "(38,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.46: Thus these models exhibit distinct sets of phenotypes, and there is little known about the underlying mechanisms of dysfunction. 

Phrase: "Thus"

Phrase: "these models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "distinct sets of phenotypes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "there"

Phrase: "is"

Phrase: "little known about the underlying mechanisms of dysfunction."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   744   C0205309:Known [Qualitative Concept]
   744   C0700321:Little [Quantitative Concept]
   744   C2700395:Little [Quantitative Concept]
Processing 00000000.tx.47: The assessment of mitochondrial function has not been reported in these or in any of the other published transgenic models of HCM. 

Phrase: "The assessment of mitochondrial function"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0278372:Functional assessment [Diagnostic Procedure]
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reported in these"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "or in any of the"

Phrase: "other published transgenic models of HCM."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1519606:Transgenic Model [Experimental Model of Disease]
   748   C3161035:Models [Intellectual Product]
Processing 00000000.tx.48: Most genetic models of HCM are characterized by some measure of hemodynamic dysfunction, and, in the case of the mutant MyHC model, the -adrenergic pathway is altered similarly to that seen in human heart failure (13). 

Phrase: "Most genetic models of HCM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026343:Models, Genetic [Intellectual Product]
   753   C3161035:Models [Intellectual Product]

Phrase: "are"

Phrase: "characterized by some measure of hemodynamic dysfunction,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0019010:Hemodynamic [Organ or Tissue Function]
   748   C0031847:dysfunction [Functional Concept]
   748   C0079809:Measure [Quantitative Concept]
   748   C0242485:Measure [Functional Concept]
   748   C0277785:Dysfunction, NOS [Qualitative Concept]
   748   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: ","

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of the mutant MyHC model,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C3161035:Model [Intellectual Product]
   709   C0678941:mutant gene [Gene or Genome]

Phrase: "the -adrenergic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "similarly to that"

Phrase: "seen in human heart failure"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0018801:Heart failure [Disease or Syndrome]
   806   C0018802:Heart Failure [Disease or Syndrome]
   760   C0018787:Heart [Body Part, Organ, or Organ Component]
   760   C0086418:Human [Human]
   760   C0205397:Seen [Qualitative Concept]
   760   C0231174:Failure [Functional Concept]
   760   C0680095:failure [Individual Behavior]
   760   C1281570:Heart [Body Part, Organ, or Organ Component]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.49: That is, -adrenergic receptor kinase (ARK) activity is elevated and catecholamine responsiveness is blunted. 

Phrase: "That"

Phrase: "is"

Phrase: ", -"

Phrase: "adrenergic receptor kinase (ARK) activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2252679:adrenergic receptor kinase activity [Molecular Function]
   923   C1152722:adrenergic receptor activity [Molecular Function]
   875   C1152633:receptor activity [Molecular Function]
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "and"

Phrase: "catecholamine responsiveness"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   789   C0205342:Responsive [Functional Concept]
   761 E C2371924:Responsivity [Mental Process]

Phrase: "is"

Phrase: "blunted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1997138:Blunted [Qualitative Concept]
Processing 00000000.tx.50: In contrast, several manipulations in the adrenergic pathway have been shown to result in enhanced hemodynamic function (4, 8, 14, 35). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "several manipulations in the adrenergic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185111:MANIPULATIONS [Therapeutic or Preventive Procedure]
   753   C0947647:Manipulations NOS [Therapeutic or Preventive Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in enhanced hemodynamic function"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0019010:Hemodynamic [Organ or Tissue Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1705273:Function [Intellectual Product]
   760   C2349975:Enhanced [Activity]
   760   C2825142:Result [Finding]

Phrase: "(4,"

Phrase: "8,"

Phrase: "14,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.51: For example, overexpression of the 2-adrenergic receptor, expression of an inhibitor of ARK, and ablation of phospholamban all result in enhanced cardiovascular function (20, 26, 35). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "overexpression of the 2-adrenergic receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "expression of an inhibitor of ARK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "ablation of phospholamban"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0547070:Ablation [Therapeutic or Preventive Procedure]
   790   C1261381:ablation [Therapeutic or Preventive Procedure]

Phrase: "all"

Phrase: "result in enhanced cardiovascular function"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0007227:Cardiovascular function [Organ or Tissue Function]
   760   C0007226:Cardiovascular [Body System]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1705273:Function [Intellectual Product]
   760   C2349975:Enhanced [Activity]
   760   C2825142:Result [Finding]

Phrase: "(20,"

Phrase: "26,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.52: Therefore, a crossbreeding strategy was implemented to investigate the effects of manipulations in the adrenergic pathway on the phenotypes of mutant MyHC mice. 

Phrase: "Therefore,"

Phrase: "a crossbreeding strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "was"

Phrase: "implemented"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effects of manipulations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in the adrenergic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "on the phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031437:Phenotypes [Organism Attribute]
   966 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "of mutant MyHC mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   709   C0678941:mutant gene [Gene or Genome]
Processing 00000000.tx.53: COOH-terminal ARK (ARKct)/MyHC doubly transgenic mice have normal hemodynamic function and none of the cardiomyopathic phenotypes (14). 

Phrase: "COOH-terminal ARK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(ARKct"

Phrase: ")"

Phrase: "/MyHC doubly transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0025936:Mice, Transgenic [Mammal]
   795   C0003069:Transgenic [Animal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "normal hemodynamic function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "none of the cardiomyopathic phenotypes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0031437:Phenotypes [Organism Attribute]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   726 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.54: In this paper, we demonstrate that hearts isolated from mutant male MyHC transgenic mice exhibit ultrastructural alterations in mitochondrial organization similar to those reported in the R92Q cTnT mouse (40) and an increase in mitochondrial size. 

Phrase: "In this paper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that hearts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018787:Hearts [Body Part, Organ, or Organ Component]
   966 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "isolated from mutant male MyHC transgenic mice"
Meta Candidates (Total=24; Excluded=2; Pruned=0; Remaining=22)
   782   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025936:Mice, Transgenic [Mammal]
   760   C1420192:heavy chain [Gene or Genome]
   757   C0678941:Gene Mutant [Gene or Genome]
   757   C1417166:MICE gene [Gene or Genome]
   739   C0003069:Transgenic [Animal]
   739   C0017337:Gene [Gene or Genome]
   739   C0024554:Male [Finding]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0086582:male [Population Group]
   739   C0205409:Isolated [Functional Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C0439539:Heavy [Qualitative Concept]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]
   739   C1524075:Chain [Idea or Concept]
   739   C1548221:Isolated [Idea or Concept]
   739   C1706180:Male [Qualitative Concept]
   739   C1706428:Male [Qualitative Concept]
   739   C1706429:Male [Organism Attribute]
   706 E C0370215:Isolate [Substance]
   706 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "ultrastructural alterations in mitochondrial organization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   726   C1515926:Alteration [Idea or Concept]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "reported in the R92Q cTnT mouse"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1096316:cardiac troponin [Laboratory Procedure]
   770   C1420827:TROPONIN T [Gene or Genome]
   744   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C1522601:Cardiac [Spatial Concept]
   744   C3496591:Reported [Clinical Attribute]
   711 E C3273238:Report [Intellectual Product]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "an increase in mitochondrial size."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1268652:Increase in size [Finding]
           increase size
   760   C0442805:Increase [Functional Concept]
Processing 00000000.tx.55: Cardiac mitochondrial respiration is significantly decreased in mutant male MyHC mice but not in R92Q cTnT mice. 

Phrase: "Cardiac mitochondrial respiration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035203:Respiration [Physiologic Function]
   827   C0282636:respiration [Cell Function]
   827   C1160636:respiration [Biologic Function]

Phrase: "is"

Phrase: "significantly"

Phrase: "decreased in mutant male MyHC mice"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   790   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1420192:heavy chain [Gene or Genome]
   762   C0678941:Gene Mutant [Gene or Genome]
   762   C1417166:MICE gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0024554:Male [Finding]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0086582:male [Population Group]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0337112:Chain [Manufactured Object]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0439539:Heavy [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1524075:Chain [Idea or Concept]
   742   C1706180:Male [Qualitative Concept]
   742   C1706428:Male [Qualitative Concept]
   742   C1706429:Male [Organism Attribute]
   708 E C0547047:Decrease [Quantitative Concept]

Phrase: "but"

Phrase: "not in R92Q cTnT mice."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1096316:cardiac troponin [Laboratory Procedure]
   778   C1420827:TROPONIN T [Gene or Genome]
   748   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1518422:Not [Functional Concept]
   748   C1522601:Cardiac [Spatial Concept]
Processing 00000000.tx.56: Mitochondrial dysfunction is observed as early as 4mo of age and, significantly, it precedes hemodynamic dysfunction. 

Phrase: "Mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "observed as early"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1279919:Early [Temporal Concept]
   790   C1441672:Observed [Functional Concept]

Phrase: "as 4mo"

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: ","

Phrase: "significantly,"

Phrase: "it"

Phrase: "precedes"

Phrase: "hemodynamic dysfunction."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.57: The decrease in mitochondrial respiration is due, at least in part, to inactivation of -KGDH. 

Phrase: "The decrease in mitochondrial respiration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "is"

Phrase: "due,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0678226:due [Functional Concept]
  1000   C3146286:Due [Idea or Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "to inactivation of -KGDH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.58: Although a decrease in both complex I and IV activity was observed in hearts isolated from mutant MyHC mice, this was not likely of sufficient magnitude to cause declines in mitochondrial respiratory activity. 

Phrase: "Although"

Phrase: "a decrease in both complex I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "IV activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "observed in hearts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0018787:Hearts [Body Part, Organ, or Organ Component]
   790   C1441672:Observed [Functional Concept]
   756 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "isolated from mutant MyHC mice,"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   800   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420192:heavy chain [Gene or Genome]
   767   C0678941:Gene Mutant [Gene or Genome]
   767   C1417166:MICE gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205409:Isolated [Functional Concept]
   744   C0337112:Chain [Manufactured Object]
   744   C0439539:Heavy [Qualitative Concept]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C1524075:Chain [Idea or Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "this"

Phrase: "was"

Phrase: "not likely of sufficient magnitude to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205410:Sufficient [Qualitative Concept]
   753   C0332148:Likely [Qualitative Concept]
   753   C0449286:magnitude [Quantitative Concept]
   753   C0750492:Likely [Idea or Concept]
   753   C1518422:Not [Functional Concept]
   753   C1704240:Magnitude [Quantitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "declines in mitochondrial respiratory activity."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0026237:Mitochondrial [Cell Component]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0521346:respiratory [Functional Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C1546767:Respiratory [Intellectual Product]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.59: These decreases, however, may play an important role in providing insight into mechanisms contributing to the decease in oxidative phosphorylation. 

Phrase: "These decreases,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0547047:decreases [Quantitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]

Phrase: "however,"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in providing insight"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "into mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "contributing to the decease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contributing [Activity]

Phrase: "in oxidative phosphorylation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0030013:Oxidative Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C0311404:Oxidative [Functional Concept]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.60: Defects in the -adrenergic pathway may contribute to oxidative phosphorylation defects because inhibition of ARK in mutant MyHC mice prevents mitochondrial respiratory dysfunction. 

Phrase: "Defects in the -adrenergic pathway"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "may"

Phrase: "contribute to oxidative phosphorylation defects"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0030013:Oxidative Phosphorylation [Molecular Function]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0243067:defects [Functional Concept]
   760   C0311404:Oxidative [Functional Concept]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1880177:Contribute [Activity]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "because"

Phrase: "inhibition of ARK"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1514761:Receptor Inhibition [Cell Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "in mutant MyHC mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   709   C0678941:mutant gene [Gene or Genome]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "mitochondrial respiratory dysfunction."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C1260922:RESPIRATORY DYSFUNCTION NOS [Sign or Symptom]
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.61: This study suggests that altered mitochondria function may contribute to the hemodynamic dysfunction seen in HCM and offers a plausible mechanism underlying some of the heterogeneity of this disease. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that altered mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "may"

Phrase: "contribute to the hemodynamic dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0019010:Hemodynamic [Organ or Tissue Function]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   760   C1880177:Contribute [Activity]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "seen in HCM"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   770   C0020564:Hypertrophic [Pathologic Function]
   770   C0205397:Seen [Qualitative Concept]
   770   C0333959:Hypertrophic [Functional Concept]
   770   C0878544:Cardiomyopathy [Disease or Syndrome]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "and"

Phrase: "offers"

Phrase: "a plausible mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "some of the heterogeneity of this disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0012634:Disease [Disease or Syndrome]
   748   C0019409:Heterogeneity [Qualitative Concept]
   748   C0205392:Some [Quantitative Concept]
   748   C3540770:Some [Intellectual Product]
Processing 00000000.tx.62: These experiments expand approaches that can be applied to the characterization of the pathogenesis of HCM at the cellular and molecular level.  

Phrase: "These experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "expand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expand [Spatial Concept]

Phrase: "approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approach [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "applied to the characterization of the pathogenesis of HCM"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   739   C0020564:Hypertrophic [Pathologic Function]
   739   C0185125:Applied [Health Care Activity]
   739   C0333959:Hypertrophic [Functional Concept]
   739   C0543483:pathogenesis [Functional Concept]
   739   C0699748:Pathogenesis [Pathologic Function]
   739   C0878544:Cardiomyopathy [Disease or Syndrome]
   739   C1880022:Characterization [Activity]
   706 E C1632850:Apply [Functional Concept]
   706 E C1879355:Apply [Functional Concept]

Phrase: "at the cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "molecular level."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.63: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Experimental animals. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Experimental animals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0003064:experimental animal [Animal]
   861   C0003062:Animals [Animal]
   861   C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.64: Mutant MyHC, R92Q cTnT, and ARKct/MyHC mice were developed as previously described (13, 14, 38, 39, 40, 43). 

Phrase: "Mutant MyHC,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C0678941:mutant gene [Gene or Genome]
   884   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1420192:heavy chain [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0439539:Heavy [Qualitative Concept]
   804   C1524075:Chain [Idea or Concept]

Phrase: "R92Q cTnT,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1096316:cardiac troponin [Laboratory Procedure]
   861   C1420827:TROPONIN T [Gene or Genome]
   812   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   812   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1522601:Cardiac [Spatial Concept]

Phrase: "and"

Phrase: "ARKct/MyHC mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "developed as previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(13,"

Phrase: "14,"

Phrase: "38,"

Phrase: "39,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.65: Briefly, the mouse -MyHC HCM transgene was developed by inducing a point mutation, G1445A, resulting in Arg403Gln and a deletion of amino acids 468-527 bridged by the addition of nine nonmyosin amino acids. 

Phrase: "Briefly,"

Phrase: "the mouse -MyHC HCM transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0282641:Transgene [Gene or Genome]

Phrase: "was"

Phrase: "developed by inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Inducing [Functional Concept]

Phrase: "a point mutation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
   861   C2347617:point [Quantitative Concept]

Phrase: "G1445A,"

Phrase: "resulting in Arg403Gln"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   882   C0332294:Resulting in [Functional Concept]
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "a deletion of amino acids 468-527 bridged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "by the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of nine nonmyosin amino acids."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.66: R92Q cTnT mice contain a missence mutation of mouse cTnT R92Q, and hearts of these animals express 67% of the total cTnT as the transgene, without a change in the total amount of cTnT. 

Phrase: "R92Q cTnT mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a missence mutation of mouse cTnT R92Q,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "hearts of these animals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0018787:Hearts [Body Part, Organ, or Organ Component]
   737 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "express"

Phrase: "67% of the total cTnT"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1096316:cardiac troponin [Laboratory Procedure]
   778   C1420827:TROPONIN T [Gene or Genome]
   748   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   748   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C1522601:Cardiac [Spatial Concept]

Phrase: "as the transgene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgene [Gene or Genome]

Phrase: "without a change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "in the total amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "of cTnT."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1096316:cardiac troponin [Laboratory Procedure]
   901   C1420827:TROPONIN T [Gene or Genome]
   827   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   827   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1522601:Cardiac [Spatial Concept]
Processing 00000000.tx.67: To investigate ARK inhibition on HCM, mutant MyHC mice were crossbred with mice expressing ARKct. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "ARK inhibition on HCM,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1514761:Receptor Inhibition [Cell Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "mutant MyHC mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   709   C0678941:mutant gene [Gene or Genome]

Phrase: "were"

Phrase: "crossbred with mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   756   C0020202:crossbreed [Genetic Function]

Phrase: "expressing"

Phrase: "ARKct."
Processing 00000000.tx.68: The phenotypes of these mice have been described by Freeman et al. 

Phrase: "The phenotypes of these mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0031437:Phenotypes [Organism Attribute]
   726 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "described by Freeman et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.69: (14). 

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.70: Only males were used for this study, and age-matched littermate nontransgenic (NTG) mice were used as controls. 

Phrase: "Only males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0024554:Males [Finding]
   861   C0086582:Males [Population Group]
   827 E C1706180:Male [Qualitative Concept]
   827 E C1706428:Male [Qualitative Concept]
   827 E C1706429:Male [Organism Attribute]

Phrase: "were"

Phrase: "used for this study,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "age-matched littermate nontransgenic (NTG) mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.71: Electromicroscopic analysis. 

Phrase: "Electromicroscopic analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.72: Ventricles from NTG and mutant MyHC, cTnT, ARKct, and ARKct/MyHC mouse hearts were dissected into 1-mm3 sections in a fixative consisting of 2% glutaraldehyde in 0.16M sodium phosphate, pH 7.2,for 1h. 

Phrase: "Ventricles from NTG"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007799:Ventricles [Body Space or Junction]
   790   C0018827:Ventricles [Body Part, Organ, or Organ Component]
   756 E C2355627:Ventricle [Body Part, Organ, or Organ Component]
   706 E C1522565:Ventricular [Spatial Concept]

Phrase: "and"

Phrase: "mutant MyHC,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C0678941:mutant gene [Gene or Genome]
   884   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1420192:heavy chain [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0439539:Heavy [Qualitative Concept]
   804   C1524075:Chain [Idea or Concept]

Phrase: "cTnT,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1096316:cardiac troponin [Laboratory Procedure]
   901   C1420827:TROPONIN T [Gene or Genome]
   827   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   827   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1522601:Cardiac [Spatial Concept]

Phrase: "ARKct,"

Phrase: "and"

Phrase: "ARKct/MyHC mouse hearts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   801   C1512359:Mouse Heart [Tissue]
   795   C0018787:Hearts [Body Part, Organ, or Organ Component]
   762 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "dissected into 1-mm3 sections"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205239:dissected [Functional Concept]
   760   C0439243:mm3 [Quantitative Concept]
   760   C1300557:/mm3 [Quantitative Concept]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "in a fixative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016184:Fixative [Indicator, Reagent, or Diagnostic Aid]

Phrase: "consisting of 2% glutaraldehyde"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0017814:Glutaraldehyde [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   737   C0332529:CONSIST [Qualitative Concept]
   715 E C0878318:Cidex [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "in 0.16M sodium phosphate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 1h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]
Processing 00000000.tx.73: Sections were additionally fixed in 1% osmium tetroxide buffer for 1h. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "additionally"

Phrase: "fixed in 1% osmium tetroxide buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0029385:Osmium Tetroxide [Hazardous or Poisonous Substance,Inorganic Chemical]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0029383:Osmium [Element, Ion, or Isotope]
   753   C0231441:Fixed [Finding]
   753   C0443218:Fixed [Qualitative Concept]
   753   C2827483:Fixed [Body Substance]

Phrase: "for 1h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]
Processing 00000000.tx.74: The fixed tissue was then dehydrated in a graded ethanol series, followed by propylene oxide and embedding in Epon-Arldite. 

Phrase: "The fixed tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dehydrated in a graded ethanol series,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001962:Ethanol [Organic Chemical]
   753   C0011175:Dehydrated [Disease or Syndrome]
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "followed by propylene oxide"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0072229:propylene oxide [Organic Chemical]
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0030015:oxide [Inorganic Chemical]
   770   C0072221:propylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C2986642:oxide [Chemical Viewed Functionally]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "embedding in Epon-Arldite."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707903:Embedding [Laboratory Procedure]
Processing 00000000.tx.75: Sections (60-70 mm thick) were stained with 2% uranyl acetate and lead citrate and viewed with a Phillips CM-10 electron microscope operating at 80kV. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "(60-70 mm"

Phrase: "thick"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thick [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "stained with 2% uranyl acetate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C2984971:URANYL ACETATE STAIN [Laboratory Procedure]
   806   C0077854:uranyl acetate [Organic Chemical,Pharmacologic Substance]
   760   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "lead citrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008857:Citrate [Organic Chemical]
   861   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "viewed with a Phillips CM-10 electron microscope"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0181845:Electron Microscope [Medical Device]
   744   C0013852:Electron [Quantitative Concept]
   744   C0181839:Microscope [Medical Device]
   744   C1706379:Microscope [Medical Device]
   744   C3463986:Electron [Bird]
   711   C0449911:View [Spatial Concept]

Phrase: "operating at 80kV."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C3242339:operate [Functional Concept]
Processing 00000000.tx.76: Quantitative analysis of mitochondrial density and size were carried out at 11,500 using NIH Image software. 

Phrase: "Quantitative analysis of mitochondrial density"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out at 11,500"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NIH Image software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.77: Mitochondrial isolation. 

Phrase: "Mitochondrial isolation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]
Processing 00000000.tx.78: Subsarcolemmal mitochondria were isolated from cardiac tissue as previously described (21). 

Phrase: "Subsarcolemmal mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "isolated from cardiac tissue"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1272575:cardiac tissue [Tissue]
   770   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   770   C0040300:Tissue [Tissue]
   770   C0205409:Isolated [Functional Concept]
   770   C1522601:Cardiac [Spatial Concept]
   770   C1547928:Tissue [Intellectual Product]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.79: Briefly, male NTG and mutant MyHC cTnT, ARKct, and ARKct/MyHC mice (8mo of age) were euthanized by cervical dislocation. 

Phrase: "Briefly,"

Phrase: "male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0024554:Male [Finding]
  1000   C0086582:male [Population Group]
  1000   C1706180:Male [Qualitative Concept]
  1000   C1706428:Male [Qualitative Concept]
  1000   C1706429:Male [Organism Attribute]

Phrase: "NTG"

Phrase: "and"

Phrase: "mutant MyHC cTnT,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   835   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1096316:cardiac troponin [Laboratory Procedure]
   812   C1420827:TROPONIN T [Gene or Genome]
   793   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   793   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1522601:Cardiac [Spatial Concept]

Phrase: "ARKct,"

Phrase: "and"

Phrase: "ARKct/MyHC mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "(8mo of age)"

Phrase: "were"

Phrase: "euthanized by cervical dislocation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2983594:Cervical Dislocation [Research Activity]
   770   C0012691:Dislocation [Injury or Poisoning]
   770   C0027530:Cervical [Body Location or Region]
   770   C0205064:Cervical [Spatial Concept]
Processing 00000000.tx.80: Hearts were rapidly excised and then immersed and rinsed in ice-cold buffer containing 180mM KCl, 5.0mM MOPS, and 2.0mM EGTA at pH 7.25(I-buffer). 

Phrase: "Hearts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018787:Hearts [Body Part, Organ, or Organ Component]
   966 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "excised"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immersed"

Phrase: "and"

Phrase: "rinsed in ice-cold buffer containing 180mM KCl,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0456963:Ice cold [Qualitative Concept]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0009264:Cold [Natural Phenomenon or Process]
   744   C0009443:Cold [Disease or Syndrome]
   744   C0020746:Ice [Inorganic Chemical]
   744   C0234192:Cold [Physiologic Function]
   744   C0332256:Containing [Functional Concept]
   744   C2700400:Containing [Activity]
   711   C1701810:Rinse [Functional Concept]
   711   C1882955:Rinse [Activity]

Phrase: "5.0mM MOPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0066823:MOPS [Organic Chemical]
   827   C1271466:Mops [Mammal]

Phrase: "and"

Phrase: "2.0mM EGTA at pH 7.25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(I-buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.81: Ventricles were isolated, dry blotted, weighed, and then minced with scissors, followed by homogenization in 20ml I-buffer/g tissue with a Polytron homogenizer (low setting, 3s). 

Phrase: "Ventricles"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007799:Ventricles [Body Space or Junction]
  1000   C0018827:Ventricles [Body Part, Organ, or Organ Component]
   966 E C2355627:Ventricle [Body Part, Organ, or Organ Component]
   916 E C1522565:Ventricular [Spatial Concept]
   893 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: ","

Phrase: "dry blotted,"

Phrase: "weighed"

Phrase: ","

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "minced with scissors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0175735:Scissors [Medical Device]

Phrase: "followed by homogenization"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "in 20ml I-buffer/g tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0040300:Tissue [Tissue]
   804   C1547928:Tissue [Intellectual Product]

Phrase: "with a Polytron homogenizer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0181200:homogenizer [Medical Device]

Phrase: "(low setting,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0542559:setting [Functional Concept]
   861   C1318139:{Setting} [Quantitative Concept]

Phrase: "3s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552117:3s [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.82: Elapsed time between the removal of hearts and completion of weighing was typically 30-60 s. 

Phrase: "Elapsed time between the removal of hearts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2826303:Elapsed Time [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C1707889:Elapsed [Temporal Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "completion of weighing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205197:Completion [Qualitative Concept]
   790   C1554962:completion [Qualitative Concept]

Phrase: "was"

Phrase: "typically 30-60 s."
Processing 00000000.tx.83: We previously determined that no declines in the quality of the mitochondria are evident (as judged by the rates of state 3and state 4respiration and by the respiratory control ratio) if the time from heart extraction through weighing was extended up to 5min. 

Phrase: "We previously"

Phrase: "determined"

Phrase: "that"

Phrase: "no"

Phrase: "declines in the quality of the mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026237:Mitochondria [Cell Component]
   748   C0332306:Quality [Qualitative Concept]

Phrase: "are"

Phrase: "evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "("

Phrase: "as"

Phrase: "judged by the rates of state 3and state 4respiration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C1301808:State [Geographic Area]
   742   C1442792:State [Functional Concept]
   742   C3148680:State [Geographic Area]
   708   C0221191:Judge [Professional or Occupational Group]
   708   C0871208:Rate [Activity]
   708   C1521828:Rate [Quantitative Concept]

Phrase: "and by the respiratory control ratio"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C0429743:Respiratory ratio [Finding]
   753   C0243148:control [Qualitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C0521346:respiratory [Functional Concept]
   753   C1515981:And [Idea or Concept]
   753   C1546767:Respiratory [Intellectual Product]
   753   C1547037:Ratio [Intellectual Product]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "if"

Phrase: "the time from heart extraction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "through weighing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305866:Weighing [Diagnostic Procedure]

Phrase: "was"

Phrase: "extended up to 5min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0231448:Extended [Functional Concept]
   770   C0231449:Extended [Spatial Concept]
   770   C0439792:extended [Spatial Concept]
Processing 00000000.tx.84: The homogenate was centrifuged at 500g for 7.5min at 4C to remove nuclear and myofibrillar material. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged at 500g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 7.5min"

Phrase: "at 4C to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "and"

Phrase: "myofibrillar material."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]
Processing 00000000.tx.85: The supernatant was filtered through cheesecloth and centrifuged at 5,000g for 10min at 4C. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "filtered through cheesecloth"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   756   C0180860:Filter [Manufactured Object]
   756   C0581406:Filter [Medical Device]
   756   C1522664:Filter [Intellectual Product]
   756   C1704449:Filter [Conceptual Entity]
   756   C1704684:Filter [Medical Device]
   756   C1875155:FILTER [Medical Device]
   718 E C0080194:Strain [Injury or Poisoning]
   718 E C0442694:Straining [Physiologic Function]
   718 E C0456178:strain [Intellectual Product]
   718 E C1518614:Strain [Organism]
   718 E C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "centrifuged at 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 10min"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.86: The resulting mitochondrial pellet was washed two times (ice-cold I-buffer) and resuspended in 100l I-buffer. 

Phrase: "The resulting mitochondrial pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441436:Pellet [Manufactured Object]
   827   C0993610:Pellet [Biomedical or Dental Material]
   827   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "two times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1948050:Two Times [Quantitative Concept]
   861   C0040223:times [Temporal Concept]
   861   C0205448:Two [Quantitative Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "(ice-cold I-buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "resuspended in 100l I-buffer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.87: A small aliquot was taken from the final suspension and used for protein determination using a Bio-Rad protein assay kit. 

Phrase: "A small aliquot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510844:Aliquot [Quantitative Concept]

Phrase: "was"

Phrase: "taken from the final suspension"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0038960:Suspension [Biomedical or Dental Material]
   760   C0205088:Final [Temporal Concept]
   760   C1382107:Suspension [Substance]
   760   C1546485:Final [Idea or Concept]
   760   C1705537:Suspension [Functional Concept]
   760   C1883727:Taken [Conceptual Entity]
   726 E C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "used for protein determination"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1148554:determination [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bio-Rad protein assay kit."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0812225:KIT [Medical Device]
   804   C1150635:KIT [Molecular Function]
   804   C1705212:Kit [Medical Device]
   804   C1705213:KIT [Medical Device]
   804   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.88: Mitochondria kept at 4C exhibited no change in state 3or state 4respiratory rates for up to 3.0h. 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "kept at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C0333118:Keep [Functional Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "no change in state 3or state 4respiratory rates for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C0871208:Rate [Activity]
   708   C1521828:Rate [Quantitative Concept]

Phrase: "up to 3.0h."
Processing 00000000.tx.89: A portion of each mitochondrial preparation was frozen and stored for later enzymatic analyses. 

Phrase: "A portion of each mitochondrial preparation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "was"

Phrase: "frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: "and"

Phrase: "stored for later enzymatic analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726   C1698986:Store [Functional Concept]
Processing 00000000.tx.90: Evaluation of mitochondrial O2 consumption. 

Phrase: "Evaluation of mitochondrial O2 consumption."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0220825:Evaluation [Functional Concept]
   760   C1261322:Evaluation [Health Care Activity]
Processing 00000000.tx.91: ADP-independent (state 4) and -dependent (state 3) respiration were measured using a Clark-type oxygen electrode (Instech) as described previously (21). 

Phrase: "ADP-independent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085862:Independent [Idea or Concept]
   861   C1299583:Independent [Finding]

Phrase: "(state 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: ")"

Phrase: "and -"

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "(state 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: ")"

Phrase: "respiration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035203:Respiration [Physiologic Function]
  1000   C0282636:respiration [Cell Function]
  1000   C1160636:respiration [Biologic Function]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Clark-type oxygen electrode"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013812:electrode [Medical Device]
   812   C1705652:Electrode [Medical Device]

Phrase: "(Instech"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.92: Mitochondria were diluted to a protein concentration of 0.25mg/ml in respiration buffer (120mM KCl, 5.0mM KH2PO4, 5.0mM MOPS, and 1.0mM EGTA at pH 7.25). 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "diluted to a protein concentration of 0.25mg/ml"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0427716:Protein concentration [Laboratory Procedure]
   764   C1304757:Protein concentration [Laboratory or Test Result]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086045:Concentration [Mental Process]
   742   C0439526:/mL [Quantitative Concept]
   742   C1446561:Concentration [Quantitative Concept]
   708   C1720119:Dilute [Functional Concept]
   708   C1948037:Dilute [Functional Concept]

Phrase: "in respiration buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(120mM KCl,"

Phrase: "5.0mM KH2PO4,"

Phrase: "5.0mM MOPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0066823:MOPS [Organic Chemical]
   827   C1271466:Mops [Mammal]

Phrase: "and"

Phrase: "1.0mM EGTA at pH 7.25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")."
Processing 00000000.tx.93: State 2respiration was initiated by the addition of glutamate (15mM) for the supply of reducing equivalents (NADH) to the electron transport chain. 

Phrase: "State 2respiration"

Phrase: "was"

Phrase: "initiated by the addition of glutamate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   753   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1883712:Addition [Functional Concept]
   719   C1548602:Initiate [Idea or Concept]
   719   C1704686:Initiate [Functional Concept]

Phrase: "(15mM"

Phrase: ")"

Phrase: "for the supply"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0243163:supply [Idea or Concept]
  1000   C0699914:supply [Quantitative Concept]
  1000   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
  1000   C1561604:supply [Functional Concept]
  1000   C1875802:SUPPLY [Medical Device]
  1000   C1999230:Supply [Activity]

Phrase: "of reducing equivalents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439185:Equivalents [Quantitative Concept]
   827 E C0205163:Equivalent [Qualitative Concept]

Phrase: "(NADH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: "to the electron transport chain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]
Processing 00000000.tx.94: After a 2.0-min equilibration period, state 3respiration was initiated by addition of ADP (0.25mM). 

Phrase: "After a 2.0-min equilibration period,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0439531:/period [Temporal Concept]
   804   C1948053:Period [Temporal Concept]
   733 E C0332182:Periodic [Temporal Concept]
   733 E C1706381:PERIODIC [Intellectual Product]
   704 E C0031084:Periodicities [Temporal Concept]

Phrase: "state 3respiration"

Phrase: "was"

Phrase: "initiated by addition of ADP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0523452:ADP [Laboratory Procedure]
   760   C1883712:Addition [Functional Concept]
   726   C1548602:Initiate [Idea or Concept]
   726   C1704686:Initiate [Functional Concept]

Phrase: "(0.25mM"

Phrase: ")."
Processing 00000000.tx.95: Upon depletion of ADP, state 4respiration was monitored. 

Phrase: "Upon depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333668:Depletion [Functional Concept]

Phrase: "of ADP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "state 4respiration"

Phrase: "was"

Phrase: "monitored."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.96: Assay of -KGDH activity. 

Phrase: "Assay of -KGDH activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.97: Mitochondria were diluted to 0.025mg/ml in 25.0mM KH2PO4, pH 7.2,containing 0.05% Triton X-100 and placed in a sonicating water bath for 30s (Fisher Scientific). 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "diluted to 0.025mg/ml"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439526:/mL [Quantitative Concept]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "in 25.0mM KH2PO4,"

Phrase: "pH 7.2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.05% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "placed in a sonicating water bath"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0179245:bath water [Medical Device]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0150141:Bath [Therapeutic or Preventive Procedure]
   753   C0599638:WATER [Substance]
   753   C1550678:Water [Inorganic Chemical]
   719   C0442504:Place [Spatial Concept]
   719   C1704765:Place [Functional Concept]
   719   C1882509:Place [Activity]
   719   C3496241:place [Disease or Syndrome]

Phrase: "for 30s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0227073:30S [Body Part, Organ, or Organ Component]

Phrase: "(Fisher"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "Scientific"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Scientific [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.98: -KGDH activity was measured spectrophotometrically (Hitachi U-2000 spectrophotometer) by the reduction of NAD+ at 340nm on the addition of 5.0mM MgCl2, 40.0M rotenone, 2.0mM -ketoglutarate, 40M acetyl coenzyme A, 0.2mM thymine pyrophosphate, and 0.5mM NAD+ to sonicated mitochondria. 

Phrase: "-KGDH activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "spectrophotometrically"

Phrase: "(Hitachi U-2000 spectrophotometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0183400:Spectrophotometer [Medical Device]

Phrase: ")"

Phrase: "by the reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of NAD+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027270:NAD+ [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "at 340nm"

Phrase: "on the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 5.0mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "40.0M rotenone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "2.0mM -ketoglutarate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C1291208:2-Ketoglutarate [Organic Chemical,Pharmacologic Substance]

Phrase: "40M acetyl coenzyme A,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0001026:Acetyl Coenzyme A [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
           acetyl coenzyme
   861   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "0.2mM thymine pyrophosphate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.5mM"

Phrase: "NAD+ to sonicated mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027270:NAD+ [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.99: Assays were performed at room temperature. 

Phrase: "Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed at room temperature."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1547703:Room [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.100: Electron transport chain component assays. 

Phrase: "Electron transport chain component assays."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   771   C0005507:Assay [Laboratory Procedure]
   771   C0243073:assay [Qualitative Concept]
   771   C1510438:Assay [Laboratory Procedure]
   717   C2244392:electron transport chain [Molecular Function]
Processing 00000000.tx.101: To measure the activities of complexes I and III, mitochondria were diluted to 0.025mg/ml of protein in buffer containing 35.0mM KH2PO4, 5.0mM MgCl2, and 2.0mM NaCN (to block complex IV) at pH 7.25.

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "the activities of complexes I"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "diluted to 0.025mg/ml of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439526:/mL [Quantitative Concept]
   714   C1720119:Dilute [Functional Concept]
   714   C1948037:Dilute [Functional Concept]

Phrase: "in buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "35.0mM KH2PO4,"

Phrase: "5.0mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "2.0mM NaCN"

Phrase: "(to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "complex IV) at pH 7.25."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0010760:Complex IV [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.102: After three freeze-thaw cycles, enzyme activity was evaluated as previously described with minor modifications (22). 

Phrase: "After three freeze-thaw cycles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1511572:Cycle [Temporal Concept]

Phrase: "enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "evaluated as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0220825:Evaluated [Functional Concept]

Phrase: "described with minor modifications"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0026193:Minor [Population Group]
   770   C0205165:Minor [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   737   C0392747:Modification [Functional Concept]
   737   C1554963:modification [Qualitative Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.103: Complex I activity was assayed as the rate of NADH consumption (340nm, =6,200M1 cm1) on addition of 2g antimycin A (to inhibit complex III), 50M ubiquinone-1, and 75M NADH to a 1.0-ml vol of mitochondria (0.025mg/ml mitochondrial protein). 

Phrase: "Complex I activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C2245017:Complex I [Cell Component]

Phrase: "was"

Phrase: "assayed as the rate of NADH consumption"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0009830:Consumption [Activity]
   748   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
   748   C1947907:Consumption [Physiologic Function]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "(340nm,"

Phrase: "=6,"

Phrase: "200M1 cm1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750929:CM1 [Congenital Abnormality,Disease or Syndrome]

Phrase: ")"

Phrase: "on addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 2g antimycin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003387:Antimycin A [Antibiotic,Organic Chemical]
   827   C0052078:antimycin [Antibiotic,Organic Chemical]

Phrase: "(to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "complex III"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1167295:complex III [Cell Component]
  1000   C1176474:Complex III [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "50M ubiquinone-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041536:Ubiquinone [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "75M NADH to a 1.0-ml vol of mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(0.025mg/ml mitochondrial protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0949610:Mitochondrial Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.104: Complex III activity was measured as the initial rate of the reduction of cytochrome c at 550nm (=18,500M1 cm1) on addition of 40M reduced decylubiquinone and 50M cytochrome c to 2.5g/ml mitochondrial protein. 

Phrase: "Complex III activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C1167295:complex III [Cell Component]
   734   C1176474:Complex III [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured as the initial rate of the reduction of cytochrome c"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   756   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   756   C1153524:cytochrome c [Molecular Function]
   756   C1426584:CYTOCHROME C [Gene or Genome]
   738   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0205265:Initial [Temporal Concept]
   738   C0301630:Reduction [Natural Phenomenon or Process]
   738   C0392756:Reduction [Qualitative Concept]
   738   C0441610:Reduction [Therapeutic or Preventive Procedure]
   738   C0444706:Measured [Qualitative Concept]
   738   C0871208:Rate [Activity]
   738   C1279901:Initial [Qualitative Concept]
   738   C1325304:cytochrome [Molecular Function]
   738   C1521828:Rate [Quantitative Concept]
   738   C1555582:Initial [Idea or Concept]
   738   C1705685:INITIAL [Functional Concept]
   738   C3541902:MEASURED [Diagnostic Procedure]
   704 E C0079809:Measure [Quantitative Concept]
   704 E C0242485:Measure [Functional Concept]

Phrase: "at 550nm"

Phrase: "("

Phrase: "=18,"

Phrase: "500M1 cm1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750929:CM1 [Congenital Abnormality,Disease or Syndrome]

Phrase: ")"

Phrase: "on addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 40M"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "decylubiquinone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0245763:decyl-ubiquinone [Organic Chemical]

Phrase: "and"

Phrase: "50M cytochrome c to 2.5g/ml mitochondrial protein."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   784   C0056953:Cytochrome C-2 [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   764   C1153524:cytochrome c [Molecular Function]
   764   C1426584:CYTOCHROME C [Gene or Genome]
   762   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C1168438:Protein C [Laboratory Procedure]
   762   C1418943:PROTEIN C [Gene or Genome]
   762   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1325304:cytochrome [Molecular Function]
Processing 00000000.tx.105: The addition of 2g antimycin A completely inhibited the reduction of cytochrome c. 

Phrase: "The addition of 2g antimycin A completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the reduction of cytochrome c."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.106: For the assay of complex IV, mitochondria were diluted in hypotonic buffer (20mM KH2PO4 at pH 7.25) followed by sonication for 10s in a sonicator bath. 

Phrase: "For the assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "of complex IV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010760:Complex IV [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "diluted in hypotonic buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0241938:Hypotonic [Pathologic Function]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "(20mM KH2PO4 at pH 7.25"

Phrase: ")"

Phrase: "followed by sonication"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0037680:Sonication [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "for 10s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552124:10s [Body Part, Organ, or Organ Component]

Phrase: "in a sonicator bath."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0150141:Bath [Therapeutic or Preventive Procedure]
Processing 00000000.tx.107: Enzyme activity was measured as the rate of oxygen consumption on addition of 5.0mM ascorbate, 250M N,N,N',N'-tetramethyl-p-phenyldiamine, and 10M cytochrome c. 

Phrase: "Enzyme activity"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "measured as the rate of oxygen consumption"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C0030055:Oxygen Consumption [Clinical Attribute]
   778   C1305742:oxygen consumption [Diagnostic Procedure]
   748   C0009830:Consumption [Activity]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0444706:Measured [Qualitative Concept]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
   748   C1947907:Consumption [Physiologic Function]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "on addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 5.0mM ascorbate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0178487:Ascorbate [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "250M N,N,N',N'-tetramethyl-p-phenyldiamine,"

Phrase: "and"

Phrase: "10M cytochrome c."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   901   C1153524:cytochrome c [Molecular Function]
   901   C1426584:CYTOCHROME C [Gene or Genome]
   827   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1325304:cytochrome [Molecular Function]
Processing 00000000.tx.108: All assays were performed at room temperature.  

Phrase: "All assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed at room temperature."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1547703:Room [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.109: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Ultrastructural analysis. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Ultrastructural analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.110: Mitochondria have been observed to undergo significant ultrastructural alterations in various cardiomyopathies (1, 2, 40). 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "have"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "significant ultrastructural alterations in various cardiomyopathies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.111: Therefore, we decided to examine the morphology and structure of mitochondria in 8-mo-old male mutant MyHC transgenic mice. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "structure of mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678594:Structure [Spatial Concept]

Phrase: "in 8-mo-old male mutant MyHC transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   801   C0025936:Mice, Transgenic [Mammal]
   788   C0003069:Transgenic [Animal]
   788   C0025914:Mice [Mammal]
   788   C0025929:mice [Mammal]
   788   C0026809:Mice [Mammal]
Processing 00000000.tx.112: For this study, we focused on male mice because of the significant changes in ventricular geometry and function that occur progressively from 4to 8mo of age in male but not female transgenic mice (13). 

Phrase: "For this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "focused on male mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0024554:Male [Finding]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0086582:male [Population Group]
   770   C0205234:Focused [Spatial Concept]
   770   C1285542:focused [Functional Concept]
   770   C1706180:Male [Qualitative Concept]
   770   C1706428:Male [Qualitative Concept]
   770   C1706429:Male [Organism Attribute]

Phrase: "because of the significant changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "in ventricular geometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449829:Geometry [Spatial Concept]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "that"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "progressively from 4to 8mo of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0001779:Age [Organism Attribute]

Phrase: "in male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0024554:Male [Finding]
  1000   C0086582:male [Population Group]
  1000   C1706180:Male [Qualitative Concept]
  1000   C1706428:Male [Qualitative Concept]
  1000   C1706429:Male [Organism Attribute]

Phrase: "but"

Phrase: "not female transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.113: Compared with NTG mouse hearts (Fig. 1, a and b), mitochondria from mutant male MyHC mice exhibited gross disorganization and appeared to be larger in size (Fig. 1, c and d). 

Phrase: "Compared with NTG mouse hearts"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1512359:Mouse Heart [Tissue]
   760   C0018787:Hearts [Body Part, Organ, or Organ Component]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C1707455:Compared [Activity]
   726 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "a"

Phrase: "and"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "mitochondria from mutant male MyHC mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0026237:Mitochondria [Cell Component]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "gross disorganization"

Phrase: "and"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "larger in size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0443228:larger [Quantitative Concept]
   790   C0549177:Larger [Quantitative Concept]
   790   C1704243:Larger [Quantitative Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "c"

Phrase: "and"

Phrase: "d)."
Processing 00000000.tx.114: Micrographs were analyzed for the percentage of the field occupied by mitochondria, the number of mitochondria in the field, and the cross-sectional area of individual mitochondrial. 

Phrase: "Micrographs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   893   C0240341:Micrographia [Finding]
   893   C0596928:micrography [Laboratory Procedure]

Phrase: "were"

Phrase: "analyzed for the percentage of the field"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0439165:Percentage [Quantitative Concept]
   748   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   748   C0936012:Analyzed [Research Activity]
   748   C1521738:Field [Conceptual Entity]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   748   C2346620:Field [Conceptual Entity]
   748   C2349184:Field [Conceptual Entity]
   748   C3539073:FIELD [Spatial Concept]

Phrase: "occupied by mitochondria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1548223:Occupied [Idea or Concept]

Phrase: "the number of mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in the field,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C3539073:In the Field [Spatial Concept]
           FIELD
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]

Phrase: "and"

Phrase: "the cross-sectional area of individual mitochondrial."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]
   748   C0205155:Sectional [Spatial Concept]
   748   C2828360:Cross [Conceptual Entity]
   743   C0552389:cross sections [Spatial Concept]
Processing 00000000.tx.115: The percentage of the field occupied by mitochondria was the same in NTG (43.3%) and mutant MyHC (44.2%) mice. 

Phrase: "The percentage of the field"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "occupied by mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1548223:Occupied [Idea or Concept]

Phrase: "was"

Phrase: "the same in NTG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0445247:Same [Qualitative Concept]

Phrase: "(43.3%"

Phrase: ")"

Phrase: "and"

Phrase: "mutant MyHC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C0678941:mutant gene [Gene or Genome]
   884   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1420192:heavy chain [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0439539:Heavy [Qualitative Concept]
   804   C1524075:Chain [Idea or Concept]

Phrase: "(44.2%"

Phrase: ")"

Phrase: "mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.116: However, there were significantly fewer mitochondria per field in mutant MyHC hearts (27.8vs. 38.6mitochondria/field in MyHC vs. NTG hearts, P<0.02). 

Phrase: "However,"

Phrase: "there"

Phrase: "were"

Phrase: "significantly fewer mitochondria per field"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026237:Mitochondria [Cell Component]

Phrase: "in mutant MyHC hearts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0018787:Hearts [Body Part, Organ, or Organ Component]
   766 E C1281570:Heart [Body Part, Organ, or Organ Component]
   709   C0678941:mutant gene [Gene or Genome]

Phrase: "(27.8vs. 38.6mitochondria/field"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   804   C1521738:Field [Conceptual Entity]
   804   C2346620:Field [Conceptual Entity]
   804   C2349184:Field [Conceptual Entity]
   804   C3539073:FIELD [Spatial Concept]

Phrase: "in MyHC"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420192:heavy chain [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C0439539:Heavy [Qualitative Concept]
   812   C1524075:Chain [Idea or Concept]

Phrase: "vs. NTG hearts,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018787:Hearts [Body Part, Organ, or Organ Component]
   827 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "P<0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.117: Finally, mutant MyHC mitochondria were significantly larger (1.5-fold, P<0.0001) than those in the NTG hearts (Fig. 1e). 

Phrase: "Finally,"

Phrase: "mutant MyHC mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0026237:Mitochondria [Cell Component]
   709   C0678941:mutant gene [Gene or Genome]

Phrase: "were"

Phrase: "significantly larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443228:larger [Quantitative Concept]
   861   C0549177:Larger [Quantitative Concept]
   861   C1704243:Larger [Quantitative Concept]

Phrase: "(1.5-fold,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "P<0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "than those"

Phrase: "in the NTG hearts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018787:Hearts [Body Part, Organ, or Organ Component]
   827 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1e"

Phrase: ")."
Processing 00000000.tx.118: The mitochondrial ultrastructural alterations observed in the mutant MyHC mice were similar to those previously described in the (5wk old) mutant R92Q cTnT transgenic mouse model of HCM (40). 

Phrase: "The mitochondrial ultrastructural alterations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   793   C1515926:Alteration [Idea or Concept]

Phrase: "observed in the mutant MyHC mice"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1420192:heavy chain [Gene or Genome]
   762   C0678941:Gene Mutant [Gene or Genome]
   762   C1417166:MICE gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0337112:Chain [Manufactured Object]
   742   C0439539:Heavy [Qualitative Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1441672:Observed [Functional Concept]
   742   C1524075:Chain [Idea or Concept]

Phrase: "were"

Phrase: "similar to those previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "in the (5wk old) mutant R92Q cTnT transgenic mouse model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   813   C1519606:Transgenic Model [Experimental Model of Disease]
   804   C2986594:Mouse Model [Experimental Model of Disease]
   790   C3161035:Model [Intellectual Product]

Phrase: "of HCM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   861   C0020564:Hypertrophic [Pathologic Function]
   861   C0333959:Hypertrophic [Functional Concept]
   861   C0878544:Cardiomyopathy [Disease or Syndrome]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.119: View larger version (118K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(118K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.120: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.121: Electron micrographs of sections from nontransgenic (NTG; a and b) and myosin heavy chain (MyHC) mutant (c and d) 8-mo-old male mouse hearts. 

Phrase: "Electron micrographs of sections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0013852:Electron [Quantitative Concept]
   770   C3463986:Electron [Bird]

Phrase: "from nontransgenic"

Phrase: "(NTG"

Phrase: ";"

Phrase: "a"

Phrase: "and"

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "myosin heavy chain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420192:heavy chain [Gene or Genome]
   827   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0337112:Chain [Manufactured Object]
   827   C0439539:Heavy [Qualitative Concept]
   827   C1524075:Chain [Idea or Concept]

Phrase: "(MyHC"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420192:heavy chain [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C0439539:Heavy [Qualitative Concept]
   812   C1524075:Chain [Idea or Concept]

Phrase: ")"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(c"

Phrase: "and"

Phrase: "d)"

Phrase: "8-mo-old male mouse hearts."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   810   C1512359:Mouse Heart [Tissue]
   799   C0018787:Hearts [Body Part, Organ, or Organ Component]
   766 E C1281570:Heart [Body Part, Organ, or Organ Component]
Processing 00000000.tx.122: Magnifications are as follows: 6,600 (a and b) and 11,600 (b and d). 

Phrase: "Magnifications"

Phrase: "are"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "6,600"

Phrase: "("

Phrase: "a"

Phrase: "and"

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "11,600"

Phrase: "(b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "d)."
Processing 00000000.tx.123: e: histogram showing the distribution of individual mitochondrial size in NTG and mutant MyHC analyzed from 11,600 electron micrographs. 

Phrase: "e"

Phrase: ":"

Phrase: "histogram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348974:Histogram [Manufactured Object]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the distribution of individual mitochondrial size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1522855:mitochondrial distribution [Cell Function]
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in NTG"

Phrase: "and"

Phrase: "mutant MyHC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C0678941:mutant gene [Gene or Genome]
   884   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1420192:heavy chain [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0439539:Heavy [Qualitative Concept]
   804   C1524075:Chain [Idea or Concept]

Phrase: "analyzed from 11,600 electron micrographs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0013852:Electron [Quantitative Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C3463986:Electron [Bird]
Processing 00000000.tx.124: *P<0.0001(unpaired t-test). 

Phrase: "*P<0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(unpaired t-test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1710574:Unpaired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.125: Mitochondrial respiration in transgenic mouse hearts. 

Phrase: "Mitochondrial respiration in transgenic mouse hearts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035203:Respiration [Physiologic Function]
   753   C0282636:respiration [Cell Function]
   753   C1160636:respiration [Biologic Function]
Processing 00000000.tx.126: To determine whether the rate of mitochondrial respiration is affected in these two transgenic models of HCM, cardiac mitochondria were isolated and oxygen consumption was measured (Table 1). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the rate of mitochondrial respiration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0231832:Rate of respiration [Clinical Attribute]
           Respiration Rate
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "is"

Phrase: "affected in these two transgenic models of HCM,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   748   C1519606:Transgenic Model [Experimental Model of Disease]
   742   C0003069:Transgenic [Animal]
   742   C0020564:Hypertrophic [Pathologic Function]
   742   C0205448:Two [Quantitative Concept]
   742   C0333959:Hypertrophic [Functional Concept]
   742   C0392760:Affected [Functional Concept]
   742   C0878544:Cardiomyopathy [Disease or Syndrome]
   742   C1314939:Affected [Functional Concept]
   742   C3161035:Models [Intellectual Product]
   708 E C0001721:Affect [Mental Process]

Phrase: "cardiac mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "oxygen consumption"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0030055:Oxygen Consumption [Clinical Attribute]
  1000   C1305742:oxygen consumption [Diagnostic Procedure]
   861   C0009830:Consumption [Activity]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.127: Mitochondria isolated from 4-mo-old mutant MyHC transgenic mouse hearts exhibited a 29.25% decrease (P0.001) in NADH-linked state 3(ADP dependent) respiration. 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "from 4-mo-old mutant MyHC transgenic mouse hearts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   788   C0018787:Hearts [Body Part, Organ, or Organ Component]
   784   C1512359:Mouse Heart [Tissue]
   755 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a 29.25% decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392756:Decrease [Qualitative Concept]
   827   C0547047:Decrease [Quantitative Concept]

Phrase: "(P0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417248:P0 [Gene or Genome]
   861   C1419691:P0 [Gene or Genome]

Phrase: ")"

Phrase: "in NADH-linked state 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C1301808:State [Geographic Area]
   812   C1442792:State [Functional Concept]
   812   C3148680:State [Geographic Area]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]

Phrase: "(ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: ")"

Phrase: "respiration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035203:Respiration [Physiologic Function]
  1000   C0282636:respiration [Cell Function]
  1000   C1160636:respiration [Biologic Function]
Processing 00000000.tx.128: State 3respiratory rates were 187.8424.61and 132.9019.20nmol O2 min1 mg mitochondrial protein1 in NTG and mutant MyHC mice, respectively. 

Phrase: "State 3respiratory rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "187.8424.61and 132.9019.20nmol O2 min1 mg mitochondrial protein1"

Phrase: "in NTG"

Phrase: "and"

Phrase: "mutant MyHC mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   709   C0678941:mutant gene [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.129: Mitochondria isolated from 8-mo-old mutant MyHC mice demonstrated a similar 22.64% decrease in NADH-linked respiration compared with age-matched littermate NTG controls (P0.01). 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 8-mo-old mutant MyHC mice"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   775   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1420192:heavy chain [Gene or Genome]
   754   C0678941:Gene Mutant [Gene or Genome]
   754   C1417166:MICE gene [Gene or Genome]
   738   C0017337:Gene [Gene or Genome]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205409:Isolated [Functional Concept]
   738   C0337112:Chain [Manufactured Object]
   738   C0439539:Heavy [Qualitative Concept]
   738   C0580836:Old [Temporal Concept]
   738   C0596988:Mutant [Cell or Molecular Dysfunction]
   738   C1524075:Chain [Idea or Concept]
   738   C1548221:Isolated [Idea or Concept]
   738   C3538743:MO [Idea or Concept]
   704 E C0370215:Isolate [Substance]
   704 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "demonstrated"

Phrase: "a similar 22.64% decrease in NADH-linked respiration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "compared with age-matched littermate NTG controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0001779:Age [Organism Attribute]
   748   C0150103:matched [Research Activity]
   748   C1707455:Compared [Activity]
   748   C1708943:Matched [Qualitative Concept]
   714   C0243148:control [Qualitative Concept]
   714   C1550141:Control [Substance]
   714   C1882979:Control [Conceptual Entity]
   714   C2587213:Control [Functional Concept]
   714   C3274648:Control [Qualitative Concept]

Phrase: "(P0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417248:P0 [Gene or Genome]
   861   C1419691:P0 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.130: Rates were 181.9028.07and 140.7314.01nmol O2 min1 mg mitochondrial protein1 in NTG and mutant MyHC mice, respectively (Table 1). 

Phrase: "Rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "181.9028.07and 140.7314.01nmol O2 min1 mg mitochondrial protein1"

Phrase: "in NTG"

Phrase: "and"

Phrase: "mutant MyHC mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   709   C0678941:mutant gene [Gene or Genome]

Phrase: "respectively"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.131: In contrast to the mitochondria isolated from mutant MyHC transgenic mouse hearts, mitochondria isolated from 8-mo-old R92Q cTnT transgenic mouse hearts did not exhibit any significant decrease in state 3respiration compared with NTG controls (Table 1). 

Phrase: "In contrast to the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from mutant MyHC transgenic mouse hearts,"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   782   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025936:Mouse, Transgenic [Mammal]
   760   C1420192:heavy chain [Gene or Genome]
   757   C0678941:Gene Mutant [Gene or Genome]
   743   C1512359:Mouse Heart [Tissue]
   739   C0003069:Transgenic [Animal]
   739   C0017337:Gene [Gene or Genome]
   739   C0018787:Hearts [Body Part, Organ, or Organ Component]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205409:Isolated [Functional Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C0439539:Heavy [Qualitative Concept]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]
   739   C1524075:Chain [Idea or Concept]
   739   C1548221:Isolated [Idea or Concept]
   706 E C0370215:Isolate [Substance]
   706 E C1281570:Heart [Body Part, Organ, or Organ Component]
   706 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 8-mo-old R92Q cTnT transgenic mouse hearts"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   770   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0025936:Mouse, Transgenic [Mammal]
   753   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1096316:cardiac troponin [Laboratory Procedure]
   753   C1420827:TROPONIN T [Gene or Genome]
   736   C0003069:Transgenic [Animal]
   736   C0018787:Cardiac [Body Part, Organ, or Organ Component]
           Hearts
   736   C0025914:Mouse [Mammal]
   736   C0025929:mouse [Mammal]
   736   C0026809:Mouse [Mammal]
   736   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0205409:Isolated [Functional Concept]
   736   C0580836:Old [Temporal Concept]
   736   C1512359:Mouse Heart [Tissue]
   736   C1522601:Cardiac [Spatial Concept]
   736   C1548221:Isolated [Idea or Concept]
   736   C3538743:MO [Idea or Concept]
   703 E C0370215:Isolate [Substance]
   703 E C1281570:Heart [Body Part, Organ, or Organ Component]
   703 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "any significant decrease in state 3respiration"

Phrase: "compared with NTG controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1707455:Compared [Activity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.132: The state 3respiratory rate was 180.9611.52nmol O2 min1 mg mitochondrial protein1. 

Phrase: "The state 3respiratory rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "180.9611.52nmol O2 min1 mg mitochondrial protein1."
Processing 00000000.tx.133: It should be noted that mitochondrial respiration was unchanged in liver mitochondria isolated from age-matched mutant MyHC and R92Q cTnT mice, demonstrating that the dysfunction in mutant MyHC mice was specific to cardiac mitochondria (data not shown).  

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that mitochondrial respiration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035203:Respiration [Physiologic Function]
   861   C0282636:respiration [Cell Function]
   861   C1160636:respiration [Biologic Function]

Phrase: "was"

Phrase: "unchanged in liver mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442739:Unchanged [Finding]
   770   C2346711:Unchanged [Qualitative Concept]

Phrase: "isolated from age-matched mutant MyHC"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   790   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1420192:heavy chain [Gene or Genome]
   762   C0678941:Gene Mutant [Gene or Genome]
   742   C0001779:Age [Organism Attribute]
   742   C0017337:Gene [Gene or Genome]
   742   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0150103:matched [Research Activity]
   742   C0205409:Isolated [Functional Concept]
   742   C0337112:Chain [Manufactured Object]
   742   C0439539:Heavy [Qualitative Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1524075:Chain [Idea or Concept]
   742   C1548221:Isolated [Idea or Concept]
   742   C1708943:Matched [Qualitative Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "R92Q cTnT mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "demonstrating"

Phrase: "that"

Phrase: "the dysfunction in mutant MyHC mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031847:dysfunction [Functional Concept]
   742   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "was"

Phrase: "specific to cardiac mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.134: View this table: [in this window] [in a new window]  Table 1.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.135: Mitochondrial yield and respiratory activities No significant differences were observed in state 4(ADP independent) respiration in any of the transgenic mouse models studied (Table 1). 

Phrase: "Mitochondrial yield"

Phrase: "and"

Phrase: "respiratory activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "No significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in state 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "(ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "independent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085862:Independent [Idea or Concept]
  1000   C1299583:Independent [Finding]

Phrase: ")"

Phrase: "respiration in any of the transgenic mouse models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0035203:Respiration [Physiologic Function]
   744   C0282636:respiration [Cell Function]
   744   C1160636:respiration [Biologic Function]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.136: This suggests that mitochondrial oxidative phosphorylation was coupled and that no disruption to the inner membrane of the mitochondria occurred. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mitochondrial oxidative phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0030013:Oxidative Phosphorylation [Molecular Function]
   827   C0031715:Phosphorylation [Molecular Function]
   827   C0311404:Oxidative [Functional Concept]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "and"

Phrase: "that"

Phrase: "no disruption to the inner membrane of the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332453:Disruption [Functional Concept]

Phrase: "occurred."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.137: In addition, cardiac mitochondrial yields were not significantly different between NTG and transgenic mice. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "cardiac mitochondrial yields"

Phrase: "were"

Phrase: "not significantly different between NTG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.138: Therefore, the decrease in the ratio of state 3to state 4(respiratory control ratio) observed in the mutant MyHC transgenic mouse reflects damage to components responsible for oxidative phosphorylation. 

Phrase: "Therefore,"

Phrase: "the decrease in the ratio of state 3to state 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0392756:Decrease [Qualitative Concept]
   739   C0547047:Decrease [Quantitative Concept]

Phrase: "(respiratory control ratio"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   913   C0429743:Respiratory ratio [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C0521346:respiratory [Functional Concept]
   827   C1546767:Respiratory [Intellectual Product]
   827   C1547037:Ratio [Intellectual Product]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "observed in the mutant MyHC transgenic mouse"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   782   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025936:Mouse, Transgenic [Mammal]
   760   C1420192:heavy chain [Gene or Genome]
   757   C0678941:Gene Mutant [Gene or Genome]
   739   C0003069:Transgenic [Animal]
   739   C0017337:Gene [Gene or Genome]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0337112:Chain [Manufactured Object]
   739   C0439539:Heavy [Qualitative Concept]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]
   739   C1441672:Observed [Functional Concept]
   739   C1524075:Chain [Idea or Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "damage to components"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0010957:Damage [Injury or Poisoning]
   790   C1883709:Damage [Functional Concept]

Phrase: "responsible for oxidative phosphorylation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.139: Dehydrogenase activities. 

Phrase: "Dehydrogenase activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.140: It is widely accepted that the supply of NADH to the electron transport chain is the rate-controlling step of NADH-linked mitochondrial respiration (3, 5, 10, 17, 29). 

Phrase: "It"

Phrase: "is"

Phrase: "widely"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "that"

Phrase: "the supply of NADH"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243163:supply [Idea or Concept]
   770   C0699914:supply [Quantitative Concept]
   770   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   770   C1561604:supply [Functional Concept]
   770   C1875802:SUPPLY [Medical Device]
   770   C1999230:Supply [Activity]

Phrase: "to the electron transport chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2244392:electron transport chain [Molecular Function]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   734   C0013846:Electron Transport [Molecular Function]

Phrase: "is"

Phrase: "the rate-controlling step of NADH-linked mitochondrial respiration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1261552:Step [Conceptual Entity]
   742   C1704379:Step [Functional Concept]
   742   C1705117:Step [Quantitative Concept]
   742   C2825408:Step [Manufactured Object]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "10,"

Phrase: "17,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.141: Inactivation of dehydrogenases responsible for the synthesis of NADH would likely have adverse effects on mitochondrial respiratory function. 

Phrase: "Inactivation of dehydrogenases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "responsible for the synthesis of NADH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "would"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "adverse effects on mitochondrial respiratory function."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0001688:adverse effects [Functional Concept]
   790   C0879626:Adverse effects [Pathologic Function]
   756 E C0559546:Adverse Effect [Finding]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.142: Therefore, -KGDH was assayed because its activity is required for the synthesis of NADH from glutamate, the respiratory substrate used in the respiration assay. 

Phrase: "Therefore, -KGDH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "because"

Phrase: "its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "required for the synthesis of NADH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0220781:synthesis [Biologic Function]
   753   C1514873:Required [Functional Concept]
   753   C1883254:Synthesis [Activity]

Phrase: "from glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the respiratory substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "used in the respiration assay."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0035203:Respiration [Physiologic Function]
   760   C0243073:assay [Qualitative Concept]
   760   C0282636:respiration [Cell Function]
   760   C1160636:respiration [Biologic Function]
   760   C1273517:used [Finding]
   760   C1510438:Assay [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.143: Glutamate was chosen as an NADH-linked substrate based on comparisons of rates of oxygen consumption utilizing glutamate-malate, pyruvate-malate, and palmitoylcarnitine. 

Phrase: "Glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "chosen as an NADH-linked substrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C1707391:Chosen [Activity]
   753   C1710236:Substrate [Manufactured Object]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "based on comparisons of rates of oxygen consumption utilizing glutamate-malate,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   756   C0030055:Oxygen Consumption [Clinical Attribute]
   756   C1305742:oxygen consumption [Diagnostic Procedure]
   738   C0009830:Consumption [Activity]
   738   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   738   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   738   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0220873:malate [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   738   C1527178:Based [Functional Concept]
   738   C1705938:Based [Idea or Concept]
   738   C1947907:Consumption [Physiologic Function]
   704 E C0002055:base [Inorganic Chemical]
   704 E C0178499:Base [Chemical Viewed Functionally]
   704   C0871208:Rate [Activity]
   704   C1521828:Rate [Quantitative Concept]
   704   C1707455:Comparison [Activity]
   704 E C1880279:Base [Biomedical or Dental Material]

Phrase: "pyruvate-malate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220873:malate [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "palmitoylcarnitine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030242:Palmitoylcarnitine [Amino Acid, Peptide, or Protein,Vitamin]
Processing 00000000.tx.144: Our mitochondrial preparations exhibited the greatest rate of NADH-linked ADP-dependent (state 3) respiration with glutamate as the substrate. 

Phrase: "Our mitochondrial preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "the greatest rate of NADH-linked ADP-dependent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "(state 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: ")"

Phrase: "respiration with glutamate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035203:Respiration [Physiologic Function]
   790   C0282636:respiration [Cell Function]
   790   C1160636:respiration [Biologic Function]

Phrase: "as the substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.145: In our hands, the addition of malate did not enhance glutamate-supported respiration further. 

Phrase: "In our hands,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0018563:Hands [Body Part, Organ, or Organ Component]
   966 E C1281583:Hand [Body Part, Organ, or Organ Component]
   966 E C1552914:hand [Quantitative Concept]
   928 E C0024763:Manual [Intellectual Product,Manufactured Object]
   928 E C0175674:Manual [Functional Concept]

Phrase: "the addition of malate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "glutamate-supported respiration further."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035203:Respiration [Physiologic Function]
   812   C0282636:respiration [Cell Function]
   812   C1160636:respiration [Biologic Function]
Processing 00000000.tx.146: This is in contrast to liver or brain mitochondria, neither of which utilize glutamate efficiently in the absence of malate. 

Phrase: "This"

Phrase: "is in contrast to liver"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C1979874:Contrast [Qualitative Concept]
   760   C2346688:LIVER [Food]
   704 E C0205054:Hepatic [Body Location or Region]

Phrase: "or"

Phrase: "brain mitochondria,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0026237:Mitochondria [Cell Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "neither of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3274651:Neither [Qualitative Concept]

Phrase: "utilize"

Phrase: "glutamate efficiently in the absence of malate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   748   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.147: As shown in Table 2, -KGDH activity was significantly decreased by 27.78% (P0.002) in cardiac mitochondria isolated from 8-mo-old mutant MyHC mice. 

Phrase: "As"

Phrase: "shown in Table 2, -KGDH activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0039224:Table [Manufactured Object]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   748   C1706073:Table [Medical Device]
   748   C1706074:Table [Intellectual Product]
   714   C1547282:Show [Intellectual Product]

Phrase: "was"

Phrase: "significantly"

Phrase: "decreased by 27.78%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "(P0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417248:P0 [Gene or Genome]
   861   C1419691:P0 [Gene or Genome]

Phrase: ")"

Phrase: "in cardiac mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from 8-mo-old mutant MyHC mice."
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   775   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1420192:heavy chain [Gene or Genome]
   754   C0678941:Gene Mutant [Gene or Genome]
   754   C1417166:MICE gene [Gene or Genome]
   738   C0017337:Gene [Gene or Genome]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205409:Isolated [Functional Concept]
   738   C0337112:Chain [Manufactured Object]
   738   C0439539:Heavy [Qualitative Concept]
   738   C0580836:Old [Temporal Concept]
   738   C0596988:Mutant [Cell or Molecular Dysfunction]
   738   C1524075:Chain [Idea or Concept]
   738   C1548221:Isolated [Idea or Concept]
   738   C3538743:MO [Idea or Concept]
   704 E C0370215:Isolate [Substance]
   704 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.148: Rates were 111.2014.22and 80.3014.42nmol NADH min1 mg protein1 in NTG and mutant MyHC mice, respectively. 

Phrase: "Rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "111.2014.22and 80.3014.42nmol NADH min1 mg protein1"

Phrase: "in NTG"

Phrase: "and"

Phrase: "mutant MyHC mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   709   C0678941:mutant gene [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.149: It is interesting to note that the decrease in -KGDH directly paralleled the loss in state 3respiration observed in the mutant MyHC transgenic mice. 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the decrease in -KGDH directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "paralleled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C2348042:Parallel [Qualitative Concept]
   966   C2826345:PARALLEL [Research Activity]

Phrase: "the loss in state 3respiration"

Phrase: "observed in the mutant MyHC transgenic mice."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   782   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025936:Mice, Transgenic [Mammal]
   760   C1420192:heavy chain [Gene or Genome]
   757   C0678941:Gene Mutant [Gene or Genome]
   757   C1417166:MICE gene [Gene or Genome]
   739   C0003069:Transgenic [Animal]
   739   C0017337:Gene [Gene or Genome]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0337112:Chain [Manufactured Object]
   739   C0439539:Heavy [Qualitative Concept]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]
   739   C1441672:Observed [Functional Concept]
   739   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.150: -KGDH activity measured from cardiac mitochondria isolated from R92Q cTnT mutant mice was unchanged compared with NTG controls. 

Phrase: "-KGDH activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "measured from cardiac mitochondria"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0449770:Measured from [Quantitative Concept]
   802   C0588131:Cardiac measure [Diagnostic Procedure]
   770   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   770   C0026237:Mitochondria [Cell Component]
   770   C0444706:Measured [Qualitative Concept]
   770   C1522601:Cardiac [Spatial Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "isolated from R92Q cTnT mutant mice"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   800   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1096316:cardiac troponin [Laboratory Procedure]
   770   C1420827:TROPONIN T [Gene or Genome]
   744   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205409:Isolated [Functional Concept]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C1522601:Cardiac [Spatial Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "was"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "compared with NTG controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1707455:Compared [Activity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.151: The rate was 106.0811.58nmol NADH min1 mg mitochondrial protein1 for the R92Q cTnT mutant mice. 

Phrase: "The rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "106.0811.58nmol NADH min1 mg mitochondrial protein1"

Phrase: "for the R92Q cTnT mutant mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
Processing 00000000.tx.152: Glutamate dehydrogenase (GDH) activity was unaffected in any of the transgenic mice studied. 

Phrase: "Glutamate dehydrogenase (GDH) activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151821:glutamate dehydrogenase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0017786:Glutamate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "unaffected in any of the transgenic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986417:Unaffected [Conceptual Entity]

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.153: These results identify -KGDH as a potential mediator of mitochondrial dysfunction in hearts isolated from mutant MyHC mice.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "identify -KGDH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as a potential mediator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "in hearts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018787:Hearts [Body Part, Organ, or Organ Component]
   966 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "isolated from mutant MyHC mice."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   800   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420192:heavy chain [Gene or Genome]
   767   C0678941:Gene Mutant [Gene or Genome]
   767   C1417166:MICE gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205409:Isolated [Functional Concept]
   744   C0337112:Chain [Manufactured Object]
   744   C0439539:Heavy [Qualitative Concept]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C1524075:Chain [Idea or Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.154: View this table: [in this window] [in a new window]  Table 2.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.155: -KGDH and GDH activities Complex activities. 

Phrase: "-KGDH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "GDH activities Complex activities."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C1151821:glutamate dehydrogenase activity [Molecular Function]
Processing 00000000.tx.156: Abnormalities in electron transport chain activities have been observed in various models of heart failure (1, 2, 46). 

Phrase: "Abnormalities in electron transport chain activities"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0000768:Abnormalities [Congenital Abnormality]
   753   C0000769:abnormalities [Functional Concept]
   719 E C1704258:Abnormality [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "observed in various models of heart failure"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0018801:Heart failure [Disease or Syndrome]
   778   C0018802:Heart Failure [Disease or Syndrome]
   748   C0018787:Heart [Body Part, Organ, or Organ Component]
   748   C0231174:Failure [Functional Concept]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C0680095:failure [Individual Behavior]
   748   C1281570:Heart [Body Part, Organ, or Organ Component]
   748   C1441672:Observed [Functional Concept]
   748   C3161035:Models [Intellectual Product]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.157: Therefore, NADH-linked electron transport chain complexes I, III, and IV were measured in mitochondria isolated from 8-mo-old mutant MyHC and R92Q cTnT mouse hearts. 

Phrase: "Therefore,"

Phrase: "NADH-linked electron transport chain complexes I,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   866   C1167290:electron transport complex I [Cell Component]
   866   C2363240:Electron Transport Complex I [Amino Acid, Peptide, or Protein,Enzyme]
   801   C2245017:Complex I [Cell Component]
   795   C0021966:I- [Inorganic Chemical]
   795   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "IV"

Phrase: "were"

Phrase: "measured in mitochondria"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0026237:Mitochondria [Cell Component]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "isolated from 8-mo-old mutant MyHC"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   782   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1420192:heavy chain [Gene or Genome]
   757   C0678941:Gene Mutant [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205409:Isolated [Functional Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C0439539:Heavy [Qualitative Concept]
   739   C0580836:Old [Temporal Concept]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]
   739   C1524075:Chain [Idea or Concept]
   739   C1548221:Isolated [Idea or Concept]
   739   C3538743:MO [Idea or Concept]
   706 E C0370215:Isolate [Substance]
   706 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "R92Q cTnT mouse hearts."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   810   C1512359:Mouse Heart [Tissue]
   799   C0018787:Hearts [Body Part, Organ, or Organ Component]
   766 E C1281570:Heart [Body Part, Organ, or Organ Component]
Processing 00000000.tx.158: Measurement of complex III revealed no significant decrease in activity of mitochondria isolated from either transgenic group (Table 3). 

Phrase: "Measurement of complex III"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "no significant decrease in activity of mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "isolated from either transgenic group"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0003069:Transgenic [Animal]
   760   C0205409:Isolated [Functional Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1548221:Isolated [Idea or Concept]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.159: A significant decrease in complex I activity was observed in mutant MyHC cardiac mitochondria. 

Phrase: "A significant decrease in complex I activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed in mutant MyHC cardiac mitochondria."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1420192:heavy chain [Gene or Genome]
   762   C0678941:Gene Mutant [Gene or Genome]
   762   C0949656:Cardiac Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0017337:Gene [Gene or Genome]
   742   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   742   C0026237:Mitochondria [Cell Component]
   742   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0337112:Chain [Manufactured Object]
   742   C0439539:Heavy [Qualitative Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1441672:Observed [Functional Concept]
   742   C1522601:Cardiac [Spatial Concept]
   742   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.160: The degree of inactivation was 18.90% with rates of 146.4415.65and 118.7711.88nmol NADH min1 mg mitochondrial protein1 in NTG and mutant MyHC mice, respectively (P0.004; Table 3). 

Phrase: "The degree of inactivation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "was"

Phrase: "18.90% with rates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "of 146.4415.65and 118.7711.88nmol NADH min1 mg mitochondrial protein1"

Phrase: "in NTG"

Phrase: "and"

Phrase: "mutant MyHC mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   709   C0678941:mutant gene [Gene or Genome]

Phrase: "respectively"

Phrase: "(P0.004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417248:P0 [Gene or Genome]
   861   C1419691:P0 [Gene or Genome]

Phrase: "; Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.161: Complex IV also exhibited a significant decrease in activity with rates of 779.0433.64and 699.9556.10nmol NADH min1 mg mitochondrial protein1 (P0.004). 

Phrase: "Complex IV also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0010760:Complex IV [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a significant decrease in activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "with rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]

Phrase: "of 779.0433.64and 699.9556.10nmol NADH min1 mg mitochondrial protein1"

Phrase: "(P0.004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417248:P0 [Gene or Genome]
   861   C1419691:P0 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.162: Complex I and IV activities of R92Q cTnT mutant mice were unchanged compared with NTG mice.  

Phrase: "Complex I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IV activities of R92Q cTnT mutant mice"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C0443168:Cardiac activity [Finding]
   742   C0441655:Activities [Activity]
   708 E C0205177:Activity [Functional Concept]
   708 E C0439167:% activity [Quantitative Concept]
   708 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "compared with NTG mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1707455:Compared [Activity]
Processing 00000000.tx.163: View this table: [in this window] [in a new window]  Table 3.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.164: NADH-linked electron transport chain activities ARKct/MyHC crossbreeding. 

Phrase: "NADH-linked electron transport chain activities ARKct/MyHC crossbreeding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   787   C0020202:Crossbreeding [Genetic Function]
   705   C0314613:Linked gene [Genetic Function]
Processing 00000000.tx.165: To begin to dissect the contribution of different pathways to the mitochondrial respiratory dysfunction seen in mutant MyHC mice, we examined the effect of manipulating -adrenergic function. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "dissect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissect [Functional Concept]

Phrase: "the contribution of different pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "to the mitochondrial respiratory dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C1260922:RESPIRATORY DYSFUNCTION NOS [Sign or Symptom]
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "seen in mutant MyHC mice,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   800   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420192:heavy chain [Gene or Genome]
   767   C0678941:Gene Mutant [Gene or Genome]
   767   C1417166:MICE gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205397:Seen [Qualitative Concept]
   744   C0337112:Chain [Manufactured Object]
   744   C0439539:Heavy [Qualitative Concept]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C1524075:Chain [Idea or Concept]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of manipulating -adrenergic function."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C3179174:Adrenergic Effect [Physiologic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.166: A ARKct/MyHC double-transgenic cross was originally developed to determine the role of ARK inhibition on the pathogenesis of disease in mutant MyHC mice. 

Phrase: "A ARKct/MyHC"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1420192:heavy chain [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0439539:Heavy [Qualitative Concept]
   804   C1524075:Chain [Idea or Concept]

Phrase: "double-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "transgenic cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828360:Cross [Conceptual Entity]

Phrase: "was"

Phrase: "originally"

Phrase: "developed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the role of ARK inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "on the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "in mutant MyHC mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   709   C0678941:mutant gene [Gene or Genome]
Processing 00000000.tx.167: These doubly transgenic mice exhibit a wild-type phenotype in terms of hemodynamic function, the lack of expression of hypertrophic markers, and exercise (14). 

Phrase: "These doubly transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a wild-type phenotype in terms of hemodynamic function,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031437:Phenotype [Organism Attribute]
   742   C1285572:Phenotype [Laboratory Procedure]

Phrase: "the lack of expression of hypertrophic markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332268:lack [Qualitative Concept]

Phrase: "and"

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.168: Therefore, mitochondrial morphology, respiratory rates, and enzymatic activities were measured in these doubly transgenic mice to determine the effect of ARK inhibition on mitochondrial dysfunction of mutant MyHC hearts. 

Phrase: "Therefore,"

Phrase: "mitochondrial morphology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "respiratory rates,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0231832:RESPIRATORY RATES [Clinical Attribute]
   966 E C0489258:Respiratory rate [Clinical Attribute]
   861   C0521346:respiratory [Functional Concept]
   861   C1546767:Respiratory [Intellectual Product]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "enzymatic activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C2267219:Enzymatic Activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "measured in these doubly transgenic mice to"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0025936:Mice, Transgenic [Mammal]
   774   C0449768:Measured to [Quantitative Concept]
   748   C0003069:Transgenic [Animal]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0444706:Measured [Qualitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "determine"

Phrase: "the effect of ARK inhibition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3179174:Adrenergic Effect [Physiologic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "of mutant MyHC hearts."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0018787:Hearts [Body Part, Organ, or Organ Component]
   766 E C1281570:Heart [Body Part, Organ, or Organ Component]
   709   C0678941:mutant gene [Gene or Genome]
Processing 00000000.tx.169: ARKct singly transgenic mice had no indication of mitochondrial ultrastructural abnormalities (Fig. 2c) compared with NTG mice (Fig. 2a). 

Phrase: "ARKct singly transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "no indication of mitochondrial ultrastructural abnormalities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0521090:No indication of [Qualitative Concept]
   753   C0392360:indication [Idea or Concept]
   753   C3146298:Indication [Functional Concept]

Phrase: "(Fig. 2c"

Phrase: ")"

Phrase: "compared with NTG mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1707455:Compared [Activity]

Phrase: "(Fig. 2a"

Phrase: ")."
Processing 00000000.tx.170: ARKct/MyHC crossbred mice exhibited disorganization of mitochondria in some limited regions of the heart, whereas, in other regions, the mitochondria appeared to be normal (Fig. 2d). 

Phrase: "ARKct/MyHC crossbred mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "disorganization of mitochondria"

Phrase: "in some limited regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of the heart,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "whereas"

Phrase: ","

Phrase: "in other regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "(Fig. 2d"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.171: Both the ARKct and ARKct/MyHC doubly transgenic mice exhibited state 3respiratory rates that were not significantly different from NTG mice at 8mo of age (Table 4). 

Phrase: "Both"

Phrase: "the ARKct"

Phrase: "and"

Phrase: "ARKct/MyHC doubly transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0025936:Mice, Transgenic [Mammal]
   793   C0003069:Transgenic [Animal]
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "state 3respiratory rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "not significantly different from NTG mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "at 8mo"

Phrase: "of age (Table 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0001779:Age [Organism Attribute]
   827   C0039224:Table [Manufactured Object]
   827   C1706073:Table [Medical Device]
   827   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.172: State 3respiration was 191.5430.51and 181.4916.65nmol O2 min1 mg mitochondrial protein1 for ARKct and ARKct/MyHC transgenic mice, respectively. 

Phrase: "State 3respiration"

Phrase: "was"

Phrase: "191.5430.51and 181.4916.65nmol O2 min1 mg mitochondrial protein1"

Phrase: "for ARKct"

Phrase: "and"

Phrase: "ARKct/MyHC transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0025936:Mice, Transgenic [Mammal]
   795   C0003069:Transgenic [Animal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "respectively."
Processing 00000000.tx.173: In addition, ARKct and ARKct/MyHC mice did not exhibit any significant difference in -KGDH or GDH activity (Table 4). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "ARKct"

Phrase: "and"

Phrase: "ARKct/MyHC mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "any significant difference in -KGDH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "GDH activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151821:glutamate dehydrogenase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0017786:Glutamate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.174: Comparatively, ARKct and ARKct/MyHC mutant mice did not exhibit any significant difference in any NADH-linked electron transport chain complex activities compared with NTG littermate controls. 

Phrase: "Comparatively,"

Phrase: "ARKct"

Phrase: "and"

Phrase: "ARKct/MyHC mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "any significant difference in any NADH-linked electron transport chain complex activities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1705241:*Difference [Quantitative Concept]
   736   C1705242:Difference [Qualitative Concept]

Phrase: "compared with NTG littermate controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.175: View larger version (164K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(164K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.176: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.177: Electron micrographs of sections from hearts of 8-mo-old NTG (a), MyHC mutant (b), COOH-terminal -adrenergic receptor kinase (ARKct; c), and ARKct/MyHC male mice (d). 

Phrase: "Electron micrographs of sections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0013852:Electron [Quantitative Concept]
   770   C3463986:Electron [Bird]

Phrase: "from hearts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018787:Hearts [Body Part, Organ, or Organ Component]
   966 E C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "of 8-mo-old NTG"

Phrase: "("

Phrase: "a"

Phrase: ")"

Phrase: ","

Phrase: "MyHC mutant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0678941:Gene Mutant [Gene or Genome]
   804   C0596988:Mutant [Cell or Molecular Dysfunction]
   717   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "COOH-terminal -adrenergic receptor kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(ARKct"

Phrase: "; c),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "ARKct/MyHC male mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "("

Phrase: "d)."
Processing 00000000.tx.178: Magnifications are 6,600.  

Phrase: "Magnifications"

Phrase: "are"

Phrase: "6,600."
Processing 00000000.tx.179: View this table: [in this window] [in a new window]  Table 4.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.180: Dehydrogenase activities and NADH-linked electron transport chain components  DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Although the basis for the diverse disease heterogeneity of HCM is unknown, it seems likely that different downstream cellular mechanisms resulting from the specific mutation contribute to the overall phenotype. 

Phrase: "Dehydrogenase activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "NADH-linked electron transport chain components  DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Although"

Phrase: "the basis for the diverse disease heterogeneity of HCM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1527178:Basis [Functional Concept]
   739   C1874451:Basis [Pharmacologic Substance]

Phrase: "is"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "it"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that different downstream cellular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "resulting from the specific mutation"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0026882:Mutation [Genetic Function]
   760   C0205369:Specific [Qualitative Concept]
   760   C0678226:resulting [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "contribute to the overall phenotype."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031437:Phenotype [Organism Attribute]
   760   C0282416:Overall [Intellectual Product]
   760   C1285572:Phenotype [Laboratory Procedure]
   760   C1561607:Overall [Qualitative Concept]
   760   C1880177:Contribute [Activity]
Processing 00000000.tx.181: In this study, we tested the hypothesis that alterations in mitochondrial structure and function may contribute to the diversity of phenotypes in HCM. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that alterations in mitochondrial structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   726   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "may"

Phrase: "contribute to the diversity of phenotypes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0031437:Phenotypes [Organism Attribute]
   753   C1880177:Contribute [Activity]
   753   C1880371:Diversity [Qualitative Concept]
   719 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "in HCM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   861   C0020564:Hypertrophic [Pathologic Function]
   861   C0333959:Hypertrophic [Functional Concept]
   861   C0878544:Cardiomyopathy [Disease or Syndrome]
Processing 00000000.tx.182: The conclusions of this paper are fourfold. 

Phrase: "The conclusions of this paper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707478:Conclusions [Idea or Concept]

Phrase: "are"

Phrase: "fourfold."
Processing 00000000.tx.183: First, overall mitochondrial respiratory dysfunction was demonstrated in the mutant MyHC but not the R92Q cTnT transgenic mouse model. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "overall mitochondrial respiratory dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C1260922:RESPIRATORY DYSFUNCTION NOS [Sign or Symptom]
   812   C0031847:dysfunction [Functional Concept]
   812   C0277785:Dysfunction, NOS [Qualitative Concept]
   756 E C0231174:Malfunction [Functional Concept]
   756 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "was"

Phrase: "demonstrated in the mutant MyHC"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420192:heavy chain [Gene or Genome]
   767   C0678941:Gene Mutant [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0337112:Chain [Manufactured Object]
   744   C0439539:Heavy [Qualitative Concept]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C1524075:Chain [Idea or Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the R92Q cTnT transgenic mouse model."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C1519606:Transgenic Model [Experimental Model of Disease]
   818   C2986594:Mouse Model [Experimental Model of Disease]
   795   C3161035:Model [Intellectual Product]
Processing 00000000.tx.184: Second, a decrease in a specific mitochondrial enzyme, -KGDH, was identified, which most likely contributes to the decrease in state 3respiration. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "a decrease in a specific mitochondrial enzyme, -KGDH,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205369:Specific [Qualitative Concept]
   742   C0392756:Decrease [Qualitative Concept]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C0547047:Decrease [Quantitative Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "which most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "contributes to the decrease in state 3respiration."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C1880177:Contribute [Activity]
   748   C3148680:State [Geographic Area]
Processing 00000000.tx.185: Third, mitochondrial dysfunction precedes hemodynamic dysfunction, consistent with a causal role. 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "precedes"

Phrase: "hemodynamic dysfunction,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "consistent with a causal role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.186: Finally, alterations in the -adrenergic pathway prevent mitochondrial dysfunction in mutant MyHC mice. 

Phrase: "Finally,"

Phrase: "alterations in the -adrenergic pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1515926:Alteration [Idea or Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "mitochondrial dysfunction in mutant MyHC mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031847:dysfunction [Functional Concept]
   742   C0277785:Dysfunction, NOS [Qualitative Concept]
Processing 00000000.tx.187: Thus this study suggests that mitochondrial function may play a role in the pathogenesis of and may contribute to heterogeneity of HCM. 

Phrase: "Thus"

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mitochondrial function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the pathogenesis of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "may"

Phrase: "contribute to heterogeneity of HCM."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   753   C0019409:Heterogeneity [Qualitative Concept]
   753   C0020564:Hypertrophic [Pathologic Function]
   753   C0333959:Hypertrophic [Functional Concept]
   753   C0878544:Cardiomyopathy [Disease or Syndrome]
   753   C1880177:Contribute [Activity]
Processing 00000000.tx.188: Mitochondria isolated from hearts of 4-mo-old mutant MyHC transgenic mice displayed a 29.3% decrease in activity that remained constant through 8mo of age. 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from hearts"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0018787:Hearts [Body Part, Organ, or Organ Component]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1281570:Heart [Body Part, Organ, or Organ Component]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "of 4-mo-old mutant MyHC transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0025936:Mice, Transgenic [Mammal]
   790   C0003069:Transgenic [Animal]
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a 29.3% decrease in activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "that remained constant through 8mo of age."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1547014:*Constant [Quantitative Concept]
   748   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.189: Because hemodynamic dysfunction is not present at 4mo of age, this result is consistent with the idea that the observed decrease in mitochondrial respiratory activity is not an effect of cardiac dysfunction but may play a causal or contributory role. 

Phrase: "Because"

Phrase: "hemodynamic dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present at 4mo of age,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001779:Age [Organism Attribute]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "this result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "consistent with the idea"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "the observed decrease in mitochondrial respiratory activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an effect of cardiac dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a causal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0015127:causality [Functional Concept]
   928   C1314792:Causalities [Functional Concept]

Phrase: "or"

Phrase: "contributory role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.190: Mitochondria isolated from R92Q cTnT transgenic mouse hearts did not demonstrate a significant decrease in mitochondrial respiration, despite some evidence of ultrastructural alterations (40). 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "isolated from R92Q cTnT transgenic mouse hearts"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   790   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0025936:Mouse, Transgenic [Mammal]
   764   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1096316:cardiac troponin [Laboratory Procedure]
   764   C1420827:TROPONIN T [Gene or Genome]
   748   C1512359:Mouse Heart [Tissue]
   742   C0003069:Transgenic [Animal]
   742   C0018787:Cardiac [Body Part, Organ, or Organ Component]
           Hearts
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205409:Isolated [Functional Concept]
   742   C1522601:Cardiac [Spatial Concept]
   742   C1548221:Isolated [Idea or Concept]
   708 E C0370215:Isolate [Substance]
   708 E C1281570:Heart [Body Part, Organ, or Organ Component]
   708 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "demonstrate"

Phrase: "a significant decrease in mitochondrial respiration,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "despite some evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "of ultrastructural alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.191: In addition, all NADH-linked electron transport chain components and dehydrogenases measured were unchanged in R92Q cTnT transgenic mice. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "all NADH-linked electron transport chain components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0449432:Components [Manufactured Object]
   766 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "dehydrogenases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030016:Dehydrogenases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "were"

Phrase: "unchanged in R92Q cTnT transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0442739:Unchanged [Finding]
   744   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.192: Therefore, although myocyte disorganization caused by mutations in contractile proteins may result in changes in mitochondrial morphology, the alterations do not always result in respiratory dysfunction. 

Phrase: "Therefore,"

Phrase: "although"

Phrase: "myocyte disorganization"

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in contractile proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009915:Contractile Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "result in changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in mitochondrial morphology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "the alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "do"

Phrase: "not always"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C2003902:Always [Temporal Concept]

Phrase: "result in respiratory dysfunction."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C1260922:RESPIRATORY DYSFUNCTION NOS [Sign or Symptom]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C0521346:respiratory [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1546767:Respiratory [Intellectual Product]
   770   C2825142:Result [Finding]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.193: Also, because mitochondrial respiration was not affected in this model and was significantly decreased in the mutant MyHC model, this offers a plausible mechanism for at least some of the heterogeneity of the distinct phenotypes exhibited by the two models. 

Phrase: "Also,"

Phrase: "because"

Phrase: "mitochondrial respiration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035203:Respiration [Physiologic Function]
   861   C0282636:respiration [Cell Function]
   861   C1160636:respiration [Biologic Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected in this model"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C3161035:Model [Intellectual Product]
   737 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "was"

Phrase: "significantly"

Phrase: "decreased in the mutant MyHC model,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1420192:heavy chain [Gene or Genome]
   762   C0678941:Gene Mutant [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0337112:Chain [Manufactured Object]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0439539:Heavy [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1524075:Chain [Idea or Concept]
   742   C3161035:Model [Intellectual Product]
   708 E C0547047:Decrease [Quantitative Concept]

Phrase: "this"

Phrase: "offers"

Phrase: "a plausible mechanism for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "some of the heterogeneity of the distinct phenotypes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0019409:Heterogeneity [Qualitative Concept]
   744   C0031437:Phenotypes [Organism Attribute]
   744   C0205392:Some [Quantitative Concept]
   744   C3540770:Some [Intellectual Product]
   711 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "exhibited by the two models."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205448:Two [Quantitative Concept]
   760   C3161035:Models [Intellectual Product]
   726   C0015272:Exhibit [Intellectual Product]
Processing 00000000.tx.194: Of the NADH-linked electron transport chain components measured, complexes I and IV exhibited decreases in mutant MyHC transgenic mice, whereas no significant differences were observed in R92Q cTnT mutant mice. 

Phrase: "Of the NADH-linked electron transport chain components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0449432:Components [Manufactured Object]
   766 E C1705248:Component [Conceptual Entity]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "complexes I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IV exhibited decreases in mutant MyHC transgenic mice,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0547047:decreases [Quantitative Concept]
   704 E C0392756:Decrease [Qualitative Concept]

Phrase: "whereas"

Phrase: "no significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed in R92Q cTnT mutant mice."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1096316:cardiac troponin [Laboratory Procedure]
   770   C1420827:TROPONIN T [Gene or Genome]
   744   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C1441672:Observed [Functional Concept]
   744   C1522601:Cardiac [Spatial Concept]
Processing 00000000.tx.195: In addition, cardiac mitochondria from MyHC but not R92Q cTnT mutants exhibited declines in NADH-linked state 3respiration and inhibition of the tricarboxylic acid cycle enzyme -KGDH. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "cardiac mitochondria from MyHC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0026237:Mitochondria [Cell Component]

Phrase: "but"

Phrase: "not R92Q cTnT mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "declines in NADH-linked state 3respiration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "inhibition of the tricarboxylic acid cycle enzyme -KGDH."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0877008:enzyme inhibition [Disease or Syndrome]
   762   C1524081:Enzyme Inhibition [Physiologic Function]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]
Processing 00000000.tx.196: It has previously been demonstrated that when cardiac mitochondria were titrated with varying concentrations of the specific complex I inhibitor rotenone, declines in mitochondrial respiratory rates were evident only when complex I had been inhibited by >50% (22). 

Phrase: "It"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "when"

Phrase: "cardiac mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "titrated with varying concentrations of the specific complex I inhibitor rotenone,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   756   C2245017:Complex I [Cell Component]
   738   C0021966:I- [Inorganic Chemical]
   738   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]
   738   C0086045:Concentrations [Mental Process]
   738   C0205369:Specific [Qualitative Concept]
   738   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0439855:Complex [Qualitative Concept]
   738   C1552740:specific [Intellectual Product]
   738   C1704241:Complex [Chemical Viewed Structurally]
   738   C1999216:Inhibitor [Qualitative Concept]
   704 E C1446561:Concentration [Quantitative Concept]
   704   C1883350:Titrate [Health Care Activity]

Phrase: "declines in mitochondrial respiratory rates"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0231832:RESPIRATORY RATES [Clinical Attribute]
   773 E C0489258:Respiratory rate [Clinical Attribute]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521346:respiratory [Functional Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C1546767:Respiratory [Intellectual Product]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "evident only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]
   789   C0332120:Evidence [Functional Concept]

Phrase: "when"

Phrase: "complex I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "had"

Phrase: "been"

Phrase: "inhibited by"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   833   C0311403:Inhibited [Qualitative Concept]
   761 E C0018790:arrested [Disease or Syndrome]
   761 E C0237477:Arrest [Temporal Concept]
   761 E C0392351:arrest [Governmental or Regulatory Activity]
   761 E C0521111:Retarded [Qualitative Concept]
   740 E C3463820:Inhibiting [Activity]

Phrase: ">50%"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.197: In contrast, when cardiac mitochondria were treated with a specific inhibitor of -KGDH, a 1:1 relationship between the degree to which NADH-linked state 3respiration was inhibited and the magnitude of -KGDH inactivation was observed (16, 17). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "when"

Phrase: "cardiac mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]

Phrase: "were"

Phrase: "treated with a specific inhibitor of -KGDH,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205369:Specific [Qualitative Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1552740:specific [Intellectual Product]
   744   C1999216:Inhibitor [Qualitative Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "a 1"

Phrase: ":"

Phrase: "1 relationship between the degree"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "to which NADH-linked state 3respiration"

Phrase: "was"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "and"

Phrase: "the magnitude of -KGDH inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.198: In the current study, the magnitude to which complex I was inhibited in cardiac mitochondria from mutant MyHC mice is <50% (18.90%). 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the magnitude to which complex I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449286:magnitude [Quantitative Concept]
   753   C1704240:Magnitude [Quantitative Concept]

Phrase: "was"

Phrase: "inhibited in cardiac mitochondria"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0018790:Cardiac Arrest [Disease or Syndrome]
   770   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   770   C0026237:Mitochondria [Cell Component]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C1522601:Cardiac [Spatial Concept]

Phrase: "from mutant MyHC mice is <50%"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   850   C0678941:mutant gene [Gene or Genome]
   835   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1420192:heavy chain [Gene or Genome]
   793   C0017337:Gene [Gene or Genome]
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]
   793   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0337112:Chain [Manufactured Object]
   793   C0439539:Heavy [Qualitative Concept]
   793   C0596988:Mutant [Cell or Molecular Dysfunction]
   793   C1524075:Chain [Idea or Concept]

Phrase: "(18.90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.199: This defect is therefore unlikely to contribute significantly to observed declines in NADH-linked state 3respiration. 

Phrase: "This defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1457869:Defect [Functional Concept]
  1000   C1861101:DEFECT [Disease or Syndrome]

Phrase: "is"

Phrase: "therefore unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0750558:Unlikely [Conceptual Entity]
   827   C1710571:Unlikely [Qualitative Concept]

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "significantly to observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "declines in NADH-linked state 3respiration."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]
Processing 00000000.tx.200: In contrast, the magnitude of -KGDH inactivation (27.78%) was closely paralleled by the degree to which the state 3respiratory rate declined (22.64%). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the magnitude of -KGDH inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "(27.78%"

Phrase: ")"

Phrase: "was"

Phrase: "closely"

Phrase: "paralleled by the degree"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]
   737   C2348042:Parallel [Qualitative Concept]
   737   C2826345:PARALLEL [Research Activity]

Phrase: "to which"

Phrase: "the state 3respiratory rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "declined"

Phrase: "(22.64%"

Phrase: ")."
Processing 00000000.tx.201: Therefore, with glutamate as the respiratory substrate, -KGDH inhibition appears responsible in a large part for inhibition of state 3respiration. 

Phrase: "Therefore,"

Phrase: "with glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as the respiratory substrate, -KGDH inhibition"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   818   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0021467:Inhibition [Mental Process]
   795   C0021469:Inhibition [Molecular Function]
   795   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0521346:respiratory [Functional Concept]
   795   C1546767:Respiratory [Intellectual Product]
   795   C1628982:% inhibition [Quantitative Concept]
   795   C1710236:Substrate [Manufactured Object]
   795   C3463820:Inhibition [Activity]
   724 E C0311403:Inhibited [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "responsible in a large part"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "for inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of state 3respiration."
Processing 00000000.tx.202: Although the observed decrease in complex I and IV activities may not be directly responsible for the loss in mitochondrial respiration, this process may play an alternative role(s) in the decrease in mitochondrial respiratory activity in the MyHC transgene. 

Phrase: "Although"

Phrase: "the observed decrease in complex I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "IV activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "directly responsible for the loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in mitochondrial respiration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035203:Respiration [Physiologic Function]
   861   C0282636:respiration [Cell Function]
   861   C1160636:respiration [Biologic Function]

Phrase: "this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an alternative role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "("

Phrase: "s) in the decrease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C2603362:S' [Clinical Attribute]

Phrase: "in mitochondrial respiratory activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "in the MyHC transgene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0282641:Transgene [Gene or Genome]
   717   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.203: The mechanisms responsible for decreases in complex I and IV activities and their potential role in mitochondrial dysfunction in the pathogenesis of HCM need to be further investigated. 

Phrase: "The mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for decreases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "in complex I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IV activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "their potential role in mitochondrial dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of HCM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   861   C0020564:Hypertrophic [Pathologic Function]
   861   C0333959:Hypertrophic [Functional Concept]
   861   C0878544:Cardiomyopathy [Disease or Syndrome]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.204: The downstream functional consequences of mutations in sarcomeric proteins linked to HCM in humans are not well understood. 

Phrase: "The downstream functional consequences of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "in sarcomeric proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "linked to HCM"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   770   C0020564:Hypertrophic [Pathologic Function]
   770   C0333959:Hypertrophic [Functional Concept]
   770   C0878544:Cardiomyopathy [Disease or Syndrome]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "are"

Phrase: "not well understood."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   793   C0162340:Understand [Mental Process]
Processing 00000000.tx.205: However, several hypotheses on the mechanisms involved in the development of the diverse phenotypes are being investigated. 

Phrase: "However,"

Phrase: "several hypotheses on the mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1512571:Hypothesis [Idea or Concept]

Phrase: "involved in the development of the diverse phenotypes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0031437:Phenotypes [Organism Attribute]
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1314939:Involved [Functional Concept]
   744   C1527148:Development [Functional Concept]
   744   C1880371:Diverse [Qualitative Concept]
   711 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "are"

Phrase: "being"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.206: One area of intense investigation is the role that Ca2+ plays in the pathogenesis of heart disease. 

Phrase: "One area of intense investigation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Area [Geographic Area]
   760   C0205146:Area [Spatial Concept]

Phrase: "is"

Phrase: "the role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "that Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "plays in the pathogenesis of heart disease."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   805   C0018799:Diseases of the heart [Disease or Syndrome]
           Heart disease
   748   C0012634:Disease [Disease or Syndrome]
   748   C0018787:Heart [Body Part, Organ, or Organ Component]
   748   C0032214:Play [Daily or Recreational Activity]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0600138:Plays [Finding]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1281570:Heart [Body Part, Organ, or Organ Component]
Processing 00000000.tx.207: In fact, it has long been known that chronic elevation of intracellular Ca2+ is associated with the development of heart failure (7, 15, 27, 36). 

Phrase: "In fact,"

Phrase: "it"

Phrase: "has"

Phrase: "long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "been"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that chronic elevation of intracellular Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]

Phrase: "is"

Phrase: "associated with the development of heart failure"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   778   C0018801:Heart failure [Disease or Syndrome]
   778   C0018802:Heart Failure [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C1749797:development heart [Organ or Tissue Function]
   748   C0018787:Heart [Body Part, Organ, or Organ Component]
   748   C0231174:Failure [Functional Concept]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C0680095:failure [Individual Behavior]
   748   C1281570:Heart [Body Part, Organ, or Organ Component]
   748   C1527148:Development [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(7,"

Phrase: "15,"

Phrase: "27,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.208: Myocytes isolated from mutant MyHC mouse myocardium exhibit prolonged Ca2+ cycling (M.C.Olsson, B.M.Palmer, L.A.Leinwand, and R.L.Moore, unpublished observations). 

Phrase: "Myocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596981:Myocytes [Cell]

Phrase: "isolated from mutant MyHC mouse myocardium exhibit prolonged Ca2+ cycling"
Meta Candidates (Total=22; Excluded=2; Pruned=0; Remaining=20)
   766   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1420192:heavy chain [Gene or Genome]
   749   C0678941:Gene Mutant [Gene or Genome]
   749   C1413043:CA2 gene [Gene or Genome]
   735   C0015272:Exhibit [Intellectual Product]
   735   C0017337:Gene [Gene or Genome]
   735   C0025914:Mouse [Mammal]
   735   C0025929:mouse [Mammal]
   735   C0026809:Mouse [Mammal]
   735   C0027061:Myocardium [Tissue]
   735   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   735   C0205409:Isolated [Functional Concept]
   735   C0337112:Chain [Manufactured Object]
   735   C0439539:Heavy [Qualitative Concept]
   735   C0439590:Prolonged [Temporal Concept]
   735   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   735   C0596988:Mutant [Cell or Molecular Dysfunction]
   735   C1524075:Chain [Idea or Concept]
   735   C1548221:Isolated [Idea or Concept]
   702 E C0370215:Isolate [Substance]
   702   C1511572:Cycle [Temporal Concept]
   702 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(M.C.Olsson,"

Phrase: "B.M.Palmer,"

Phrase: "L.A.Leinwand,"

Phrase: "and"

Phrase: "R.L.Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0443030:moore [Intellectual Product]

Phrase: "unpublished observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.209: In contrast, it has been recently reported that myofibrils from R92Q cTnT mutant mice have increased Ca2+ sensitivity of tension development, resulting in hypercontractility (6). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that myofibrils from R92Q cTnT mutant mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0027075:Myofibrils [Cell Component]

Phrase: "have"

Phrase: "increased Ca2+ sensitivity of tension development,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C1881189:INCREASED SENSITIVITY [Phenomenon or Process]
   783   C2346484:INCREASED SENSITIVITY [Phenomenon or Process]
           SENSITIVITY
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "resulting in hypercontractility"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   882   C0332294:Resulting in [Functional Concept]
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.210: Mitochondria can sequester large amounts of Ca2+ from the cytosol, which can be deleterious in pathological states (12). 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "can"

Phrase: "sequester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:sequester [Functional Concept]

Phrase: "large amounts of Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "from the cytosol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "deleterious in pathological states"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.211: The prolongation of Ca2+ transients in mutant MyHC transgenic mice may therefore result in an increase in mitochondrial Ca2+ concentrations. 

Phrase: "The prolongation of Ca2+ transients"

Phrase: "in mutant MyHC transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0025936:Mice, Transgenic [Mammal]
   795   C0003069:Transgenic [Animal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "may"

Phrase: "therefore"

Phrase: "result in an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442805:Increase [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in mitochondrial Ca2+ concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.212: In vitro studies have shown that increased accumulation of mitochondrial Ca2+ can stimulate calcium-dependent proteases, nucleases, and phospholipases, such as phospholipase 2(PLA2) (23, 31). 

Phrase: "In vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that increased accumulation of mitochondrial Ca2+"

Phrase: "can"

Phrase: "stimulate"

Phrase: "calcium-dependent proteases,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0851827:Dependent [Qualitative Concept]
   827   C1701901:Dependent [Qualitative Concept]
   827   C1947941:Proteases [Enzyme]
   827   C2936886:Calcium [Pharmacologic Substance]
   827   C3244310:dependent [Functional Concept]

Phrase: "nucleases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597094:nucleases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "phospholipases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031671:Phospholipases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "such as phospholipase 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(PLA2) (23,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450348:23 [Quantitative Concept]
   861   C3540622:PLA2 [Gene or Genome]

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.213: Activation of PLA2 results in an increase in the concentration of acrachidonic acid. 

Phrase: "Activation of PLA2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "results in an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442805:Increase [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in the concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of acrachidonic acid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.214: In vitro studies have reported that complex I is inhibited by arachidonic acid (12, 30). 

Phrase: "In vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that complex I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "inhibited by arachidonic acid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0003695:Arachidonic Acid [Eicosanoid]
   833   C2316832:Arachidonic Acid [Laboratory Procedure]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0311403:Inhibited [Qualitative Concept]

Phrase: "(12,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.215: Arachidonic acid has been reported to inhibit complex I, uncouple mitochondrial respiration, and induce the permeability transition. 

Phrase: "Arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "complex I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "uncouple"

Phrase: "mitochondrial respiration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035203:Respiration [Physiologic Function]
   861   C0282636:respiration [Cell Function]
   861   C1160636:respiration [Biologic Function]

Phrase: "and"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the permeability transition."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0031164:Permeability [Natural Phenomenon or Process]
   861   C0599156:Transition [Cell or Molecular Dysfunction]
   861   C2700061:Transition [Activity]
   789 E C0205326:Permeable [Functional Concept]
   789 E C1182674:Transitional [Spatial Concept]
   789 E C1548597:Transitional [Idea or Concept]
Processing 00000000.tx.216: Complex I inhibition may be due to tight associations between arachidonic acid and this multisubunit enzyme. 

Phrase: "Complex I inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]
   734   C2245017:Complex I [Cell Component]

Phrase: "may"

Phrase: "be due to tight associations"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0004083:Associations [Mental Process]
   760   C0439816:Tight [Qualitative Concept]
   760   C0453911:tight [Manufactured Object]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]
   726 E C0439849:Association [Qualitative Concept]
   726 E C0596306:Association [Phenomenon or Process]
   726 E C0699792:association [Social Behavior]

Phrase: "between arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "this multisubunit enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.217: Uncoupling, as manifested by high rates of state 4respiration, may result from interactions between free arachidonic acid and mitochondrial membranes, thereby enabling collapse of the proton gradient independent of ATP synthesis. 

Phrase: "Uncoupling"

Phrase: ","

Phrase: "as"

Phrase: "manifested by high rates of state 4respiration,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1280444:Manifested by [Qualitative Concept]
           manifested
   748   C0205250:High [Qualitative Concept]
   748   C0205319:manifested [Functional Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C2700149:HIGH [Intellectual Product]
   748   C3148680:State [Geographic Area]
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "may"

Phrase: "result from interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   756   C1704675:Interaction [Functional Concept]

Phrase: "between free arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003695:Arachidonic Acid [Eicosanoid]
   901   C2316832:Arachidonic Acid [Laboratory Procedure]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "mitochondrial membranes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0596952:Mitochondrial Membranes [Cell Component]
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "thereby"

Phrase: "enabling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1171285:Enabling [Mental Process]
   966 E C0562342:enable [Mental Process]

Phrase: "collapse of the proton gradient"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0036974:collapse [Pathologic Function]
   760   C0332521:Collapse [Phenomenon or Process]
   760   C0344329:Collapse [Finding]
   760   C1880118:COLLAPSE [Phenomenon or Process]

Phrase: "independent of ATP synthesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1157223:ATP synthesis [Molecular Function]
  1000   C1510700:ATP Synthesis [Functional Concept]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]
Processing 00000000.tx.218: In this study, the mitochondria are not uncoupled as reflected by relatively low state 4respiratory rates (and respiratory control ratio values >6). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "uncoupled"

Phrase: "as"

Phrase: "reflected by relatively low state 4respiratory rates"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0205251:low [Qualitative Concept]
   748   C0558058:reflected [Mental Process]
   748   C1299352:Low [Qualitative Concept]
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C1550472:low [Idea or Concept]
   748   C3148680:State [Geographic Area]
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "("

Phrase: "and"

Phrase: "respiratory control ratio values"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C1532109:Ratio value [Quantitative Concept]
   812   C0042295:Values [Qualitative Concept]
   779 E C1522609:Value [Quantitative Concept]
   708   C0429743:Respiratory ratio [Finding]

Phrase: ">6"

Phrase: ")."
Processing 00000000.tx.219: This is likely because during mitochondrial preparation, free arachidonic acid is not retained within the mitochondria and the effects of free arachidonic acid (e.g., uncoupled respiration and activation of the permeability transition) would not be expected to be evident. 

Phrase: "This"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "because during mitochondrial preparation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0026237:Mitochondrial [Cell Component]
   770   C0455052:Preparation [Health Care Activity]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C1521827:Preparation [Functional Concept]

Phrase: "free arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003695:Arachidonic Acid [Eicosanoid]
   901   C2316832:Arachidonic Acid [Laboratory Procedure]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "retained within the mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026237:Mitochondria [Cell Component]
   770   C0333118:Retained [Functional Concept]

Phrase: "and"

Phrase: "the effects of free arachidonic acid"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "uncoupled respiration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035203:Respiration [Physiologic Function]
   861   C0282636:respiration [Cell Function]
   861   C1160636:respiration [Biologic Function]

Phrase: "and"

Phrase: "activation of the permeability transition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: ")"

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "evident."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.220: Importantly, tight associations between complex I and arachidonic acid may be preserved and could contribute to the observed inhibition of complex I. 

Phrase: "Importantly,"

Phrase: "tight associations between complex I"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0004083:Associations [Mental Process]
   726 E C0439849:Association [Qualitative Concept]
   726 E C0596306:Association [Phenomenon or Process]
   726 E C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "preserved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033085:Preserved [Laboratory Procedure]

Phrase: "and"

Phrase: "could"

Phrase: "contribute to the observed inhibition of complex I."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C2245017:Complex I [Cell Component]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0021966:I- [Inorganic Chemical]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0439855:Complex [Qualitative Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]
   744   C1880177:Contribute [Activity]
   744   C3463820:Inhibition [Activity]
Processing 00000000.tx.221: Consistent with the notion that Ca2+ plays a role in the observed mitochondrial dysfunction is the fact that the -adrenergic pathway is responsible for the strength of cardiac contraction by regulation of Ca2+ cycling. 

Phrase: "Consistent with the notion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in the observed mitochondrial dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "the fact"

Phrase: "that"

Phrase: "the -adrenergic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "responsible for the strength of cardiac contraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "by regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of Ca2+ cycling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.222: Activation of cardiac -adrenergic receptors increases cardiac contraction by a number of different mechanisms. 

Phrase: "Activation of cardiac -adrenergic receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1514758:Receptor Activation [Cell Function]
   760   C1879547:Activation [Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "cardiac contraction by a number of different mechanisms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027045:cardiac contraction [Organ or Tissue Function]
   744   C1140999:Contraction [Pathologic Function]
Processing 00000000.tx.223: However, continual adrenergic activation, which is observed in clinical cardiac failure and in the mutant MyHC transgenic mouse, results in an upregulation of ARK1, an uncoupler of the -adrenergic pathway. 

Phrase: "However,"

Phrase: "continual adrenergic activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "which"

Phrase: "is"

Phrase: "observed in clinical cardiac failure"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0018801:Cardiac Failure [Disease or Syndrome]
   806   C0018802:Cardiac Failure [Disease or Syndrome]
   797   C3640841:Clinical Failure [Finding]
   760   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   760   C0205210:Clinical [Qualitative Concept]
   760   C0231174:Failure [Functional Concept]
   760   C0680095:failure [Individual Behavior]
   760   C1441672:Observed [Functional Concept]
   760   C1522601:Cardiac [Spatial Concept]

Phrase: "and in the mutant MyHC transgenic mouse,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   782   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025936:Mouse, Transgenic [Mammal]
   760   C1420192:heavy chain [Gene or Genome]
   757   C0678941:Gene Mutant [Gene or Genome]
   739   C0003069:Transgenic [Animal]
   739   C0017337:Gene [Gene or Genome]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0337112:Chain [Manufactured Object]
   739   C0439539:Heavy [Qualitative Concept]
   739   C0596988:Mutant [Cell or Molecular Dysfunction]
   739   C1515981:And [Idea or Concept]
   739   C1524075:Chain [Idea or Concept]

Phrase: "results in an upregulation of ARK1,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]
   753   C1274040:Result [Functional Concept]
   753   C1420466:ARK1 [Gene or Genome]
   753   C1546471:Result [Idea or Concept]
   753   C1706168:ARK1 [Gene or Genome]
   753   C2825142:Result [Finding]

Phrase: "an uncoupler of the -adrenergic pathway."
Processing 00000000.tx.224: As a result, Ca2+ cycling is altered. 

Phrase: "As a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Ca2+ cycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "is"

Phrase: "altered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]
Processing 00000000.tx.225: Expression of a ARKct peptide inhibitor has been shown to provide beneficial effects in several models of cardiomyopathy (14, 35). 

Phrase: "Expression of a ARKct peptide inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "beneficial effects in several models of cardiomyopathy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "(14,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.226: ARKct/MyHC doubly transgenic mice were not hypertrophied and were similar to the wild type with respect to hemodynamic function and exercise tolerance. 

Phrase: "ARKct/MyHC doubly transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0025936:Mice, Transgenic [Mammal]
   793   C0003069:Transgenic [Animal]
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "hypertrophied"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020564:hypertrophied [Pathologic Function]

Phrase: "and"

Phrase: "were"

Phrase: "similar to the wild type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "with respect to hemodynamic function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "exercise tolerance."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162521:Exercise Tolerance [Clinical Attribute]
   861   C0013220:Tolerance [Finding]
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0020963:Tolerance [Pathologic Function]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]
Processing 00000000.tx.227: The observed prevention of the cardiomyopathy seems likely due to the prevention of altered Ca2+ cycling observed in the mutant MyHC mice, and it is possible that the beneficial effects of ARK1 inhibition are due to other biological effects in cardiac myocytes than increased cardiac contractility. 

Phrase: "The observed prevention of the cardiomyopathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0199176:Prevention [Therapeutic or Preventive Procedure]
   753   C1706420:PREVENTION [Research Activity]
   753   C2700409:prevention [Qualitative Concept]

Phrase: "seems"

Phrase: "likely due to the prevention of altered Ca2+ cycling"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0199176:Prevention [Therapeutic or Preventive Procedure]
   742   C0332148:Likely [Qualitative Concept]
   742   C0392747:Altered [Functional Concept]
   742   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0750492:Likely [Idea or Concept]
   742   C1706420:PREVENTION [Research Activity]
   742   C2700409:prevention [Qualitative Concept]
   742   C3146286:Due [Idea or Concept]
   708   C1511572:Cycle [Temporal Concept]

Phrase: "observed in the mutant MyHC mice,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1420192:heavy chain [Gene or Genome]
   762   C0678941:Gene Mutant [Gene or Genome]
   762   C1417166:MICE gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0337112:Chain [Manufactured Object]
   742   C0439539:Heavy [Qualitative Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1441672:Observed [Functional Concept]
   742   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the beneficial effects of ARK1 inhibition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "are due to other biological effects"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0205460:biological [Qualitative Concept]
   753   C1280500:effects [Qualitative Concept]
   753   C1551058:Are [Quantitative Concept]
   753   C3146286:Due [Idea or Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in cardiac myocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0225828:Myocytes, Cardiac [Cell]
   861   C0596981:Myocytes [Cell]

Phrase: "than increased cardiac contractility."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   827   C1522601:Cardiac [Spatial Concept]
   755   C0026820:Contractile [Physiologic Function]
Processing 00000000.tx.228: For example, another possibility is that increased Ca2+ cycling in ARKct/MyHC mice may prevent Ca2+ sequestration by the mitochondria. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that increased Ca2+ cycling in ARKct/MyHC mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C1511572:Cycle [Temporal Concept]

Phrase: "may"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "Ca2+ sequestration by the mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443301:Sequestration [Functional Concept]
Processing 00000000.tx.229: Therefore, the potential role of Ca2+ mediated mechanisms of mitochondrial damage in mutant MyHC mice deserves attention. 

Phrase: "Therefore,"

Phrase: "the potential role of Ca2+ mediated mechanisms of mitochondrial damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "in mutant MyHC mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
   709   C0678941:mutant gene [Gene or Genome]

Phrase: "deserves"

Phrase: "attention."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004268:Attention [Mental Process]
Processing 00000000.tx.230: The majority of investigations into potential sites responsible for degeneration of mitochondrial function during the development of heart failure have focused on alterations in the activities and composition of various electron transport chain components. 

Phrase: "The majority of investigations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "into potential sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "responsible for degeneration of mitochondrial function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "during the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of heart failure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0018801:Heart failure [Disease or Syndrome]
  1000   C0018802:Heart Failure [Disease or Syndrome]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "have"

Phrase: "focused on alterations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205234:Focused [Spatial Concept]
   790   C1285542:focused [Functional Concept]
   756   C1515926:Alteration [Idea or Concept]

Phrase: "in the activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441655:Activities [Activity]
   966 E C0205177:Activity [Functional Concept]
   966 E C0439167:% activity [Quantitative Concept]
   966 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "composition of various electron transport chain components."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0486616:Composition [Clinical Attribute]
   748   C1555710:composition [Idea or Concept]
Processing 00000000.tx.231: The findings presented in this study indicate that other mechanisms can be responsible for the development of cardiac mitochondrial dysfunction. 

Phrase: "The findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "presented in this study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0449450:Presented [Idea or Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "indicate"

Phrase: "that"

Phrase: "other mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "can"

Phrase: "be"

Phrase: "responsible for the development of cardiac mitochondrial dysfunction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]
Processing 00000000.tx.232: It is well established that the supply of reducing equivalents (i.e., NADH) controls the rate of NADH-linked mitochondrial respiration and ATP synthesis (3, 5, 10, 17, 29). 

Phrase: "It"

Phrase: "is"

Phrase: "well established"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C0443211:Established [Qualitative Concept]
   861   C1272684:Established [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "that"

Phrase: "the supply of reducing equivalents"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243163:supply [Idea or Concept]
   760   C0699914:supply [Quantitative Concept]
   760   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   760   C1561604:supply [Functional Concept]
   760   C1875802:SUPPLY [Medical Device]
   760   C1999230:Supply [Activity]

Phrase: "(i.e., NADH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: ")"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the rate of NADH-linked mitochondrial respiration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0231832:Rate of respiration [Clinical Attribute]
           Respiration Rate
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "ATP synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1157223:ATP synthesis [Molecular Function]
  1000   C1510700:ATP Synthesis [Functional Concept]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "10,"

Phrase: "17,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.233: Thus, in contrast to electron transport, any alterations in concentrations of NADH would likely be reflected in the rate of NADH-linked mitochondrial respiration. 

Phrase: "Thus,"

Phrase: "in contrast to electron transport,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013846:Electron Transport [Molecular Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "any alterations in concentrations of NADH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "would"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "reflected in the rate of NADH-linked mitochondrial respiration."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   784   C0231832:Rate of respiration [Clinical Attribute]
           Respiration Rate
   742   C0026237:Mitochondrial [Cell Component]
   742   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   742   C0035203:Respiration [Physiologic Function]
   742   C0282636:respiration [Cell Function]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C0558058:reflected [Mental Process]
   742   C0871208:Rate [Activity]
   742   C1160636:respiration [Biologic Function]
   742   C1521828:Rate [Quantitative Concept]
   708   C1517892:Link [Intellectual Product]
   708   C1704666:Link [Intellectual Product]
Processing 00000000.tx.234: -KGDH, a multienzyme complex, has previously been reported to be responsible for mitochondrial dysfunction in cardiac ischemia-reperfusion injury, Alzheimer's disease, and Parkinson's disease (21, 19, 25, 28). 

Phrase: "-KGDH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a multienzyme complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "responsible for mitochondrial dysfunction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in cardiac ischemia-reperfusion injury,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C0035126:Ischemia-Reperfusion Injury [Injury or Poisoning]
           Reperfusion Injury
   887 E C0349419:Ischaemic reperfusion injury [Injury or Poisoning]
   812   C3263722:Injury [Injury or Poisoning]
   812   C3263723:Injury [Injury or Poisoning]

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(21,"

Phrase: "19,"

Phrase: "25,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.235: In vitro studies have revealed that selective inhibition of -KGDH leads to a loss in NADH-linked respiration, which directly correlates with the degree of -KGDH inactivation (16, 26). 

Phrase: "In vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that selective inhibition of -KGDH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "leads to a loss"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1517945:Loss [Quantitative Concept]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in NADH-linked respiration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035203:Respiration [Physiologic Function]
   827   C0282636:respiration [Cell Function]
   827   C1160636:respiration [Biologic Function]

Phrase: "which directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "correlates with the degree of -KGDH inactivation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0441889:Degree [Qualitative Concept]
   744   C0449286:Degree [Quantitative Concept]
   744   C0542560:Degree [Intellectual Product]
   744   C0544461:Inactivation [Cell or Molecular Dysfunction]
   744   C1561545:degree [Quantitative Concept]
   744   C2348088:Degree [Quantitative Concept]

Phrase: "(16,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.236: In addition, -KGDH is highly sensitive to free radical-mediated inactivation (16). 

Phrase: "In addition, -KGDH"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0150312:In [Quantitative Concept]
   812   C0332285:In [Spatial Concept]
   812   C1883712:Addition [Functional Concept]
   741 E C1524062:Additional [Functional Concept]

Phrase: "is"

Phrase: "highly sensitive to free radical-mediated inactivation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0332324:Sensitive to [Functional Concept]
           Sensitive
   778   C0439822:Highly sensitive [Qualitative Concept]
   748   C1550474:sensitive [Idea or Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.237: In the current study, the decrease in -KGDH activity in mutant MyHC transgenic mice reflected declines in mitochondrial respiration. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the decrease in -KGDH activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "in mutant MyHC transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0025936:Mice, Transgenic [Mammal]
   795   C0003069:Transgenic [Animal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "declines in mitochondrial respiration."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0026237:Mitochondrial [Cell Component]
   770   C0035203:Respiration [Physiologic Function]
   770   C0282636:respiration [Cell Function]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C1160636:respiration [Biologic Function]
Processing 00000000.tx.238: In contrast, GDH activity was unaffected in any of the transgenic mice, indicating the specificity of the affect to -KGDH. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "GDH activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151821:glutamate dehydrogenase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0017786:Glutamate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "unaffected in any of the transgenic mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986417:Unaffected [Conceptual Entity]

Phrase: "indicating"

Phrase: "the specificity of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "to -KGDH."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.239: This study has identified specific sites of enzymatic dysfunction responsible for the decrease in mitochondrial respiratory activity that play a role in the pathogenesis of HCM. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "identified specific sites of enzymatic dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   791   C0449686:Site of malfunction [Spatial Concept]
   773   C0449604:Specific site [Spatial Concept]
   773   C2945843:Site of [Qualitative Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "responsible for the decrease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in mitochondrial respiratory activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the pathogenesis of HCM."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.240: In summary, this study suggests a role of mitochondrial dysfunction in the heterogeneity of HCM. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role of mitochondrial dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "of HCM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   861   C0020564:Hypertrophic [Pathologic Function]
   861   C0333959:Hypertrophic [Functional Concept]
   861   C0878544:Cardiomyopathy [Disease or Syndrome]
Processing 00000000.tx.241: Furthermore, inhibition of ARK1 in the mutant MyHC transgenic mouse prevents mitochondrial dysfunction and offers plausible mechanisms responsible for the pathogenesis of HCM. 

Phrase: "Furthermore,"

Phrase: "inhibition of ARK1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "in the mutant MyHC transgenic mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0025936:Mouse, Transgenic [Mammal]
   795   C0003069:Transgenic [Animal]
   795   C0025914:Mouse [Mammal]
   795   C0025929:mouse [Mammal]
   795   C0026809:Mouse [Mammal]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "offers"

Phrase: "plausible mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for the pathogenesis of HCM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]
Processing 00000000.tx.242: Increasing knowledge in the relationship between mitochondrial calcium concentrations and oxidative damage to specific mitochondrial proteins responsible for mitochondrial dysfunction will likely result in the development of potential therapeutic agents for the treatment of HCM.  

Phrase: "Increasing knowledge in the relationship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0376554:Knowledge [Intellectual Product]

Phrase: "between mitochondrial calcium concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "oxidative damage to specific mitochondrial proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1096176:Mitochondrial Damage [Pathologic Function]
   753   C0010957:Damage [Injury or Poisoning]
   753   C1883709:Damage [Functional Concept]

Phrase: "responsible for mitochondrial dysfunction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "will"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "result in the development of potential therapeutic agents"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0304231:therapeutic agents [Intellectual Product]
   770   C1611640:therapeutic agents [Pharmacologic Substance]
   744   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   744   C0243107:development [Physiologic Function]
   744   C0302350:Therapeutic [Functional Concept]
   744   C0678723:Development [Organism Function]
   744   C1274040:Result [Functional Concept]
   744   C1527148:Development [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
   744   C3245505:Potential [Qualitative Concept]
   711   C0450442:Agent [Chemical Viewed Functionally]
   711   C1254351:Agent [Pharmacologic Substance]
   711   C1521826:Agent [Intellectual Product]

Phrase: "for the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of HCM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   861   C0020564:Hypertrophic [Pathologic Function]
   861   C0333959:Hypertrophic [Functional Concept]
   861   C0878544:Cardiomyopathy [Disease or Syndrome]
Processing 00000000.tx.243: ACKNOWLEDGEMENTS We thank Karen L.

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Karen L."
Processing 00000000.tx.244: Vikstrom and Jill C.

Phrase: "Vikstrom"

Phrase: "and"

Phrase: "Jill C."
Processing 00000000.tx.245: Tardiff for the donation of the transgenic mouse models. 

Phrase: "Tardiff for the donation of the transgenic mouse models."
Processing 00000000.tx.246: We thank Tom Giddings for assistance in the preparation of heart tissue for electron microscopy. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Tom Giddings for assistance"

Phrase: "in the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of heart tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1272575:Heart tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "for electron microscopy."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]
Processing 00000000.tx.247: Also, we thank Jill Jones and Janice Rublee for support in the preparation of this manuscript.  

Phrase: "Also,"

Phrase: "we"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Jill Jones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "and"

Phrase: "Janice Rublee for support"

Phrase: "in the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of this manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.248: FOOTNOTES This work was funded by National Heart, Lung, and Blood Institute Grants 1-F32-HL-10423-01 (to D.T.Lucas) and HL-56510 (to L.A.Leinwand). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "funded by National Heart,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0016820:funded [Quantitative Concept]
   770   C0018787:Heart [Body Part, Organ, or Organ Component]
   770   C1281570:Heart [Body Part, Organ, or Organ Component]
   770   C3245503:national [Intellectual Product]

Phrase: "Lung,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0024109:Lung [Body Part, Organ, or Organ Component]
  1000   C0819757:LUNG [Tissue]
  1000   C1278908:Lung [Body Part, Organ, or Organ Component]
   944 E C2707265:Pulmonary [Clinical Attribute]
   944 E C2709248:Pulmonary [Qualitative Concept]
   907 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "and"

Phrase: "Blood Institute Grants 1-F32-HL-10423-01"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   793   C0005767:Blood [Tissue]
   793   C0005768:blood [Body Substance]
   793   C0018173:Grants [Quantitative Concept]
   793   C0021622:institute [Organization]
   793   C0229664:Blood [Body Substance]
   793   C1272753:Institute [Idea or Concept]
   760 E C1548284:Grant [Idea or Concept]
   721 E C0333275:Bloody [Qualitative Concept]
   710 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   710 E C0392895:Bloods [Population Group]
   710 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   710 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "("

Phrase: "to D.T.Lucas"

Phrase: ")"

Phrase: "and"

Phrase: "HL-56510"

Phrase: "("

Phrase: "to L.A.Leinwand"

Phrase: ")."
Processing 00000000.tx.249: P.Aryal was funded by the Undergraduate Research Opportunity Program supported by the Undergraduate Research Initiative of the Howard Hughes Medical Institute at the University of Colorado (Boulder, CO). 

Phrase: "P.Aryal"

Phrase: "was"

Phrase: "funded by the Undergraduate Research Opportunity Program"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0683937:research opportunity [Research Activity]
   774   C0681805:funded research [Research Activity]
   774   C0683935:program research [Research Activity]
   748   C0016820:funded [Quantitative Concept]
   748   C0035168:research [Research Activity]
   748   C0242481:Research [Research Activity]
   748   C0682177:undergraduate [Population Group]
   748   C1547185:Undergraduate [Idea or Concept]
   748   C1709697:Program [Conceptual Entity]
   748   C2728259:Program [Pharmacologic Substance]
   748   C3484370:Program [Functional Concept]

Phrase: "supported by the Undergraduate Research Initiative of the Howard Hughes Medical Institute"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   755   C1568415:Support of Research [Intellectual Product]
   751   C0035172:Research Institute [Organization]
   751   C0035176:research supported [Quantitative Concept]
   751   C0079816:Medical Research [Research Activity]
   751   C1556038:Medical Research [Professional or Occupational Group]
   736   C0021622:institute [Organization]
   736   C0035168:research [Research Activity]
   736   C0205476:Medical [Functional Concept]
   736   C0242481:Research [Research Activity]
   736   C0424093:Initiative [Mental Process]
   736   C0682177:undergraduate [Population Group]
   736   C1272753:Institute [Idea or Concept]
   736   C1521721:Supported [Conceptual Entity]
   736   C1547185:Undergraduate [Idea or Concept]
   736   C1551730:Hughes [Population Group]
   703 E C0183683:Support [Medical Device]

Phrase: "at the University of Colorado (Boulder,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0009399:Colorado [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "CO"

Phrase: ")."
Processing 00000000.tx.250: Address for reprint requests and other correspondence: L.A.

Phrase: "Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0376649:Address [Intellectual Product]
   770   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "L.A."
Processing 00000000.tx.251: Leinwand, Dept. of Molecular, Cellular, and Developmental Biology, Campus Box 347,Univ. of Colorado, Boulder, CO 80309-0347(E-mail: Leslie.

Phrase: "Leinwand,"

Phrase: "Dept."

Phrase: "of Molecular, Cellular,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0007634:Cellular [Cell]
   861   C0178539:Cellular [Functional Concept]
   789 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "Developmental Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0011756:Developmental Biology [Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Campus Box 347,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: "Univ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041740:UNIV [Manufactured Object,Organization]

Phrase: "of Colorado,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009399:Colorado [Geographic Area]

Phrase: "Boulder,"

Phrase: "CO 80309-0347"

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Leslie."
Processing 00000000.tx.252: Leinwand{at}colorado.edu ). 

Phrase: "Leinwand{at}colorado.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.253: First published October 31,2002;10.1152/ajpheart.00619.2002 Received 17 July 2002; 

Phrase: "First"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "October 31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "2002"

Phrase: ";10.1152/ajpheart.00619.2002"

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "17 July 2002"

Phrase: ";"
Processing 00000000.tx.254: accepted in final form 15 October 2002.  

Phrase: "accepted in final form 15 October 2002."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205088:Final [Temporal Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1546485:Final [Idea or Concept]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.255: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1.  

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.256: Arbustini, E, Diegoli M, Fasani R, Grasso M, Morbini P, Banchieri N, Bellini O, Dal Bello B, Pilotto A, Magrini G, Campana C, Fortina P, Gavazzi A, Narula J, and Vigano M. 

Phrase: "Arbustini,"

Phrase: "E,"

Phrase: "Diegoli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fasani R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Grasso M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Morbini P,"

Phrase: "Banchieri N,"

Phrase: "Bellini O,"

Phrase: "Dal Bello B,"

Phrase: "Pilotto A,"

Phrase: "Magrini G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Campana C,"

Phrase: "Fortina P,"

Phrase: "Gavazzi A,"

Phrase: "Narula J,"

Phrase: "and"

Phrase: "Vigano M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.257: Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. 

Phrase: "Mitochondrial DNA mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   896   C2315666:Mitochondrial mutation [Genetic Function]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1819717:mitochondrial DNA [Cell Component]

Phrase: "and"

Phrase: "mitochondrial abnormalities in dilated cardiomyopathy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]
Processing 00000000.tx.258: Am J Pathol 153: 1501-1510, 1998[Abstract/Free FullText]. 

Phrase: "Am"

Phrase: "J Pathol 153"

Phrase: ":"

Phrase: "1501-1510,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.259: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.260: Arbustini, E, Fasani R, Morbini P, Diegoli M, Grasso M, Dal Bello B, Marangoni E, Banfi P, Banchieri N, Bellini O, Comi G, Narula J, Campana C, Gavazzi A, Danesmo C, and Vigano M. 

Phrase: "Arbustini,"

Phrase: "E,"

Phrase: "Fasani R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Morbini P,"

Phrase: "Diegoli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Grasso M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Dal Bello B,"

Phrase: "Marangoni E,"

Phrase: "Banfi P,"

Phrase: "Banchieri N,"

Phrase: "Bellini O,"

Phrase: "Comi G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Narula J,"

Phrase: "Campana C,"

Phrase: "Gavazzi A,"

Phrase: "Danesmo C,"

Phrase: "and"

Phrase: "Vigano M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.261: Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure [Erratum. 

Phrase: "Coexistence of mitochondrial DNA"

Phrase: "and"

Phrase: "beta myosin heavy chain mutations in hypertrophic cardiomyopathy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "with late congestive heart failure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0018802:Congestive heart failure [Disease or Syndrome]
           Heart Failure
   861   C0018801:Heart failure [Disease or Syndrome]
   812   C0018787:Heart [Body Part, Organ, or Organ Component]
   812   C0231174:Failure [Functional Concept]
   812   C0680095:failure [Individual Behavior]
   812   C0742742:Congestive [Qualitative Concept]
   812   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "[Erratum."
Processing 00000000.tx.262: Heart 81: Mar, p. 

Phrase: "Heart 81"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "Mar"

Phrase: ","

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.263: 330,1999]. 

Phrase: "330,"

Phrase: "1999"

Phrase: "]."
Processing 00000000.tx.264: Heart 80: 548-558, 1998[Abstract/Free FullText]. 

Phrase: "Heart 80"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "548-558,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.265: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.266: Balaban, RS. 

Phrase: "Balaban,"

Phrase: "RS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539879:RS [Idea or Concept]
Processing 00000000.tx.267: Regulation of oxidative phosphorylation in the mammalian cell. 

Phrase: "Regulation of oxidative phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1817350:regulation of oxidative phosphorylation [Molecular Function]
   881   C1158897:regulation of phosphorylation [Cell Function]
   819   C1518760:Oxidative Regulation [Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "in the mammalian cell."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.268: Am J Physiol Cell Physiol 258: C377-C389, 1990[Abstract/Free FullText]. 

Phrase: "Am"

Phrase: "J Physiol Cell Physiol 258"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "C377-C389,"

Phrase: "1990"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.269: 4.  

Phrase: "4."
Processing 00000000.tx.270: Beanlands, RS, Nahmias C, Gordon E, Coates G, deKemp R, Firnau G, and Fallen E. 

Phrase: "Beanlands,"

Phrase: "RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539879:RS [Idea or Concept]

Phrase: "Nahmias C,"

Phrase: "Gordon E,"

Phrase: "Coates G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "deKemp R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Firnau G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Fallen E."
Processing 00000000.tx.271: The effects of 1-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: a double-blind, placebo-controlled, positron-emission tomography study. 

Phrase: "The effects of 1-blockade"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on oxidative metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282636:oxidative metabolism [Cell Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "the metabolic cost of ventricular work"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0010186:Cost [Quantitative Concept]
   753   C0220812:cost [Quantitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with left ventricular dysfunction"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
  1000   C0242698:Ventricular Dysfunction, Left [Pathologic Function]
   901   C0242973:Ventricular Dysfunction [Pathologic Function]
   865   C0225897:Left Ventricle [Body Part, Organ, or Organ Component]
   865   C1269892:Left ventricle [Body Part, Organ, or Organ Component]
   827   C0018827:Ventricular [Body Part, Organ, or Organ Component]
   827   C0031847:dysfunction [Functional Concept]
   827   C0205091:Left [Spatial Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   827   C1522565:Ventricular [Spatial Concept]
   827   C1552822:left [Functional Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]
   755 E C0007799:Ventricles [Body Space or Junction]
   755 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]
   755 E C2355627:Ventricle [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "a double-blind, placebo-controlled, positron-emission tomography study."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   897   C0013072:Double-Blind Study [Research Activity]
   878   C2347038:blind study [Research Activity]
   869   C0599724:placebo-controlled study [Intellectual Product,Research Activity]
   864   C0683952:placebo study [Research Activity]
   850   C0681867:Controlled Study [Research Activity]
   835   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   793   C0032744:Positron [Quantitative Concept]
   793   C0040395:tomography [Diagnostic Procedure]
   793   C0040405:tomography [Diagnostic Procedure]
   793   C0233929:Emission [Body Substance]
   793   C0557651:Study [Manufactured Object]
   793   C2349995:Emission [Substance]
   793   C2603343:Study [Research Activity]
Processing 00000000.tx.272: Circulation 102: 2070-2075, 2000[Abstract/Free FullText]. 

Phrase: "Circulation 102"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "2070-2075,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.273: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.274: Brown, GC. 

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "GC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3537453:GC [Gene or Genome]
Processing 00000000.tx.275: Control of respiration and ATP synthesis in mammalian mitochondria and cells. 

Phrase: "Control of respiration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "ATP synthesis in mammalian mitochondria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1157223:ATP synthesis [Molecular Function]
   806   C1510700:ATP Synthesis [Functional Concept]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.276: Biochem J 284: 1-13, 1992[ISI][Medline]. 

Phrase: "Biochem J 284"

Phrase: ":"

Phrase: "1-13,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1992"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.277: 6.  

Phrase: "6."
Processing 00000000.tx.278: Chandra, M, Rundell VLM, Tardiff JC, Leinwand LA, deTombe PP, and Solaro RJ. 

Phrase: "Chandra,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Rundell VLM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0175282:VLm [Body Part, Organ, or Organ Component]

Phrase: "Tardiff JC,"

Phrase: "Leinwand LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "deTombe PP,"

Phrase: "and"

Phrase: "Solaro RJ."
Processing 00000000.tx.279: Ca2+ activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T. 

Phrase: "Ca2+ activation of myofilaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "from transgenic mouse hearts"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C1512359:Mouse Heart [Tissue]
   827   C0018787:Hearts [Body Part, Organ, or Organ Component]
   793 E C1281570:Heart [Body Part, Organ, or Organ Component]
   734   C0025936:Mouse, Transgenic [Mammal]

Phrase: "expressing"

Phrase: "R92Q mutant cardiac troponin T."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0077404:Troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1096316:cardiac troponin [Laboratory Procedure]
   840   C1420827:TROPONIN T [Gene or Genome]
   804   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   804   C0041199:Troponin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1522601:Cardiac [Spatial Concept]
Processing 00000000.tx.280: Am J Physiol Heart Circ Physiol 280: H705-H713, 2001[Abstract/Free FullText]. 

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 280"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "H705-H713,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.281: 7.  

Phrase: "7."
Processing 00000000.tx.282: Chien, KR. 

Phrase: "Chien,"

Phrase: "KR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022773:KR [Geographic Area]
Processing 00000000.tx.283: Meeting Koch's postulates for calcium signaling in cardiac hypertrophy. 

Phrase: "Meeting Koch's"

Phrase: "postulates for calcium signaling"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0600431:Calcium Signaling [Cell Function]
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C0037083:Signaling [Cell Function]
   770   C2936886:Calcium [Pharmacologic Substance]
   770   C3537152:signaling [Biologic Function]

Phrase: "in cardiac hypertrophy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1383860:Cardiac Hypertrophy [Pathologic Function]
   861   C0020564:Hypertrophy [Pathologic Function]
   789 E C0333959:Hypertrophic [Functional Concept]
Processing 00000000.tx.284: J Clin Invest 105: 1339-1342, 2000[Free FullText]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "105"

Phrase: ":"

Phrase: "1339-1342,"

Phrase: "2000"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.285: 8.  

Phrase: "8."
Processing 00000000.tx.286: Cho, MC, Rapacciuolo A, Koch WJ, Kobayashi Y, Jones LR, and Rockman HA. 

Phrase: "Cho,"

Phrase: "MC,"

Phrase: "Rapacciuolo A,"

Phrase: "Koch WJ,"

Phrase: "Kobayashi Y,"

Phrase: "Jones LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "and"

Phrase: "Rockman HA."
Processing 00000000.tx.287: Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression. 

Phrase: "Defective beta-adrenergic receptor signaling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1514762:Receptor Signaling [Molecular Function]
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]
   717   C0001643:Beta-Adrenergic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0034785:beta-adrenergic receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "precedes"

Phrase: "the development of dilated cardiomyopathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "with calsequestrin overexpression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]
Processing 00000000.tx.288: J Biol Chem 274: 22251-22256, 1999[Abstract/Free FullText]. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "22251-22256,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.289: 9.  

Phrase: "9."
Processing 00000000.tx.290: Cocco, T, Di Paola M, Papa S, and Lorusso M. 

Phrase: "Cocco,"

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Di Paola M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Papa S,"

Phrase: "and"

Phrase: "Lorusso M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.291: Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. 

Phrase: "Arachidonic acid interaction with the mitochondrial electron transport chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "reactive oxygen species generation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   756   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.292: Free Radic Biol Med 27: 51-59, 1999[ISI][Medline]. 

Phrase: "Free Radic Biol Med 27"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0534729:MED 27 [Organic Chemical,Pharmacologic Substance]
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "51-59,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.293: 10.  

Phrase: "10."
Processing 00000000.tx.294: Cooney, GJ, Taegtmeyer H, and Newsholme EA. 

Phrase: "Cooney,"

Phrase: "GJ,"

Phrase: "Taegtmeyer H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Newsholme EA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]
Processing 00000000.tx.295: Tricarboxylic acid cycle flux and enzyme activities in the isolated working rat heart. 

Phrase: "Tricarboxylic acid cycle flux"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2348693:Flux [Natural Phenomenon or Process]
   756   C0008858:Tricarboxylic Acid Cycle [Molecular Function]

Phrase: "and"

Phrase: "enzyme activities in the isolated working rat heart."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0441655:Activities [Activity]
   737   C0243102:enzyme activity [Molecular Function]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.296: Biochem J 200: 701-703, 1981[ISI][Medline]. 

Phrase: "Biochem J 200"

Phrase: ":"

Phrase: "701-703,"

Phrase: "1981"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.297: 11.  

Phrase: "11."
Processing 00000000.tx.298: Davey, GP, and Clark JB. 

Phrase: "Davey,"

Phrase: "GP,"

Phrase: "and"

Phrase: "Clark JB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]
Processing 00000000.tx.299: Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. 

Phrase: "Threshold effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "control of oxidative phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "in nonsynaptic rat brain mitochondria."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0026237:Mitochondria [Cell Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.300: J Neurochem 66: 1617-1624, 1996[ISI][Medline]. 

Phrase: "J Neurochem 66"

Phrase: ":"

Phrase: "1617-1624,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.301: 12.  

Phrase: "12."
Processing 00000000.tx.302: Duchen, MR. 

Phrase: "Duchen,"

Phrase: "MR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347167:Mr. [Conceptual Entity]
Processing 00000000.tx.303: Contributions of mitochondria to animal physiology: from homeostatic sensor to calcium signalling and cell death. 

Phrase: "Contributions of mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1880177:Contribution [Activity]

Phrase: "to animal physiology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0003062:Animal [Animal]
   861   C0031842:Physiology [Biomedical Occupation or Discipline]
   861   C0031843:physiology [Physiologic Function]
   789 E C0205463:Physiologic [Functional Concept]

Phrase: ":"

Phrase: "from homeostatic sensor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0183210:Sensor [Medical Device]
   861   C1705193:Sensor [Manufactured Object]

Phrase: "to calcium signalling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0600431:calcium signalling [Cell Function]
   861   C3537152:signalling [Biologic Function]
   827 E C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.304: J Physiol 516: 1-17, 1999[Abstract/Free FullText]. 

Phrase: "J Physiol 516"

Phrase: ":"

Phrase: "1-17,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.305: 13.  

Phrase: "13."
Processing 00000000.tx.306: Freeman, K, Colon-Rivera C, Olsson M, Moore RL, Weinberger H, Grupp I, Vikstrom KL, Iaccarino G, Koch WJ, and Leinwand LA. 

Phrase: "Freeman,"

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Colon-Rivera C,"

Phrase: "Olsson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Moore RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Weinberger H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Grupp I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vikstrom KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Iaccarino G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Koch WJ,"

Phrase: "and"

Phrase: "Leinwand LA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]
Processing 00000000.tx.307: Cardiac dysfunction and adrenergic signal amnormalities in a transgenic mouse model of hypertrophic cardiomyopathy. 

Phrase: "Cardiac dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C3277906:Cardiac dysfunction [Finding]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "adrenergic signal amnormalities in a transgenic mouse model of hypertrophic cardiomyopathy."
Processing 00000000.tx.308: Am J Physiol Heart Circ Physiol 280: H151-H159, 2001[Abstract/Free FullText]. 

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 280"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "H151-H159,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.309: 14.  

Phrase: "14."
Processing 00000000.tx.310: Freeman, K, Lerman I, Bohlmeyer T, Iaccarino G, Koch WJ, Lefkowitz RJ, Bristow MR, Kranias EG, and Leinwand LA. 

Phrase: "Freeman,"

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lerman I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Bohlmeyer T,"

Phrase: "Iaccarino G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Koch WJ,"

Phrase: "Lefkowitz RJ,"

Phrase: "Bristow MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Kranias EG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013715:EG [Geographic Area]
   861   C1705651:EG [Idea or Concept]

Phrase: "and"

Phrase: "Leinwand LA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]
Processing 00000000.tx.311: Manipulations of cardiac adrenergic signaling and calcium cycling have markedly different effects on the progression of cardiomyopathy. 

Phrase: "Manipulations of cardiac adrenergic signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185111:MANIPULATIONS [Therapeutic or Preventive Procedure]
   760   C0947647:Manipulations NOS [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "calcium cycling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "have"

Phrase: "markedly different effects on the progression of cardiomyopathy."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.312: J Clin Invest 107: 967-974, 2001[Abstract/Free FullText]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "107"

Phrase: ":"

Phrase: "967-974,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.313: 15.  

Phrase: "15."
Processing 00000000.tx.314: Gao, WD, Perez NG, Seidman CE, Seidman JG, and Marban E. 

Phrase: "Gao,"

Phrase: "WD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019202:WD [Disease or Syndrome]
  1000   C0332135:WD [Qualitative Concept]
  1000   C1862191:WD [Intellectual Product]
  1000   C3538902:WD [Gene or Genome]

Phrase: "Perez NG,"

Phrase: "Seidman CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Seidman JG,"

Phrase: "and"

Phrase: "Marban E."
Processing 00000000.tx.315: Altered cardiac excitation-contraction coupling in mutant mice with familial hypertrophic cardiomyopathy. 

Phrase: "Altered cardiac excitation-contraction coupling in mutant mice"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   800   C2717948:Excitation Contraction Coupling [Physiologic Function]
   767   C0027045:cardiac contraction [Organ or Tissue Function]
   744   C0018787:Cardiac [Body Part, Organ, or Organ Component]
   744   C0549255:Excitation [Activity]
   744   C1140999:Contraction [Pathologic Function]
   744   C1522601:Cardiac [Spatial Concept]
   744   C1948027:Coupling [Functional Concept]
   711 E C0010222:couple [Family Group]

Phrase: "with familial hypertrophic cardiomyopathy."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0949658:Cardiomyopathy, Hypertrophic, Familial [Disease or Syndrome]
   913   C0264789:Familial cardiomyopathy [Disease or Syndrome]
   901   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0020564:Hypertrophic [Pathologic Function]
   827   C0241888:Familial [Functional Concept]
   827   C0333959:Hypertrophic [Functional Concept]
   827   C0878544:Cardiomyopathy [Disease or Syndrome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.316: J Clin Invest 103: 661-666, 1999[Abstract/Free FullText]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "103"

Phrase: ":"

Phrase: "661-666,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.317: 16.  

Phrase: "16."
Processing 00000000.tx.318: Humphries, KM, and Szweda LI. 

Phrase: "Humphries,"

Phrase: "KM,"

Phrase: "and"

Phrase: "Szweda LI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]
Processing 00000000.tx.319: Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2- nonenal. 

Phrase: "Selective inactivation of alpha-ketoglutarate dehydrogenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "pyruvate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: ":"

Phrase: "reaction of lipoic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]

Phrase: "with 4-hydroxy-2- nonenal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxy-2-nonenal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.320: Biochemistry 37: 15835-15841, 1998[ISI][Medline]. 

Phrase: "Biochemistry 37"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: ":"

Phrase: "15835-15841,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.321: 17.  

Phrase: "17."
Processing 00000000.tx.322: Humphries, KM, Yoo Y, and Szweda LI. 

Phrase: "Humphries,"

Phrase: "KM,"

Phrase: "Yoo Y,"

Phrase: "and"

Phrase: "Szweda LI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]
Processing 00000000.tx.323: Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. 

Phrase: "Inhibition of NADH-linked mitochondrial respiration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C3544377:inhibition of respiration [Physiologic Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "by 4-hydroxy-2-nonenal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxy-2-nonenal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.324: Biochemistry 37: 552-557, 1198[ISI][Medline]. 

Phrase: "Biochemistry 37"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: ":"

Phrase: "552-557,"

Phrase: "1198"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.325: 18.  

Phrase: "18."
Processing 00000000.tx.326: Ide, T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N, Uchida K, Arimura K, Egashira K, and Takeshita A. 

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tsutsui H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kinugawa S,"

Phrase: "Utsumi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kang D,"

Phrase: "Hattori N,"

Phrase: "Uchida K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Arimura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Egashira K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Takeshita A."
Processing 00000000.tx.327: Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. 

Phrase: "Mitochondrial electron transport complex I"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   937   C1167290:electron transport complex I [Cell Component]
   937   C2363240:Electron Transport Complex I [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1752477:mitochondrial electron transport [Molecular Function]
   853   C0678851:mitochondrial transport [Cell Function]
   840   C0013846:Electron Transport [Molecular Function]
   840   C2245017:Complex I [Cell Component]
   804   C0005528:Transport, NOS [Cell Function]
   804   C0013852:Electron [Quantitative Concept]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0439855:Complex [Qualitative Concept]
   804   C1317949:Transport [Manufactured Object]
   804   C1704241:Complex [Chemical Viewed Structurally]
   804   C3463986:Electron [Bird]
   804   C3495449:transport [Medical Device]
   733 E C0013850:Electronic [Manufactured Object]
   733 E C1547561:Electronic [Idea or Concept]

Phrase: "is"

Phrase: "a potential source of oxygen free radicals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449416:Source [Finding]
   748   C1705919:Source [Idea or Concept]

Phrase: "in the failing myocardium."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027061:Myocardium [Tissue]
   789 E C1522564:Myocardial [Spatial Concept]
Processing 00000000.tx.328: Circ Res 85: 357-363, 1999[Abstract/Free FullText]. 

Phrase: "Circ Res 85"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "357-363,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.329: 19.  

Phrase: "19."
Processing 00000000.tx.330: Kish, SJ. 

Phrase: "Kish,"

Phrase: "SJ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515101:SJ [Geographic Area]
  1000   C2986905:SJ [Idea or Concept]
Processing 00000000.tx.331: Brain energy metabolizing enzymes in Alzheimer's disease: alpha-ketoglutarate dehydrogenase complex and cytochrome oxidase. 

Phrase: "Brain energy metabolizing enzymes in Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0014442:Enzymes [Enzyme,Organic Chemical]
   748   C0014445:enzymes [Functional Concept]

Phrase: ":"

Phrase: "alpha-ketoglutarate dehydrogenase complex"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
  1000   C0022626:alpha-Ketoglutarate Dehydrogenase Complex [Amino Acid, Peptide, or Protein,Enzyme]
           Ketoglutarate Dehydrogenase Complex
           alpha-Ketoglutarate Dehydrogenase
  1000   C1167436:alpha-ketoglutarate dehydrogenase complex [Cell Component]
   923   C1417943:ALPHA-KETOGLUTARATE DEHYDROGENASE [Gene or Genome]
   861   C0599061:ketoglutarate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1291208:alpha Ketoglutarate [Organic Chemical,Pharmacologic Substance]
   861   C2755851:dehydrogenase complex [Cell Component]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0439095:Alpha [Intellectual Product]
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "cytochrome oxidase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010760:Cytochrome Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325304:cytochrome [Molecular Function]
Processing 00000000.tx.332: Ann NY Acad Sci 826: 218-228, 1997[Abstract]. 

Phrase: "Ann NY Acad Sci 826"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0027976:NY [Geographic Area]
   804   C0268596:ACAD [Disease or Syndrome]
   804   C1879958:NY [Intellectual Product]
   804   C2700624:ACAD [Cell Function]
   804   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "218-228,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.333: 20.  

Phrase: "20."
Processing 00000000.tx.334: Koch, WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, and Lefkowitz RJ. 

Phrase: "Koch,"

Phrase: "WJ,"

Phrase: "Rockman HA,"

Phrase: "Samama P,"

Phrase: "Hamilton RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Bond RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Milano CA,"

Phrase: "and"

Phrase: "Lefkowitz RJ."
Processing 00000000.tx.335: Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. 

Phrase: "Cardiac function in mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0232164:Cardiac function [Organ or Tissue Function]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "the beta-adrenergic receptor kinase"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0053379:[Beta-adrenergic-receptor] kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   923   C0001643:Beta-Adrenergic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   923   C0034785:beta-adrenergic receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0034783:Adrenergic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0599756:adrenergic [Functional Concept]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "or"

Phrase: "a beta ARK inhibitor."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   947   C1101016:beta-adrenergic receptor kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C2757061:Beta-adrenergic Receptor Inhibitor [Molecular Function]
   901   C3536830:beta-Adrenergic Receptor Inhibitor [Pharmacologic Substance]
   827   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   827   C3537023:kinase inhibitor [Molecular Function]
   827   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C1999216:Inhibitor [Qualitative Concept]
   734   C0053379:[Beta-adrenergic-receptor] kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
Processing 00000000.tx.336: Science 268: 1350-1353, 1995[ISI][Medline]. 

Phrase: "Science 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1350-1353,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.337: 21.  

Phrase: "21."
Processing 00000000.tx.338: Lucas, DT, and Szweda LI. 

Phrase: "Lucas,"

Phrase: "DT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3539739:DT [Gene or Genome]
  1000   C3542920:DT [Idea or Concept]

Phrase: "and"

Phrase: "Szweda LI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]
Processing 00000000.tx.339: Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction. 

Phrase: "Cardiac reperfusion injury"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035126:Reperfusion Injury [Injury or Poisoning]
   827   C0035124:Reperfusion [Therapeutic or Preventive Procedure]
   827   C0684253:reperfusion [Biologic Function]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: ":"

Phrase: "aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "lipid peroxidation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: "and"

Phrase: "mitochondrial dysfunction."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.340: Proc Natl Acad Sci USA 95: 510-514, 1998[Abstract/Free FullText]. 

Phrase: "Proc Natl Acad Sci USA 95"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "510-514,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.341: 22.  

Phrase: "22."
Processing 00000000.tx.342: Lucas, DT, and Szweda LI. 

Phrase: "Lucas,"

Phrase: "DT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3539739:DT [Gene or Genome]
  1000   C3542920:DT [Idea or Concept]

Phrase: "and"

Phrase: "Szweda LI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]
Processing 00000000.tx.343: Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of alpha-ketoglutarate dehydrogenase. 

Phrase: "Declines in mitochondrial respiration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0026237:Mitochondrial [Cell Component]
   770   C0035203:Respiration [Physiologic Function]
   770   C0282636:respiration [Cell Function]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C1160636:respiration [Biologic Function]

Phrase: "during cardiac reperfusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035124:Reperfusion [Therapeutic or Preventive Procedure]
   861   C0684253:reperfusion [Biologic Function]

Phrase: ":"

Phrase: "age-dependent inactivation of alpha-ketoglutarate dehydrogenase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0544461:Inactivation [Cell or Molecular Dysfunction]
Processing 00000000.tx.344: Proc Natl Acad Sci USA 96: 6689-6693, 1999[Abstract/Free FullText]. 

Phrase: "Proc Natl Acad Sci USA 96"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "6689-6693,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.345: 23.  

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.346: Karmazyn, M. 

Phrase: "Karmazyn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.347: The 1990Merck Frosst Award. 

Phrase: "The 1990Merck Frosst Award."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004446:Award [Manufactured Object]
Processing 00000000.tx.348: Ischemic and reperfusion injury in the heart. 

Phrase: "Ischemic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475224:Ischaemic [Functional Concept]

Phrase: "and"

Phrase: "reperfusion injury in the heart."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0035126:Reperfusion Injury [Injury or Poisoning]
   797   C0018805:Heart Injury [Injury or Poisoning]
   760   C0035124:Reperfusion [Therapeutic or Preventive Procedure]
   760   C0684253:reperfusion [Biologic Function]
   760   C3263722:Injury [Injury or Poisoning]
   760   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.349: Cellular mechanisms and pharmacological interventions. 

Phrase: "Cellular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "pharmacological interventions."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0886296:interventions [Health Care Activity]
   861   C1273869:Interventions [Health Care Activity]
   861   C2979881:Interventions [Clinical Attribute]
   861   C3542921:Interventions [Classification]
   827 E C1948041:Intervention [Therapeutic or Preventive Procedure]
   777 E C3274035:INTERVENTIONAL [Research Activity]
Processing 00000000.tx.350: Can J Physiol Pharmacol 69: 719-730, 1991[ISI][Medline]. 

Phrase: "Can"

Phrase: "J Physiol Pharmacol 69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450388:69 [Intellectual Product]

Phrase: ":"

Phrase: "719-730,"

Phrase: "1991"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.351: 24.  

Phrase: "24."
Processing 00000000.tx.352: Luo, X, Pitkanen S, Kassovska-Bratinova S, Robinson BH, and Lehotay DC. 

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "X,"

Phrase: "Pitkanen S,"

Phrase: "Kassovska-Bratinova S,"

Phrase: "Robinson BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "and"

Phrase: "Lehotay DC."
Processing 00000000.tx.353: Excessive formation of hydroxyl radicals and aldehydic lipid peroxidation products in cultured skin fibroblasts from patients with complex I deficiency. 

Phrase: "Excessive formation of hydroxyl radicals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "aldehydic lipid peroxidation products in cultured skin fibroblasts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1514468:Products [Entity]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with complex I deficiency."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0342776:Complex I deficiency [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]
   734   C2245017:Complex I [Cell Component]
Processing 00000000.tx.354: J Clin Invest 99: 2877-2882, 1997[Abstract/Free FullText]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "99"

Phrase: ":"

Phrase: "2877-2882,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.355: 25.  

Phrase: "25."
Processing 00000000.tx.356: Mastrogiacomo, F, Bergeron C, and Kish SJ. 

Phrase: "Mastrogiacomo,"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bergeron C,"

Phrase: "and"

Phrase: "Kish SJ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]
Processing 00000000.tx.357: Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. 

Phrase: "Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   810   C1151632:alpha-ketoglutarate dehydrogenase activity [Molecular Function]
   762   C0443158:Brain activity [Physiologic Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.358: J Neurochem 61: 2007-2014, 1993[ISI][Medline]. 

Phrase: "J Neurochem 61"

Phrase: ":"

Phrase: "2007-2014,"

Phrase: "1993"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.359: 26.  

Phrase: "26."
Processing 00000000.tx.360: Minamisawa, S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, Martone ME, Wang Y, Ross J, Kranias EG, Giles WR, and Chien KR. 

Phrase: "Minamisawa,"

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "Hoshijima M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Chu G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ward CA,"

Phrase: "Frank K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Gu Y,"

Phrase: "Martone"

Phrase: "ME,"

Phrase: "Wang Y,"

Phrase: "Ross J,"

Phrase: "Kranias EG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013715:EG [Geographic Area]
   861   C1705651:EG [Idea or Concept]

Phrase: "Giles WR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420193:WR [Gene or Genome]
   861   C1425679:WR [Gene or Genome]
   861   C1862190:WR [Immunologic Factor]
   861   C3538902:WR [Gene or Genome]

Phrase: "and"

Phrase: "Chien KR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]
Processing 00000000.tx.361: Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. 

Phrase: "Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1704675:Interaction [Functional Concept]
   710   C0916181:Sarcoplasmic Reticulum Calcium ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "the critical calcium cycling defect in dilated cardiomyopathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1457869:Defect [Functional Concept]
   744   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.362: Cell 99: 313-322, 1999[ISI][Medline]. 

Phrase: "Cell 99"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "313-322,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.363: 27.  

Phrase: "27."
Processing 00000000.tx.364: Missiaen, L, Robberecht W, Bosch LV, Callewaert G, Parys JB, Wuytack F, Raeymaekers L, Nilius B, Eggermont J, and Smedt HD. 

Phrase: "Missiaen,"

Phrase: "L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Robberecht W,"

Phrase: "Bosch LV,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023128:LV [Geographic Area]
   861   C0731033:LV [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C1881413:LV [Chemical Viewed Structurally]

Phrase: "Callewaert G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Parys JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Wuytack F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Raeymaekers L,"

Phrase: "Nilius B,"

Phrase: "Eggermont J,"

Phrase: "and"

Phrase: "Smedt HD."
Processing 00000000.tx.365: Abnormal intracellular Ca2+ homeostasis and disease. 

Phrase: "Abnormal intracellular Ca2+ homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019868:Homeostasis [Biologic Function]

Phrase: "and"

Phrase: "disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.366: Cell Calcium 28: 1-21, 2000[ISI][Medline]. 

Phrase: "Cell Calcium 28"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: ":"

Phrase: "1-21,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.367: 28.  

Phrase: "28."
Processing 00000000.tx.368: Mizuno, Y, Ikebe S, Hattori N, Nakagawa-Hattori Y, Mochizuki H, Tanaka M, and Ozawa T. 

Phrase: "Mizuno,"

Phrase: "Y,"

Phrase: "Ikebe S,"

Phrase: "Hattori N,"

Phrase: "Nakagawa-Hattori Y,"

Phrase: "Mochizuki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tanaka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Ozawa T."
Processing 00000000.tx.369: Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. 

Phrase: "Role of mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "in the etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "and"

Phrase: "pathogenesis of Parkinson's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.370: Biochim Biophys Acta 1271: 265-274, 1995[ISI][Medline]. 

Phrase: "Biochim Biophys Acta 1271"

Phrase: ":"

Phrase: "265-274,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.371: 29.  

Phrase: "29."
Processing 00000000.tx.372: Moreno-Sanchez, R, Hogue BA, and Hansford RG. 

Phrase: "Moreno-Sanchez,"

Phrase: "R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hogue BA,"

Phrase: "and"

Phrase: "Hansford RG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]
Processing 00000000.tx.373: Influence of NAD-linked dehydrogenase activity on flux through oxidative phosphorylation. 

Phrase: "Influence of NAD-linked dehydrogenase activity"

Phrase: "on flux"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "through oxidative phosphorylation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0030013:Oxidative Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C0311404:Oxidative [Functional Concept]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.374: Biochem J 268: 421-428, 1990[ISI][Medline]. 

Phrase: "Biochem J 268"

Phrase: ":"

Phrase: "421-428,"

Phrase: "1990"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.375: 30.  

Phrase: "30."
Processing 00000000.tx.376: Morii, H, Takeuchi Y, and Watanabe Y. 

Phrase: "Morii,"

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takeuchi Y,"

Phrase: "and"

Phrase: "Watanabe Y."
Processing 00000000.tx.377: Selective inhibition of NADH-CoQ oxidoreductase (complex I) of rat brain mitochondria by arachidonic acid. 

Phrase: "Selective inhibition of NADH-CoQ oxidoreductase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "(complex I) of rat brain mitochondria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C2245017:Complex I [Cell Component]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "by arachidonic acid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.378: Biochem Biophys Res Commun 178: 1120-1126, 1190[ISI][Medline]. 

Phrase: "Biochem Biophys Res Commun 178"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "1120-1126,"

Phrase: "1190"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.379: 31.  

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.380: Nethery, D, Callahan LA, Stofan D, Mattera R, DiMarco A, and Supinski G. 

Phrase: "Nethery,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Callahan LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Stofan D,"

Phrase: "Mattera R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "DiMarco A,"

Phrase: "and"

Phrase: "Supinski G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.381: PLA2 dependence of diaphragm mitochondrial formation of reactive oxygen species. 

Phrase: "PLA2 dependence of diaphragm mitochondrial formation of reactive oxygen species."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0011546:Dependence [Mental Process]
   739   C0439857:Dependence [Mental or Behavioral Dysfunction]
   739   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.382: J Appl Physiol 89: 72-80, 2000[Abstract/Free FullText]. 

Phrase: "J Appl Physiol 89"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "72-80,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.383: 33.  

Phrase: "33."
Processing 00000000.tx.384: Pitkanen, S, Merante F, McLeod DR, Applegarth D, Tong T, and Robinson BH. 

Phrase: "Pitkanen,"

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "Merante F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "McLeod DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Applegarth D,"

Phrase: "Tong T,"

Phrase: "and"

Phrase: "Robinson BH."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]
Processing 00000000.tx.385: Familial cardiomyopathy with cataracts and lactic acidosis: a defect in complex I (NADH-dehydrogenase) of the mitochondria respiratory chain. 

Phrase: "Familial cardiomyopathy with cataracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0264789:Familial cardiomyopathy [Disease or Syndrome]
   770   C0878544:Cardiomyopathy [Disease or Syndrome]

Phrase: "and"

Phrase: "lactic acidosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001125:Acidosis, Lactic [Disease or Syndrome]
   861   C0001122:Acidosis [Pathologic Function]
   861   C0220981:Acidosis [Pathologic Function]

Phrase: ":"

Phrase: "a defect in complex I (NADH-dehydrogenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1457869:Defect [Functional Concept]
   748   C1861101:DEFECT [Disease or Syndrome]

Phrase: ")"

Phrase: "of the mitochondria respiratory chain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0162362:Respiratory Chain [Molecular Function]
   901   C1325653:respiratory chain [Cell Component]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.386: Pediatr Res 39: 513-521, 1996[Abstract]. 

Phrase: "Pediatr Res 39"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "513-521,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.387: 34.  

Phrase: "34."
Processing 00000000.tx.388: Robinson, BH. 

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "BH."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0004684:BH [Geographic Area]
  1000   C1412800:BH [Gene or Genome]
  1000   C2986890:BH [Idea or Concept]
Processing 00000000.tx.389: Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. 

Phrase: "Human complex I deficiency"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C0342776:Complex I deficiency [Disease or Syndrome]
   812   C0011155:Deficiency [Functional Concept]
   812   C0162429:Deficiency [Disease or Syndrome]
   812   C1623416:deficiency [Qualitative Concept]
   741 E C1636779:% deficient [Quantitative Concept]

Phrase: ":"

Phrase: "clinical spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "and"

Phrase: "involvement of oxygen free radicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in the pathogenicity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0030657:pathogenicity [Qualitative Concept]
  1000   C1136169:Pathogenicity [Organism Attribute]
   928 E C0450254:Pathogenic [Organism]

Phrase: "of the defect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1457869:Defect [Functional Concept]
  1000   C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.390: Biochim Biophys Acta 1364: 271-286, 1998[ISI][Medline]. 

Phrase: "Biochim Biophys Acta 1364"

Phrase: ":"

Phrase: "271-286,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.391: 35.  

Phrase: "35."
Processing 00000000.tx.392: Rockman, HA, Chien KR, Choi DJ, Iaccarino G, Hunter JJ, Ross J, Jr., Lefkowitz RJ, and Koch WJ. 

Phrase: "Rockman,"

Phrase: "HA,"

Phrase: "Chien KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Choi DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Iaccarino G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Hunter JJ,"

Phrase: "Ross J,"

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Lefkowitz RJ,"

Phrase: "and"

Phrase: "Koch WJ."
Processing 00000000.tx.393: Expression of a beta-adrenergic receptor kinase 1inhibitor prevents the development of myocardial failure in gene-targeted mice. 

Phrase: "Expression of a beta-adrenergic receptor kinase 1inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the development of myocardial failure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "in gene-targeted mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.394: Proc Natl Acad Sci USA 95: 7000-7005, 1998[Abstract/Free FullText]. 

Phrase: "Proc Natl Acad Sci USA 95"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "7000-7005,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.395: 36.  

Phrase: "36."
Processing 00000000.tx.396: Sipido, KR. 

Phrase: "Sipido,"

Phrase: "KR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022773:KR [Geographic Area]
Processing 00000000.tx.397: Local Ca2+ release in heart failure: timing is important. 

Phrase: "Local Ca2+ release in heart failure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "timing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449243:Timing [Temporal Concept]
  1000   C1704250:Timing [Conceptual Entity]

Phrase: "is"

Phrase: "important."
Processing 00000000.tx.398: Circ Res 87: 966-968, 2000[Free FullText]. 

Phrase: "Circ Res 87"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "966-968,"

Phrase: "2000"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.399: 37.  

Phrase: "37."
Processing 00000000.tx.400: Sordahl, LA, McCollum WB, Wood WG, and Schwartz A. 

Phrase: "Sordahl,"

Phrase: "LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023031:La [Element, Ion, or Isotope]

Phrase: "McCollum WB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582525:Wb [Quantitative Concept]

Phrase: "Wood WG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043092:WG [Disease or Syndrome]

Phrase: "and"

Phrase: "Schwartz A."
Processing 00000000.tx.401: Mitochondria and sarcoplasmic reticulum function in cardiac hypertrophy and failure. 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "and"

Phrase: "sarcoplasmic reticulum function in cardiac hypertrophy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0232164:Cardiac function [Organ or Tissue Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "failure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231174:Failure [Functional Concept]
  1000   C0680095:failure [Individual Behavior]
Processing 00000000.tx.402: Am J Physiol 224: 497-502, 1973[Free FullText]. 

Phrase: "Am"

Phrase: "J Physiol 224"

Phrase: ":"

Phrase: "497-502,"

Phrase: "1973"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.403: 38.  

Phrase: "38."
Processing 00000000.tx.404: Tardiff, JC, Factor SM, Tompkins BD, Hewett TE, Palmer BM, Moore RL, Schwartz S, Robbins J, and Leinwand LA. 

Phrase: "Tardiff,"

Phrase: "JC,"

Phrase: "Factor SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Tompkins BD,"

Phrase: "Hewett TE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C1705540:TE [Conceptual Entity]

Phrase: "Palmer BM,"

Phrase: "Moore RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Schwartz S,"

Phrase: "Robbins J,"

Phrase: "and"

Phrase: "Leinwand LA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]
Processing 00000000.tx.405: A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. 

Phrase: "A truncated cardiac troponin T molecule in transgenic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0567416:Molecule [Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "multiple cellular mechanisms for familial hypertrophic cardiomyopathy."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.406: J Clin Invest 101: 2800-2811, 1998[Abstract/Free FullText]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "101"

Phrase: ":"

Phrase: "2800-2811,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.407: 39.  

Phrase: "39."
Processing 00000000.tx.408: Tardiff, JC, Hewett TE, Factor SM, Vikstrom KL, Robbins J, and Leinwand LA. 

Phrase: "Tardiff,"

Phrase: "JC,"

Phrase: "Hewett TE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C1705540:TE [Conceptual Entity]

Phrase: "Factor SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Vikstrom KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Robbins J,"

Phrase: "and"

Phrase: "Leinwand LA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]
Processing 00000000.tx.409: Expression of the (slow) isoform of MyHC in the adult mouse heart results in dominant functional effects. 

Phrase: "Expression of the (slow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "isoform of MyHC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "in the adult mouse heart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1512359:Mouse Heart [Tissue]
   827   C0018787:Heart [Body Part, Organ, or Organ Component]
   827   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "results in dominant functional effects."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0205245:Functional [Functional Concept]
   760   C0542341:Functional [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1280500:effects [Qualitative Concept]
   760   C1527180:Dominant [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2700217:Functional [Conceptual Entity]
   760   C2825142:Result [Finding]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.410: Am J Physiol Heart Circ Physiol 278: H412-H419, 2000[Abstract/Free FullText]. 

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 278"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "H412-H419,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.411: 40.  

Phrase: "40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.412: Tardiff, JC, Hewett TE, Palmer BM, Olsson C, Factor SM, Moore RL, Robbins J, and Leinwand LA. 

Phrase: "Tardiff,"

Phrase: "JC,"

Phrase: "Hewett TE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039462:Te [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C1705540:TE [Conceptual Entity]

Phrase: "Palmer BM,"

Phrase: "Olsson C,"

Phrase: "Factor SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Moore RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Robbins J,"

Phrase: "and"

Phrase: "Leinwand LA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]
Processing 00000000.tx.413: Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. 

Phrase: "Cardiac troponin T mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "result in allele-specific phenotypes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0002085:Allele [Gene or Genome]
   760   C0031437:Phenotypes [Organism Attribute]
   760   C0205369:Specific [Qualitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1552740:specific [Intellectual Product]
   760   C2825142:Result [Finding]
   726 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "in a mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "for hypertrophic cardiomyopathy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   861   C0020564:Hypertrophic [Pathologic Function]
   861   C0333959:Hypertrophic [Functional Concept]
   861   C0878544:Cardiomyopathy [Disease or Syndrome]
Processing 00000000.tx.414: J Clin Invest 104: 469-481, 1999[Abstract/Free FullText]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "104"

Phrase: ":"

Phrase: "469-481,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.415: 41.  

Phrase: "41."
Processing 00000000.tx.416: Thierfelder, L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, and Seidman CE. 

Phrase: "Thierfelder,"

Phrase: "L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Watkins H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "MacRae C,"

Phrase: "Lamas R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "McKenna W,"

Phrase: "Vosberg HP,"

Phrase: "Seidman JG,"

Phrase: "and"

Phrase: "Seidman CE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]
Processing 00000000.tx.417: -Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. 

Phrase: "-Tropomyosin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041197:Tropomyosin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "cardiac troponin T mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C0522086:Cardiac troponin T [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "familial hypertrophic cardiomyopathy"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0949658:Cardiomyopathy, Hypertrophic, Familial [Disease or Syndrome]
   913   C0264789:Familial cardiomyopathy [Disease or Syndrome]
   901   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0020564:Hypertrophic [Pathologic Function]
   827   C0241888:Familial [Functional Concept]
   827   C0333959:Hypertrophic [Functional Concept]
   827   C0878544:Cardiomyopathy [Disease or Syndrome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ":"

Phrase: "a disease of the sarcomere."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.418: Cell 77: 701-712, 1994[ISI][Medline]. 

Phrase: "Cell 77"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "701-712,"

Phrase: "1994"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.419: 42.  

Phrase: "42."
Processing 00000000.tx.420: Towbin, JA. 

Phrase: "Towbin,"

Phrase: "JA."
Processing 00000000.tx.421: The role of cytoskeletal proteins in cardiomyopathies. 

Phrase: "The role of cytoskeletal proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in cardiomyopathies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878544:Cardiomyopathies [Disease or Syndrome]
Processing 00000000.tx.422: Curr Opin Cell Biol 10: 131-139, 1998[ISI][Medline]. 

Phrase: "Curr Opin Cell Biol 10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "131-139,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.423: 43.  

Phrase: "43."
Processing 00000000.tx.424: Vikstrom, KL, Factor SM, and Leinwand LA. 

Phrase: "Vikstrom,"

Phrase: "KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1366480:KL [Gene or Genome]
  1000   C1416656:KL [Gene or Genome]

Phrase: "Factor SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "and"

Phrase: "Leinwand LA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]
Processing 00000000.tx.425: Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "mutant myosin heavy chains"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0027100:Myosin Heavy Chains [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420192:heavy chain [Gene or Genome]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:chains [Manufactured Object]
   812   C0439539:Heavy [Qualitative Concept]
   812   C1524075:Chains [Idea or Concept]

Phrase: "are"

Phrase: "a model for familial hypertrophic cardiomyopathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C3161035:Model [Intellectual Product]
   748   C3640174:Model Family [Intellectual Product]
Processing 00000000.tx.426: Mol Med 2: 556-567, 1996[ISI][Medline]. 

Phrase: "Mol Med 2"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "556-567,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.427: 44.  

Phrase: "44."
Processing 00000000.tx.428: Wallace, DC. 

Phrase: "Wallace,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331925:Wallace [Health Care Related Organization]

Phrase: "DC."
Processing 00000000.tx.429: Mitochondrial diseases in man and mouse. 

Phrase: "Mitochondrial diseases in man"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0751651:Mitochondrial Diseases [Disease or Syndrome]
   770   C0012634:Diseases [Disease or Syndrome]
   770   C0026237:Mitochondrial [Cell Component]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "and"

Phrase: "mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]
Processing 00000000.tx.430: Science 283: 1482-1488, 1999[Abstract/Free FullText]. 

Phrase: "Science 283"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1482-1488,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.431: 45.  

Phrase: "45."
Processing 00000000.tx.432: Watkins, H, Seidman JG, and Seidman CE. 

Phrase: "Watkins,"

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Seidman JG,"

Phrase: "and"

Phrase: "Seidman CE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]
Processing 00000000.tx.433: Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. 

Phrase: "Familial hypertrophic cardiomyopathy"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0949658:Cardiomyopathy, Hypertrophic, Familial [Disease or Syndrome]
   913   C0264789:Familial cardiomyopathy [Disease or Syndrome]
   901   C0007194:Hypertrophic Cardiomyopathy [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0020564:Hypertrophic [Pathologic Function]
   827   C0241888:Familial [Functional Concept]
   827   C0333959:Hypertrophic [Functional Concept]
   827   C0878544:Cardiomyopathy [Disease or Syndrome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ":"

Phrase: "a genetic model of cardiac hypertrophy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026343:Model, Genetic [Intellectual Product]
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.434: Hum Mol Genet 4: 1721-1727, 1995[Abstract]. 

Phrase: "Hum Mol Genet 4"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0325074:Genet [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "1721-1727,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.435: 46.  

Phrase: "46."
Processing 00000000.tx.436: Zeviani, M, Mariotti C, Antozzi C, Fratta GM, Rustin P, and Prelle A. 

Phrase: "Zeviani,"

Phrase: "M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "Mariotti C,"

Phrase: "Antozzi C,"

Phrase: "Fratta GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Rustin P,"

Phrase: "and"

Phrase: "Prelle A."
Processing 00000000.tx.437: OXPHOS defects and mitochondrial DNA mutations in cardiomyopathy. 

Phrase: "OXPHOS defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243067:defects [Functional Concept]
   827 E C1457869:Defect [Functional Concept]
   827 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "mitochondrial DNA mutations in cardiomyopathy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C2315666:Mitochondrial mutation [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.438: Muscle Nerve 3: S170-S174, 1995[Medline]. 

Phrase: "Muscle Nerve 3"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0026845:Muscle [Tissue]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: ":"

Phrase: "S170-S174,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.439: Am J Physiol Heart Circ Physiol 284(2):H575-H583 0363-6135/03 $5.00 Copyright  2003 the American Physiological Society

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 284"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ":"

Phrase: "H575-H583 0363-6135/03 $5.00 Copyright  2003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0009993:Copyright [Intellectual Product]
   791   C1552856:copyright [Idea or Concept]

Phrase: "the American Physiological Society"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0037455:society [Organization]
   827   C0205463:Physiological [Functional Concept]
   827   C0596070:American [Population Group]
   755 E C0031842:Physiology [Biomedical Occupation or Discipline]
   755 E C0031843:physiology [Physiologic Function]

